#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


#Text=The brain's functional connectome in young children with prenatal alcohol exposure
#Text=Highlights
#Text=We used fMRI to study young children with prenatal alcohol exposure (PAE).
1-1	0-3	The	_	
1-2	4-11	brain's	_	
1-3	12-22	functional	_	
1-4	23-33	connectome	_	
1-5	34-36	in	_	
1-6	37-42	young	_	
1-7	43-51	children	_	
1-8	52-56	with	_	
1-9	57-65	prenatal	_	
1-10	66-73	alcohol	_	
1-11	74-82	exposure	_	
1-12	83-93	Highlights	_	
1-13	94-96	We	_	
1-14	97-101	used	_	
1-15	102-106	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging	
1-16	107-109	to	_	
1-17	110-115	study	_	
1-18	116-121	young	_	
1-19	122-130	children	_	
1-20	131-135	with	_	
1-21	136-144	prenatal	_	
1-22	145-152	alcohol	_	
1-23	153-161	exposure	_	
1-24	162-163	(	_	
1-25	163-166	PAE	_	
1-26	166-167	)	_	
1-27	167-168	.	_	

#Text=We measured the functional connectome and its stability within and across participants.
2-1	169-171	We	_	
2-2	172-180	measured	_	
2-3	181-184	the	_	
2-4	185-195	functional	_	
2-5	196-206	connectome	_	
2-6	207-210	and	_	
2-7	211-214	its	_	
2-8	215-224	stability	_	
2-9	225-231	within	_	
2-10	232-235	and	_	
2-11	236-242	across	_	
2-12	243-255	participants	_	
2-13	255-256	.	_	

#Text=The PAE group had similar graph theory metrics to controls.
3-1	257-260	The	_	
3-2	261-264	PAE	_	
3-3	265-270	group	_	
3-4	271-274	had	_	
3-5	275-282	similar	_	
3-6	283-288	graph	_	
3-7	289-295	theory	_	
3-8	296-303	metrics	_	
3-9	304-306	to	_	
3-10	307-315	controls	_	
3-11	315-316	.	_	

#Text=The PAE group, but not controls, had increasing intra-participant stability with age.
4-1	317-320	The	_	
4-2	321-324	PAE	_	
4-3	325-330	group	_	
4-4	330-331	,	_	
4-5	332-335	but	_	
4-6	336-339	not	_	
4-7	340-348	controls	_	
4-8	348-349	,	_	
4-9	350-353	had	_	
4-10	354-364	increasing	_	
4-11	365-382	intra-participant	_	
4-12	383-392	stability	_	
4-13	393-397	with	_	
4-14	398-401	age	_	
4-15	401-402	.	_	

#Text=Controls, but not the PAE group, had increasing inter-participant stability with age.
5-1	403-411	Controls	_	
5-2	411-412	,	_	
5-3	413-416	but	_	
5-4	417-420	not	_	
5-5	421-424	the	_	
5-6	425-428	PAE	_	
5-7	429-434	group	_	
5-8	434-435	,	_	
5-9	436-439	had	_	
5-10	440-450	increasing	_	
5-11	451-468	inter-participant	_	
5-12	469-478	stability	_	
5-13	479-483	with	_	
5-14	484-487	age	_	
5-15	487-488	.	_	

#Text=Prenatal alcohol exposure (PAE) can lead to altered brain function and structure, as well as lifelong cognitive, behavioral, and mental health difficulties.
6-1	489-497	Prenatal	_	
6-2	498-505	alcohol	_	
6-3	506-514	exposure	_	
6-4	515-516	(	_	
6-5	516-519	PAE	_	
6-6	519-520	)	_	
6-7	521-524	can	_	
6-8	525-529	lead	_	
6-9	530-532	to	_	
6-10	533-540	altered	_	
6-11	541-546	brain	_	
6-12	547-555	function	_	
6-13	556-559	and	_	
6-14	560-569	structure	_	
6-15	569-570	,	_	
6-16	571-573	as	_	
6-17	574-578	well	_	
6-18	579-581	as	_	
6-19	582-590	lifelong	_	
6-20	591-600	cognitive	_	
6-21	600-601	,	_	
6-22	602-612	behavioral	_	
6-23	612-613	,	_	
6-24	614-617	and	_	
6-25	618-624	mental	_	
6-26	625-631	health	_	
6-27	632-644	difficulties	_	
6-28	644-645	.	_	

#Text=Previous research has shown reduced brain network efficiency in older children and adolescents with PAE, but no imaging studies have examined brain differences in young children with PAE, at an age when cognitive and behavioral problems often first become apparent.
7-1	646-654	Previous	_	
7-2	655-663	research	_	
7-3	664-667	has	_	
7-4	668-673	shown	_	
7-5	674-681	reduced	_	
7-6	682-687	brain	_	
7-7	688-695	network	_	
7-8	696-706	efficiency	_	
7-9	707-709	in	_	
7-10	710-715	older	_	
7-11	716-724	children	_	
7-12	725-728	and	_	
7-13	729-740	adolescents	_	
7-14	741-745	with	_	
7-15	746-749	PAE	_	
7-16	749-750	,	_	
7-17	751-754	but	_	
7-18	755-757	no	_	
7-19	758-765	imaging	_	
7-20	766-773	studies	_	
7-21	774-778	have	_	
7-22	779-787	examined	_	
7-23	788-793	brain	_	
7-24	794-805	differences	_	
7-25	806-808	in	_	
7-26	809-814	young	_	
7-27	815-823	children	_	
7-28	824-828	with	_	
7-29	829-832	PAE	_	
7-30	832-833	,	_	
7-31	834-836	at	_	
7-32	837-839	an	_	
7-33	840-843	age	_	
7-34	844-848	when	_	
7-35	849-858	cognitive	_	
7-36	859-862	and	_	
7-37	863-873	behavioral	_	
7-38	874-882	problems	_	
7-39	883-888	often	_	
7-40	889-894	first	_	
7-41	895-901	become	_	
7-42	902-910	apparent	_	
7-43	910-911	.	_	

#Text=The present study aimed to investigate the brain's functional connectome in young children with PAE using passive viewing fMRI.
8-1	912-915	The	_	
8-2	916-923	present	_	
8-3	924-929	study	_	
8-4	930-935	aimed	_	
8-5	936-938	to	_	
8-6	939-950	investigate	_	
8-7	951-954	the	_	
8-8	955-962	brain's	_	
8-9	963-973	functional	_	
8-10	974-984	connectome	_	
8-11	985-987	in	_	
8-12	988-993	young	_	
8-13	994-1002	children	_	
8-14	1003-1007	with	_	
8-15	1008-1011	PAE	_	
8-16	1012-1017	using	_	
8-17	1018-1025	passive	_	
8-18	1026-1033	viewing	_	
8-19	1034-1038	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging	
8-20	1038-1039	.	_	

#Text=We analyzed 34 datasets from 26 children with PAE aged 2–7 years and 215 datasets from 87 unexposed typically-developing children in the same age range.
9-1	1040-1042	We	_	
9-2	1043-1051	analyzed	_	
9-3	1052-1054	34	_	
9-4	1055-1063	datasets	_	
9-5	1064-1068	from	_	
9-6	1069-1071	26	_	
9-7	1072-1080	children	_	
9-8	1081-1085	with	_	
9-9	1086-1089	PAE	_	
9-10	1090-1094	aged	_	
9-11	1095-1096	2	_	
9-12	1096-1097	–	_	
9-13	1097-1098	7	_	
9-14	1099-1104	years	_	
9-15	1105-1108	and	_	
9-16	1109-1112	215	_	
9-17	1113-1121	datasets	_	
9-18	1122-1126	from	_	
9-19	1127-1129	87	_	
9-20	1130-1139	unexposed	_	
9-21	1140-1160	typically-developing	_	
9-22	1161-1169	children	_	
9-23	1170-1172	in	_	
9-24	1173-1176	the	_	
9-25	1177-1181	same	_	
9-26	1182-1185	age	_	
9-27	1186-1191	range	_	
9-28	1191-1192	.	_	

#Text=The whole brain functional connectome was constructed using functional connectivity analysis across 90 regions for each dataset.
10-1	1193-1196	The	_	
10-2	1197-1202	whole	_	
10-3	1203-1208	brain	_	
10-4	1209-1219	functional	_	
10-5	1220-1230	connectome	_	
10-6	1231-1234	was	_	
10-7	1235-1246	constructed	_	
10-8	1247-1252	using	_	
10-9	1253-1263	functional	_	
10-10	1264-1276	connectivity	_	
10-11	1277-1285	analysis	_	
10-12	1286-1292	across	_	
10-13	1293-1295	90	_	
10-14	1296-1303	regions	_	
10-15	1304-1307	for	_	
10-16	1308-1312	each	_	
10-17	1313-1320	dataset	_	
10-18	1320-1321	.	_	

#Text=We examined intra- and inter-participant stability of the functional connectome, graph theoretical measurements, and their correlations with age.
11-1	1322-1324	We	_	
11-2	1325-1333	examined	_	
11-3	1334-1339	intra	_	
11-4	1339-1340	-	_	
11-5	1341-1344	and	_	
11-6	1345-1362	inter-participant	_	
11-7	1363-1372	stability	_	
11-8	1373-1375	of	_	
11-9	1376-1379	the	_	
11-10	1380-1390	functional	_	
11-11	1391-1401	connectome	_	
11-12	1401-1402	,	_	
11-13	1403-1408	graph	_	
11-14	1409-1420	theoretical	_	
11-15	1421-1433	measurements	_	
11-16	1433-1434	,	_	
11-17	1435-1438	and	_	
11-18	1439-1444	their	_	
11-19	1445-1457	correlations	_	
11-20	1458-1462	with	_	
11-21	1463-1466	age	_	
11-22	1466-1467	.	_	

#Text=Children with PAE had similar inter- and intra-participant stability to controls.
12-1	1468-1476	Children	_	
12-2	1477-1481	with	_	
12-3	1482-1485	PAE	_	
12-4	1486-1489	had	_	
12-5	1490-1497	similar	_	
12-6	1498-1503	inter	_	
12-7	1503-1504	-	_	
12-8	1505-1508	and	_	
12-9	1509-1526	intra-participant	_	
12-10	1527-1536	stability	_	
12-11	1537-1539	to	_	
12-12	1540-1548	controls	_	
12-13	1548-1549	.	_	

#Text=However, children with PAE, but not controls, showed increasing intra-participant stability with age, suggesting a lack of variability of intrinsic brain activity over time.
13-1	1550-1557	However	_	
13-2	1557-1558	,	_	
13-3	1559-1567	children	_	
13-4	1568-1572	with	_	
13-5	1573-1576	PAE	_	
13-6	1576-1577	,	_	
13-7	1578-1581	but	_	
13-8	1582-1585	not	_	
13-9	1586-1594	controls	_	
13-10	1594-1595	,	_	
13-11	1596-1602	showed	_	
13-12	1603-1613	increasing	_	
13-13	1614-1631	intra-participant	_	
13-14	1632-1641	stability	_	
13-15	1642-1646	with	_	
13-16	1647-1650	age	_	
13-17	1650-1651	,	_	
13-18	1652-1662	suggesting	_	
13-19	1663-1664	a	_	
13-20	1665-1669	lack	_	
13-21	1670-1672	of	_	
13-22	1673-1684	variability	_	
13-23	1685-1687	of	_	
13-24	1688-1697	intrinsic	_	
13-25	1698-1703	brain	_	
13-26	1704-1712	activity	_	
13-27	1713-1717	over	_	
13-28	1718-1722	time	_	
13-29	1722-1723	.	_	

#Text=Inter-participant stability increased with age in controls but not in children with PAE, indicating more variability of brain function across the PAE population.
14-1	1724-1741	Inter-participant	_	
14-2	1742-1751	stability	_	
14-3	1752-1761	increased	_	
14-4	1762-1766	with	_	
14-5	1767-1770	age	_	
14-6	1771-1773	in	_	
14-7	1774-1782	controls	_	
14-8	1783-1786	but	_	
14-9	1787-1790	not	_	
14-10	1791-1793	in	_	
14-11	1794-1802	children	_	
14-12	1803-1807	with	_	
14-13	1808-1811	PAE	_	
14-14	1811-1812	,	_	
14-15	1813-1823	indicating	_	
14-16	1824-1828	more	_	
14-17	1829-1840	variability	_	
14-18	1841-1843	of	_	
14-19	1844-1849	brain	_	
14-20	1850-1858	function	_	
14-21	1859-1865	across	_	
14-22	1866-1869	the	_	
14-23	1870-1873	PAE	_	
14-24	1874-1884	population	_	
14-25	1884-1885	.	_	

#Text=Global graph metrics were similar between children with PAE and controls, in line with previous studies in older children.
15-1	1886-1892	Global	_	
15-2	1893-1898	graph	_	
15-3	1899-1906	metrics	_	
15-4	1907-1911	were	_	
15-5	1912-1919	similar	_	
15-6	1920-1927	between	_	
15-7	1928-1936	children	_	
15-8	1937-1941	with	_	
15-9	1942-1945	PAE	_	
15-10	1946-1949	and	_	
15-11	1950-1958	controls	_	
15-12	1958-1959	,	_	
15-13	1960-1962	in	_	
15-14	1963-1967	line	_	
15-15	1968-1972	with	_	
15-16	1973-1981	previous	_	
15-17	1982-1989	studies	_	
15-18	1990-1992	in	_	
15-19	1993-1998	older	_	
15-20	1999-2007	children	_	
15-21	2007-2008	.	_	

#Text=This study characterizes the functional connectome in young children with PAE for the first time, suggesting that the increased brain variability seen in older children develops early in childhood, when participants with PAE fail to show the expected age-related increases in inter-individual stability.
16-1	2009-2013	This	_	
16-2	2014-2019	study	_	
16-3	2020-2033	characterizes	_	
16-4	2034-2037	the	_	
16-5	2038-2048	functional	_	
16-6	2049-2059	connectome	_	
16-7	2060-2062	in	_	
16-8	2063-2068	young	_	
16-9	2069-2077	children	_	
16-10	2078-2082	with	_	
16-11	2083-2086	PAE	_	
16-12	2087-2090	for	_	
16-13	2091-2094	the	_	
16-14	2095-2100	first	_	
16-15	2101-2105	time	_	
16-16	2105-2106	,	_	
16-17	2107-2117	suggesting	_	
16-18	2118-2122	that	_	
16-19	2123-2126	the	_	
16-20	2127-2136	increased	_	
16-21	2137-2142	brain	_	
16-22	2143-2154	variability	_	
16-23	2155-2159	seen	_	
16-24	2160-2162	in	_	
16-25	2163-2168	older	_	
16-26	2169-2177	children	_	
16-27	2178-2186	develops	_	
16-28	2187-2192	early	_	
16-29	2193-2195	in	_	
16-30	2196-2205	childhood	_	
16-31	2205-2206	,	_	
16-32	2207-2211	when	_	
16-33	2212-2224	participants	_	
16-34	2225-2229	with	_	
16-35	2230-2233	PAE	_	
16-36	2234-2238	fail	_	
16-37	2239-2241	to	_	
16-38	2242-2246	show	_	
16-39	2247-2250	the	_	
16-40	2251-2259	expected	_	
16-41	2260-2271	age-related	_	
16-42	2272-2281	increases	_	
16-43	2282-2284	in	_	
16-44	2285-2301	inter-individual	_	
16-45	2302-2311	stability	_	
16-46	2311-2312	.	_	

#Text=Introduction
#Text=Children with prenatal alcohol exposure (PAE) can have difficulties with language, attention, learning, and behavior compared to unexposed children.
17-1	2313-2325	Introduction	_	
17-2	2326-2334	Children	_	
17-3	2335-2339	with	_	
17-4	2340-2348	prenatal	_	
17-5	2349-2356	alcohol	_	
17-6	2357-2365	exposure	_	
17-7	2366-2367	(	_	
17-8	2367-2370	PAE	_	
17-9	2370-2371	)	_	
17-10	2372-2375	can	_	
17-11	2376-2380	have	_	
17-12	2381-2393	difficulties	_	
17-13	2394-2398	with	_	
17-14	2399-2407	language	_	
17-15	2407-2408	,	_	
17-16	2409-2418	attention	_	
17-17	2418-2419	,	_	
17-18	2420-2428	learning	_	
17-19	2428-2429	,	_	
17-20	2430-2433	and	_	
17-21	2434-2442	behavior	_	
17-22	2443-2451	compared	_	
17-23	2452-2454	to	_	
17-24	2455-2464	unexposed	_	
17-25	2465-2473	children	_	
17-26	2473-2474	.	_	

#Text=Structural magnetic resonance imaging (MRI) studies have shown brain alterations underlying these difficulties in children with PAE, including decreased total brain volume, increased and decreased cortical thickness, and altered white matter microstructure (lower fractional anisotropy and/or higher mean diffusivity).
18-1	2475-2485	Structural	_	
18-2	2486-2494	magnetic	_	
18-3	2495-2504	resonance	_	
18-4	2505-2512	imaging	_	
18-5	2513-2514	(	_	
18-6	2514-2517	MRI	_	
18-7	2517-2518	)	_	
18-8	2519-2526	studies	_	
18-9	2527-2531	have	_	
18-10	2532-2537	shown	_	
18-11	2538-2543	brain	_	
18-12	2544-2555	alterations	_	
18-13	2556-2566	underlying	_	
18-14	2567-2572	these	_	
18-15	2573-2585	difficulties	_	
18-16	2586-2588	in	_	
18-17	2589-2597	children	_	
18-18	2598-2602	with	_	
18-19	2603-2606	PAE	_	
18-20	2606-2607	,	_	
18-21	2608-2617	including	_	
18-22	2618-2627	decreased	_	
18-23	2628-2633	total	_	
18-24	2634-2639	brain	_	
18-25	2640-2646	volume	_	
18-26	2646-2647	,	_	
18-27	2648-2657	increased	_	
18-28	2658-2661	and	_	
18-29	2662-2671	decreased	_	
18-30	2672-2680	cortical	_	
18-31	2681-2690	thickness	_	
18-32	2690-2691	,	_	
18-33	2692-2695	and	_	
18-34	2696-2703	altered	_	
18-35	2704-2709	white	_	
18-36	2710-2716	matter	_	
18-37	2717-2731	microstructure	_	
18-38	2732-2733	(	_	
18-39	2733-2738	lower	_	
18-40	2739-2749	fractional	_	
18-41	2750-2760	anisotropy	_	
18-42	2761-2764	and	_	
18-43	2764-2765	/	_	
18-44	2765-2767	or	_	
18-45	2768-2774	higher	_	
18-46	2775-2779	mean	_	
18-47	2780-2791	diffusivity	_	
18-48	2791-2792	)	_	
18-49	2792-2793	.	_	

#Text=Functional MRI studies show that PAE is associated with altered functional connectivity at rest in infants, children and youth, and adults, as well as both increased and decreased functional connectivity within brain networks during working memory tasks.
19-1	2794-2804	Functional	_	
19-2	2805-2808	MRI	_	
19-3	2809-2816	studies	_	
19-4	2817-2821	show	_	
19-5	2822-2826	that	_	
19-6	2827-2830	PAE	_	
19-7	2831-2833	is	_	
19-8	2834-2844	associated	_	
19-9	2845-2849	with	_	
19-10	2850-2857	altered	_	
19-11	2858-2868	functional	_	
19-12	2869-2881	connectivity	_	
19-13	2882-2884	at	_	
19-14	2885-2889	rest	_	
19-15	2890-2892	in	_	
19-16	2893-2900	infants	_	
19-17	2900-2901	,	_	
19-18	2902-2910	children	_	
19-19	2911-2914	and	_	
19-20	2915-2920	youth	_	
19-21	2920-2921	,	_	
19-22	2922-2925	and	_	
19-23	2926-2932	adults	_	
19-24	2932-2933	,	_	
19-25	2934-2936	as	_	
19-26	2937-2941	well	_	
19-27	2942-2944	as	_	
19-28	2945-2949	both	_	
19-29	2950-2959	increased	_	
19-30	2960-2963	and	_	
19-31	2964-2973	decreased	_	
19-32	2974-2984	functional	_	
19-33	2985-2997	connectivity	_	
19-34	2998-3004	within	_	
19-35	3005-3010	brain	_	
19-36	3011-3019	networks	_	
19-37	3020-3026	during	_	
19-38	3027-3034	working	_	
19-39	3035-3041	memory	_	
19-40	3042-3047	tasks	_	
19-41	3047-3048	.	_	

#Text=However, no MRI studies have examined brain functional connectivity in young children with PAE (i.e., 2–6 years).
20-1	3049-3056	However	_	
20-2	3056-3057	,	_	
20-3	3058-3060	no	_	
20-4	3061-3064	MRI	_	
20-5	3065-3072	studies	_	
20-6	3073-3077	have	_	
20-7	3078-3086	examined	_	
20-8	3087-3092	brain	_	
20-9	3093-3103	functional	_	
20-10	3104-3116	connectivity	_	
20-11	3117-3119	in	_	
20-12	3120-3125	young	_	
20-13	3126-3134	children	_	
20-14	3135-3139	with	_	
20-15	3140-3143	PAE	_	
20-16	3144-3145	(	_	
20-17	3145-3148	i.e	_	
20-18	3148-3149	.	_	
20-19	3149-3150	,	_	
20-20	3151-3152	2	_	
20-21	3152-3153	–	_	
20-22	3153-3154	6	_	
20-23	3155-3160	years	_	
20-24	3160-3161	)	_	
20-25	3161-3162	.	_	

#Text=Cognitive and behavioral problems in individuals with PAE can persist throughout life, but often first become apparent in early childhood.
21-1	3163-3172	Cognitive	_	
21-2	3173-3176	and	_	
21-3	3177-3187	behavioral	_	
21-4	3188-3196	problems	_	
21-5	3197-3199	in	_	
21-6	3200-3211	individuals	_	
21-7	3212-3216	with	_	
21-8	3217-3220	PAE	_	
21-9	3221-3224	can	_	
21-10	3225-3232	persist	_	
21-11	3233-3243	throughout	_	
21-12	3244-3248	life	_	
21-13	3248-3249	,	_	
21-14	3250-3253	but	_	
21-15	3254-3259	often	_	
21-16	3260-3265	first	_	
21-17	3266-3272	become	_	
21-18	3273-3281	apparent	_	
21-19	3282-3284	in	_	
21-20	3285-3290	early	_	
21-21	3291-3300	childhood	_	
21-22	3300-3301	.	_	

#Text=Identifying emerging differences in brain function during this critical stage is important to understanding the origins of later abnormalities.
22-1	3302-3313	Identifying	_	
22-2	3314-3322	emerging	_	
22-3	3323-3334	differences	_	
22-4	3335-3337	in	_	
22-5	3338-3343	brain	_	
22-6	3344-3352	function	_	
22-7	3353-3359	during	_	
22-8	3360-3364	this	_	
22-9	3365-3373	critical	_	
22-10	3374-3379	stage	_	
22-11	3380-3382	is	_	
22-12	3383-3392	important	_	
22-13	3393-3395	to	_	
22-14	3396-3409	understanding	_	
22-15	3410-3413	the	_	
22-16	3414-3421	origins	_	
22-17	3422-3424	of	_	
22-18	3425-3430	later	_	
22-19	3431-3444	abnormalities	_	
22-20	3444-3445	.	_	

#Text=Recently, the use of graph-theory based analysis to study brain development has attracted attention.
23-1	3446-3454	Recently	_	
23-2	3454-3455	,	_	
23-3	3456-3459	the	_	
23-4	3460-3463	use	_	
23-5	3464-3466	of	_	
23-6	3467-3479	graph-theory	_	
23-7	3480-3485	based	_	
23-8	3486-3494	analysis	_	
23-9	3495-3497	to	_	
23-10	3498-3503	study	_	
23-11	3504-3509	brain	_	
23-12	3510-3521	development	_	
23-13	3522-3525	has	_	
23-14	3526-3535	attracted	_	
23-15	3536-3545	attention	_	
23-16	3545-3546	.	_	

#Text=This approach constructs a connectivity matrix representing brain regions and their structural or functional connections with each other, and then quantifies the topological features of this connectivity matrix, or graph.
24-1	3547-3551	This	_	
24-2	3552-3560	approach	_	
24-3	3561-3571	constructs	_	
24-4	3572-3573	a	_	
24-5	3574-3586	connectivity	_	
24-6	3587-3593	matrix	_	
24-7	3594-3606	representing	_	
24-8	3607-3612	brain	_	
24-9	3613-3620	regions	_	
24-10	3621-3624	and	_	
24-11	3625-3630	their	_	
24-12	3631-3641	structural	_	
24-13	3642-3644	or	_	
24-14	3645-3655	functional	_	
24-15	3656-3667	connections	_	
24-16	3668-3672	with	_	
24-17	3673-3677	each	_	
24-18	3678-3683	other	_	
24-19	3683-3684	,	_	
24-20	3685-3688	and	_	
24-21	3689-3693	then	_	
24-22	3694-3704	quantifies	_	
24-23	3705-3708	the	_	
24-24	3709-3720	topological	_	
24-25	3721-3729	features	_	
24-26	3730-3732	of	_	
24-27	3733-3737	this	_	
24-28	3738-3750	connectivity	_	
24-29	3751-3757	matrix	_	
24-30	3757-3758	,	_	
24-31	3759-3761	or	_	
24-32	3762-3767	graph	_	
24-33	3767-3768	.	_	

#Text=An increasing number of studies have investigated the development of the brain's functional connectome from infancy to adulthood.
25-1	3769-3771	An	_	
25-2	3772-3782	increasing	_	
25-3	3783-3789	number	_	
25-4	3790-3792	of	_	
25-5	3793-3800	studies	_	
25-6	3801-3805	have	_	
25-7	3806-3818	investigated	_	
25-8	3819-3822	the	_	
25-9	3823-3834	development	_	
25-10	3835-3837	of	_	
25-11	3838-3841	the	_	
25-12	3842-3849	brain's	_	
25-13	3850-3860	functional	_	
25-14	3861-3871	connectome	_	
25-15	3872-3876	from	_	
25-16	3877-3884	infancy	_	
25-17	3885-3887	to	_	
25-18	3888-3897	adulthood	_	
25-19	3897-3898	.	_	

#Text=While functional brain abnormalities are evident in school-age children and youth with PAE, very little previous research has investigated how PAE alters the brain's functional connectome.
26-1	3899-3904	While	_	
26-2	3905-3915	functional	_	
26-3	3916-3921	brain	_	
26-4	3922-3935	abnormalities	_	
26-5	3936-3939	are	_	
26-6	3940-3947	evident	_	
26-7	3948-3950	in	_	
26-8	3951-3961	school-age	_	
26-9	3962-3970	children	_	
26-10	3971-3974	and	_	
26-11	3975-3980	youth	_	
26-12	3981-3985	with	_	
26-13	3986-3989	PAE	_	
26-14	3989-3990	,	_	
26-15	3991-3995	very	_	
26-16	3996-4002	little	_	
26-17	4003-4011	previous	_	
26-18	4012-4020	research	_	
26-19	4021-4024	has	_	
26-20	4025-4037	investigated	_	
26-21	4038-4041	how	_	
26-22	4042-4045	PAE	_	
26-23	4046-4052	alters	_	
26-24	4053-4056	the	_	
26-25	4057-4064	brain's	_	
26-26	4065-4075	functional	_	
26-27	4076-4086	connectome	_	
26-28	4086-4087	.	_	

#Text=One previous study showed reduced global efficiency and higher path length in youth aged 10–17 years with PAE compared to unexposed controls.
27-1	4088-4091	One	_	
27-2	4092-4100	previous	_	
27-3	4101-4106	study	_	
27-4	4107-4113	showed	_	
27-5	4114-4121	reduced	_	
27-6	4122-4128	global	_	
27-7	4129-4139	efficiency	_	
27-8	4140-4143	and	_	
27-9	4144-4150	higher	_	
27-10	4151-4155	path	_	
27-11	4156-4162	length	_	
27-12	4163-4165	in	_	
27-13	4166-4171	youth	_	
27-14	4172-4176	aged	_	
27-15	4177-4179	10	_	
27-16	4179-4180	–	_	
27-17	4180-4182	17	_	
27-18	4183-4188	years	_	
27-19	4189-4193	with	_	
27-20	4194-4197	PAE	_	
27-21	4198-4206	compared	_	
27-22	4207-4209	to	_	
27-23	4210-4219	unexposed	_	
27-24	4220-4228	controls	_	
27-25	4228-4229	.	_	

#Text=A second study in a different sample (aged 7–17 years) found no differences in global brain metrics, but noted substantially more atypical values of global efficiency, clustering coefficient and characteristic path length in the PAE group than in controls.
28-1	4230-4231	A	_	
28-2	4232-4238	second	_	
28-3	4239-4244	study	_	
28-4	4245-4247	in	_	
28-5	4248-4249	a	_	
28-6	4250-4259	different	_	
28-7	4260-4266	sample	_	
28-8	4267-4268	(	_	
28-9	4268-4272	aged	_	
28-10	4273-4274	7	_	
28-11	4274-4275	–	_	
28-12	4275-4277	17	_	
28-13	4278-4283	years	_	
28-14	4283-4284	)	_	
28-15	4285-4290	found	_	
28-16	4291-4293	no	_	
28-17	4294-4305	differences	_	
28-18	4306-4308	in	_	
28-19	4309-4315	global	_	
28-20	4316-4321	brain	_	
28-21	4322-4329	metrics	_	
28-22	4329-4330	,	_	
28-23	4331-4334	but	_	
28-24	4335-4340	noted	_	
28-25	4341-4354	substantially	_	
28-26	4355-4359	more	_	
28-27	4360-4368	atypical	_	
28-28	4369-4375	values	_	
28-29	4376-4378	of	_	
28-30	4379-4385	global	_	
28-31	4386-4396	efficiency	_	
28-32	4396-4397	,	_	
28-33	4398-4408	clustering	_	
28-34	4409-4420	coefficient	_	
28-35	4421-4424	and	_	
28-36	4425-4439	characteristic	_	
28-37	4440-4444	path	_	
28-38	4445-4451	length	_	
28-39	4452-4454	in	_	
28-40	4455-4458	the	_	
28-41	4459-4462	PAE	_	
28-42	4463-4468	group	_	
28-43	4469-4473	than	_	
28-44	4474-4476	in	_	
28-45	4477-4485	controls	_	
28-46	4485-4486	.	_	

#Text=Functional connectome analysis has demonstrated whole brain network alterations in other neurodevelopmental disorders, and shows potential in clinical diagnosis and intervention.
29-1	4487-4497	Functional	_	
29-2	4498-4508	connectome	_	
29-3	4509-4517	analysis	_	
29-4	4518-4521	has	_	
29-5	4522-4534	demonstrated	_	
29-6	4535-4540	whole	_	
29-7	4541-4546	brain	_	
29-8	4547-4554	network	_	
29-9	4555-4566	alterations	_	
29-10	4567-4569	in	_	
29-11	4570-4575	other	_	
29-12	4576-4594	neurodevelopmental	_	
29-13	4595-4604	disorders	_	
29-14	4604-4605	,	_	
29-15	4606-4609	and	_	
29-16	4610-4615	shows	_	
29-17	4616-4625	potential	_	
29-18	4626-4628	in	_	
29-19	4629-4637	clinical	_	
29-20	4638-4647	diagnosis	_	
29-21	4648-4651	and	_	
29-22	4652-4664	intervention	_	
29-23	4664-4665	.	_	

#Text=A better understanding of the functional connectome in young children with PAE would provide a more complete picture of the effects of PAE at the whole-brain level and potentially help inform future research on interventions.
30-1	4666-4667	A	_	
30-2	4668-4674	better	_	
30-3	4675-4688	understanding	_	
30-4	4689-4691	of	_	
30-5	4692-4695	the	_	
30-6	4696-4706	functional	_	
30-7	4707-4717	connectome	_	
30-8	4718-4720	in	_	
30-9	4721-4726	young	_	
30-10	4727-4735	children	_	
30-11	4736-4740	with	_	
30-12	4741-4744	PAE	_	
30-13	4745-4750	would	_	
30-14	4751-4758	provide	_	
30-15	4759-4760	a	_	
30-16	4761-4765	more	_	
30-17	4766-4774	complete	_	
30-18	4775-4782	picture	_	
30-19	4783-4785	of	_	
30-20	4786-4789	the	_	
30-21	4790-4797	effects	_	
30-22	4798-4800	of	_	
30-23	4801-4804	PAE	_	
30-24	4805-4807	at	_	
30-25	4808-4811	the	_	
30-26	4812-4823	whole-brain	_	
30-27	4824-4829	level	_	
30-28	4830-4833	and	_	
30-29	4834-4845	potentially	_	
30-30	4846-4850	help	_	
30-31	4851-4857	inform	_	
30-32	4858-4864	future	_	
30-33	4865-4873	research	_	
30-34	4874-4876	on	_	
30-35	4877-4890	interventions	_	
30-36	4890-4891	.	_	

#Text=In the present study, we aimed to investigate the functional connectome of young children with PAE using passive viewing fMRI.
31-1	4892-4894	In	_	
31-2	4895-4898	the	_	
31-3	4899-4906	present	_	
31-4	4907-4912	study	_	
31-5	4912-4913	,	_	
31-6	4914-4916	we	_	
31-7	4917-4922	aimed	_	
31-8	4923-4925	to	_	
31-9	4926-4937	investigate	_	
31-10	4938-4941	the	_	
31-11	4942-4952	functional	_	
31-12	4953-4963	connectome	_	
31-13	4964-4966	of	_	
31-14	4967-4972	young	_	
31-15	4973-4981	children	_	
31-16	4982-4986	with	_	
31-17	4987-4990	PAE	_	
31-18	4991-4996	using	_	
31-19	4997-5004	passive	_	
31-20	5005-5012	viewing	_	
31-21	5013-5017	fMRI	_	
31-22	5017-5018	.	_	

#Text=Unlike resting state fMRI that requires participants to lie still for several minutes with minimalm stimulus, passive viewing fMRI allows participant to watch videos during their scan.
32-1	5019-5025	Unlike	_	
32-2	5026-5033	resting	_	
32-3	5034-5039	state	_	
32-4	5040-5044	fMRI	_	
32-5	5045-5049	that	_	
32-6	5050-5058	requires	_	
32-7	5059-5071	participants	_	
32-8	5072-5074	to	_	
32-9	5075-5078	lie	_	
32-10	5079-5084	still	_	
32-11	5085-5088	for	_	
32-12	5089-5096	several	_	
32-13	5097-5104	minutes	_	
32-14	5105-5109	with	_	
32-15	5110-5118	minimalm	_	
32-16	5119-5127	stimulus	_	
32-17	5127-5128	,	_	
32-18	5129-5136	passive	_	
32-19	5137-5144	viewing	_	
32-20	5145-5149	fMRI	_	
32-21	5150-5156	allows	_	
32-22	5157-5168	participant	_	
32-23	5169-5171	to	_	
32-24	5172-5177	watch	_	
32-25	5178-5184	videos	_	
32-26	5185-5191	during	_	
32-27	5192-5197	their	_	
32-28	5198-5202	scan	_	
32-29	5202-5203	.	_	

#Text=Because it provides a more natural condition, passive viewing can decrease head motion during data collection, and it is increasingly used in children.
33-1	5204-5211	Because	_	
33-2	5212-5214	it	_	
33-3	5215-5223	provides	_	
33-4	5224-5225	a	_	
33-5	5226-5230	more	_	
33-6	5231-5238	natural	_	
33-7	5239-5248	condition	_	
33-8	5248-5249	,	_	
33-9	5250-5257	passive	_	
33-10	5258-5265	viewing	_	
33-11	5266-5269	can	_	
33-12	5270-5278	decrease	_	
33-13	5279-5283	head	_	
33-14	5284-5290	motion	_	
33-15	5291-5297	during	_	
33-16	5298-5302	data	_	
33-17	5303-5313	collection	_	
33-18	5313-5314	,	_	
33-19	5315-5318	and	_	
33-20	5319-5321	it	_	
33-21	5322-5324	is	_	
33-22	5325-5337	increasingly	_	
33-23	5338-5342	used	_	
33-24	5343-5345	in	_	
33-25	5346-5354	children	_	
33-26	5354-5355	.	_	

#Text=Several previous studies have successfully examined brain activity, variability, and/or network development using naturalistic-viewing fMRI, including in young children.
34-1	5356-5363	Several	_	
34-2	5364-5372	previous	_	
34-3	5373-5380	studies	_	
34-4	5381-5385	have	_	
34-5	5386-5398	successfully	_	
34-6	5399-5407	examined	_	
34-7	5408-5413	brain	_	
34-8	5414-5422	activity	_	
34-9	5422-5423	,	_	
34-10	5424-5435	variability	_	
34-11	5435-5436	,	_	
34-12	5437-5440	and	_	
34-13	5440-5441	/	_	
34-14	5441-5443	or	_	
34-15	5444-5451	network	_	
34-16	5452-5463	development	_	
34-17	5464-5469	using	_	
34-18	5470-5490	naturalistic-viewing	_	
34-19	5491-5495	fMRI	_	
34-20	5495-5496	,	_	
34-21	5497-5506	including	_	
34-22	5507-5509	in	_	
34-23	5510-5515	young	_	
34-24	5516-5524	children	_	
34-25	5524-5525	.	_	

#Text=Passive viewing fMRI has also been applied to young children and older adults with major depressive disorder and adults with autism spectrum disorder (ASD).
35-1	5526-5533	Passive	_	
35-2	5534-5541	viewing	_	
35-3	5542-5546	fMRI	_	
35-4	5547-5550	has	_	
35-5	5551-5555	also	_	
35-6	5556-5560	been	_	
35-7	5561-5568	applied	_	
35-8	5569-5571	to	_	
35-9	5572-5577	young	_	
35-10	5578-5586	children	_	
35-11	5587-5590	and	_	
35-12	5591-5596	older	_	
35-13	5597-5603	adults	_	
35-14	5604-5608	with	_	
35-15	5609-5614	major	_	
35-16	5615-5625	depressive	_	
35-17	5626-5634	disorder	_	
35-18	5635-5638	and	_	
35-19	5639-5645	adults	_	
35-20	5646-5650	with	_	
35-21	5651-5657	autism	_	
35-22	5658-5666	spectrum	_	
35-23	5667-5675	disorder	_	
35-24	5676-5677	(	_	
35-25	5677-5680	ASD	_	
35-26	5680-5681	)	_	
35-27	5681-5682	.	_	

#Text=Here, we examined functional connectome measures including network efficiency and centrality, as well as inter- and intra-individual stability.
36-1	5683-5687	Here	_	
36-2	5687-5688	,	_	
36-3	5689-5691	we	_	
36-4	5692-5700	examined	_	
36-5	5701-5711	functional	_	
36-6	5712-5722	connectome	_	
36-7	5723-5731	measures	_	
36-8	5732-5741	including	_	
36-9	5742-5749	network	_	
36-10	5750-5760	efficiency	_	
36-11	5761-5764	and	_	
36-12	5765-5775	centrality	_	
36-13	5775-5776	,	_	
36-14	5777-5779	as	_	
36-15	5780-5784	well	_	
36-16	5785-5787	as	_	
36-17	5788-5793	inter	_	
36-18	5793-5794	-	_	
36-19	5795-5798	and	_	
36-20	5799-5815	intra-individual	_	
36-21	5816-5825	stability	_	
36-22	5825-5826	.	_	

#Text=We expected that young children with PAE would show decreased network efficiency and increased network path length compared to exposed controls, as seen in older childhood.
37-1	5827-5829	We	_	
37-2	5830-5838	expected	_	
37-3	5839-5843	that	_	
37-4	5844-5849	young	_	
37-5	5850-5858	children	_	
37-6	5859-5863	with	_	
37-7	5864-5867	PAE	_	
37-8	5868-5873	would	_	
37-9	5874-5878	show	_	
37-10	5879-5888	decreased	_	
37-11	5889-5896	network	_	
37-12	5897-5907	efficiency	_	
37-13	5908-5911	and	_	
37-14	5912-5921	increased	_	
37-15	5922-5929	network	_	
37-16	5930-5934	path	_	
37-17	5935-5941	length	_	
37-18	5942-5950	compared	_	
37-19	5951-5953	to	_	
37-20	5954-5961	exposed	_	
37-21	5962-5970	controls	_	
37-22	5970-5971	,	_	
37-23	5972-5974	as	_	
37-24	5975-5979	seen	_	
37-25	5980-5982	in	_	
37-26	5983-5988	older	_	
37-27	5989-5998	childhood	_	
37-28	5998-5999	.	_	

#Text=Previous studies have not examined inter- or intra-participant stability in children with PAE, but based on higher rates of atypical metrics seen in older children with PAE and higher variability in behavior, we expected to see lower inter- and intra-participant stability in the PAE group.
38-1	6000-6008	Previous	_	
38-2	6009-6016	studies	_	
38-3	6017-6021	have	_	
38-4	6022-6025	not	_	
38-5	6026-6034	examined	_	
38-6	6035-6040	inter	_	
38-7	6040-6041	-	_	
38-8	6042-6044	or	_	
38-9	6045-6062	intra-participant	_	
38-10	6063-6072	stability	_	
38-11	6073-6075	in	_	
38-12	6076-6084	children	_	
38-13	6085-6089	with	_	
38-14	6090-6093	PAE	_	
38-15	6093-6094	,	_	
38-16	6095-6098	but	_	
38-17	6099-6104	based	_	
38-18	6105-6107	on	_	
38-19	6108-6114	higher	_	
38-20	6115-6120	rates	_	
38-21	6121-6123	of	_	
38-22	6124-6132	atypical	_	
38-23	6133-6140	metrics	_	
38-24	6141-6145	seen	_	
38-25	6146-6148	in	_	
38-26	6149-6154	older	_	
38-27	6155-6163	children	_	
38-28	6164-6168	with	_	
38-29	6169-6172	PAE	_	
38-30	6173-6176	and	_	
38-31	6177-6183	higher	_	
38-32	6184-6195	variability	_	
38-33	6196-6198	in	_	
38-34	6199-6207	behavior	_	
38-35	6207-6208	,	_	
38-36	6209-6211	we	_	
38-37	6212-6220	expected	_	
38-38	6221-6223	to	_	
38-39	6224-6227	see	_	
38-40	6228-6233	lower	_	
38-41	6234-6239	inter	_	
38-42	6239-6240	-	_	
38-43	6241-6244	and	_	
38-44	6245-6262	intra-participant	_	
38-45	6263-6272	stability	_	
38-46	6273-6275	in	_	
38-47	6276-6279	the	_	
38-48	6280-6283	PAE	_	
38-49	6284-6289	group	_	
38-50	6289-6290	.	_	

#Text=Materials and methods
#Text=Participants
#Text=This study recruited 52 children with PAE (26 males/26 females, aged 2.78 to 7.22 years) from Alberta, Canada.
39-1	6291-6300	Materials	http://www.case.edu/ProvCaRe/provcare#StudyMethod[1]	
39-2	6301-6304	and	http://www.case.edu/ProvCaRe/provcare#StudyMethod[1]	
39-3	6305-6312	methods	http://www.case.edu/ProvCaRe/provcare#StudyMethod[1]	
39-4	6313-6325	Participants	_	
39-5	6326-6330	This	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
39-6	6331-6336	study	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
39-7	6337-6346	recruited	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
39-8	6347-6349	52	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
39-9	6350-6358	children	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
39-10	6359-6363	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
39-11	6364-6367	PAE	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
39-12	6368-6369	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
39-13	6369-6371	26	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
39-14	6372-6377	males	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
39-15	6377-6378	/	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
39-16	6378-6380	26	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
39-17	6381-6388	females	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
39-18	6388-6389	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
39-19	6390-6394	aged	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
39-20	6395-6399	2.78	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
39-21	6400-6402	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
39-22	6403-6407	7.22	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
39-23	6408-6413	years	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
39-24	6413-6414	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
39-25	6415-6419	from	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
39-26	6420-6427	Alberta	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
39-27	6427-6428	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
39-28	6429-6435	Canada	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
39-29	6435-6436	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	

#Text=Participants with PAE were recruited via advertisements (print and online) in newsletters and parent groups (n = 18), early intervention services and diagnostic clinics (n = 25), and through Child and Family Services (n = 9).
40-1	6437-6449	Participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
40-2	6450-6454	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
40-3	6455-6458	PAE	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
40-4	6459-6463	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
40-5	6464-6473	recruited	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
40-6	6474-6477	via	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
40-7	6478-6492	advertisements	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
40-8	6493-6494	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
40-9	6494-6499	print	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
40-10	6500-6503	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
40-11	6504-6510	online	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
40-12	6510-6511	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
40-13	6512-6514	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
40-14	6515-6526	newsletters	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
40-15	6527-6530	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
40-16	6531-6537	parent	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
40-17	6538-6544	groups	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
40-18	6545-6546	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
40-19	6546-6547	n	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
40-20	6547-6548	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
40-21	6548-6549	=	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
40-22	6549-6550	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
40-23	6550-6552	18	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
40-24	6552-6553	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
40-25	6553-6554	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
40-26	6555-6560	early	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
40-27	6561-6573	intervention	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
40-28	6574-6582	services	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
40-29	6583-6586	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
40-30	6587-6597	diagnostic	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
40-31	6598-6605	clinics	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
40-32	6606-6607	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
40-33	6607-6608	n	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
40-34	6608-6609	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
40-35	6609-6610	=	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
40-36	6610-6611	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
40-37	6611-6613	25	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
40-38	6613-6614	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
40-39	6614-6615	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
40-40	6616-6619	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
40-41	6620-6627	through	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
40-42	6628-6633	Child	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
40-43	6634-6637	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
40-44	6638-6644	Family	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
40-45	6645-6653	Services	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
40-46	6654-6655	(	_	
40-47	6655-6656	n	_	
40-48	6656-6657	 	_	
40-49	6657-6658	=	_	
40-50	6658-6659	 	_	
40-51	6659-6660	9	_	
40-52	6660-6661	)	_	
40-53	6661-6662	.	_	

#Text=PAE was confirmed via child welfare files (containing information from birth families), social workers, police records, medical files, and semi-structured interviews with caregivers and birth families, where possible.
41-1	6663-6666	PAE	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
41-2	6667-6670	was	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
41-3	6671-6680	confirmed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
41-4	6681-6684	via	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
41-5	6685-6690	child	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
41-6	6691-6698	welfare	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
41-7	6699-6704	files	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
41-8	6705-6706	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
41-9	6706-6716	containing	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
41-10	6717-6728	information	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
41-11	6729-6733	from	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
41-12	6734-6739	birth	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
41-13	6740-6748	families	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
41-14	6748-6749	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
41-15	6749-6750	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
41-16	6751-6757	social	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
41-17	6758-6765	workers	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
41-18	6765-6766	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
41-19	6767-6773	police	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
41-20	6774-6781	records	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
41-21	6781-6782	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
41-22	6783-6790	medical	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
41-23	6791-6796	files	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
41-24	6796-6797	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
41-25	6798-6801	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
41-26	6802-6817	semi-structured	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
41-27	6818-6828	interviews	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
41-28	6829-6833	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
41-29	6834-6844	caregivers	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
41-30	6845-6848	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
41-31	6849-6854	birth	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
41-32	6855-6863	families	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
41-33	6863-6864	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
41-34	6865-6870	where	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
41-35	6871-6879	possible	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
41-36	6879-6880	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	

#Text=No participants had been diagnosed with fetal alcohol spectrum disorder (FASD), the developmental disorder associated with PAE, because they are too young to be assessed in most diagnostic clinics in Alberta, which typically see children only after they are 7-years old. 153 unexposed typically-developing children (82 males/71 females; aged 1.97 to 8.04 years) were included from an ongoing study of typical brain development.
42-1	6881-6883	No	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-2	6884-6896	participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-3	6897-6900	had	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-4	6901-6905	been	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-5	6906-6915	diagnosed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-6	6916-6920	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-7	6921-6926	fetal	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-8	6927-6934	alcohol	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-9	6935-6943	spectrum	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-10	6944-6952	disorder	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-11	6953-6954	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-12	6954-6958	FASD	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-13	6958-6959	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-14	6959-6960	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-15	6961-6964	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-16	6965-6978	developmental	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-17	6979-6987	disorder	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-18	6988-6998	associated	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-19	6999-7003	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-20	7004-7007	PAE	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-21	7007-7008	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-22	7009-7016	because	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-23	7017-7021	they	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-24	7022-7025	are	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-25	7026-7029	too	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-26	7030-7035	young	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-27	7036-7038	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-28	7039-7041	be	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-29	7042-7050	assessed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-30	7051-7053	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-31	7054-7058	most	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-32	7059-7069	diagnostic	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-33	7070-7077	clinics	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-34	7078-7080	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-35	7081-7088	Alberta	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-36	7088-7089	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-37	7090-7095	which	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-38	7096-7105	typically	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-39	7106-7109	see	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-40	7110-7118	children	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-41	7119-7123	only	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-42	7124-7129	after	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-43	7130-7134	they	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-44	7135-7138	are	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-45	7139-7140	7	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-46	7140-7141	-	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-47	7141-7146	years	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-48	7147-7150	old	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-49	7150-7151	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-50	7152-7155	153	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-51	7156-7165	unexposed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-52	7166-7186	typically-developing	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-53	7187-7195	children	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-54	7196-7197	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-55	7197-7199	82	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-56	7200-7205	males	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-57	7205-7206	/	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-58	7206-7208	71	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-59	7209-7216	females	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-60	7216-7217	;	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-61	7218-7222	aged	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-62	7223-7227	1.97	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-63	7228-7230	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-64	7231-7235	8.04	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-65	7236-7241	years	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-66	7241-7242	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-67	7243-7247	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-68	7248-7256	included	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-69	7257-7261	from	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-70	7262-7264	an	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-71	7265-7272	ongoing	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-72	7273-7278	study	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-73	7279-7281	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-74	7282-7289	typical	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-75	7290-7295	brain	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-76	7296-7307	development	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
42-77	7307-7308	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	

#Text=These typically-developing controls were originally recruited from the Calgary community via advertisements and from the Alberta Pregnancy Outcomes and Nutrition (APrON) study, an ongoing research study that recruited women in pregnancy and is focused on child outcomes related to maternal nutrition and mental health in pregnancy.
43-1	7309-7314	These	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-2	7315-7335	typically-developing	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-3	7336-7344	controls	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-4	7345-7349	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-5	7350-7360	originally	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-6	7361-7370	recruited	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-7	7371-7375	from	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-8	7376-7379	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-9	7380-7387	Calgary	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-10	7388-7397	community	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-11	7398-7401	via	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-12	7402-7416	advertisements	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-13	7417-7420	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-14	7421-7425	from	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-15	7426-7429	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-16	7430-7437	Alberta	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-17	7438-7447	Pregnancy	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-18	7448-7456	Outcomes	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-19	7457-7460	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-20	7461-7470	Nutrition	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-21	7471-7472	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-22	7472-7477	APrON	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-23	7477-7478	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-24	7479-7484	study	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-25	7484-7485	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-26	7486-7488	an	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-27	7489-7496	ongoing	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-28	7497-7505	research	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-29	7506-7511	study	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-30	7512-7516	that	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-31	7517-7526	recruited	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-32	7527-7532	women	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-33	7533-7535	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-34	7536-7545	pregnancy	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-35	7546-7549	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-36	7550-7552	is	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-37	7553-7560	focused	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-38	7561-7563	on	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-39	7564-7569	child	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-40	7570-7578	outcomes	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-41	7579-7586	related	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-42	7587-7589	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-43	7590-7598	maternal	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-44	7599-7608	nutrition	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-45	7609-7612	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-46	7613-7619	mental	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-47	7620-7626	health	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-48	7627-7629	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-49	7630-7639	pregnancy	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-50	7639-7640	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	

#Text=For recruitment details for the APrON study, please refer to.
44-1	7641-7644	For	_	
44-2	7645-7656	recruitment	_	
44-3	7657-7664	details	_	
44-4	7665-7668	for	_	
44-5	7669-7672	the	_	
44-6	7673-7678	APrON	_	
44-7	7679-7684	study	_	
44-8	7684-7685	,	_	
44-9	7686-7692	please	_	
44-10	7693-7698	refer	_	
44-11	7699-7701	to	_	
44-12	7701-7702	.	_	

#Text=The absence of prenatal alcohol exposure in controls was verified by maternal report at multiple stages of pregnancy.
45-1	7703-7706	The	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
45-2	7707-7714	absence	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
45-3	7715-7717	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
45-4	7718-7726	prenatal	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
45-5	7727-7734	alcohol	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
45-6	7735-7743	exposure	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
45-7	7744-7746	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
45-8	7747-7755	controls	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
45-9	7756-7759	was	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
45-10	7760-7768	verified	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
45-11	7769-7771	by	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
45-12	7772-7780	maternal	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
45-13	7781-7787	report	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
45-14	7788-7790	at	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
45-15	7791-7799	multiple	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
45-16	7800-7806	stages	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
45-17	7807-7809	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
45-18	7810-7819	pregnancy	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
45-19	7819-7820	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	

#Text=Demographics of the available datasets included in the current study, including the total number of participants, age, family income brackets (unit: Canadian dollar, 8 brackets from “under $25,000″ to “over $175,000″), full scale intelligence quotient (FSIQ), head motion (average relative frame-wise displacement), and the number of participants who had multiple scans.
46-1	7821-7833	Demographics	_	
46-2	7834-7836	of	_	
46-3	7837-7840	the	_	
46-4	7841-7850	available	_	
46-5	7851-7859	datasets	_	
46-6	7860-7868	included	_	
46-7	7869-7871	in	_	
46-8	7872-7875	the	_	
46-9	7876-7883	current	_	
46-10	7884-7889	study	_	
46-11	7889-7890	,	_	
46-12	7891-7900	including	_	
46-13	7901-7904	the	_	
46-14	7905-7910	total	_	
46-15	7911-7917	number	_	
46-16	7918-7920	of	_	
46-17	7921-7933	participants	_	
46-18	7933-7934	,	_	
46-19	7935-7938	age	_	
46-20	7938-7939	,	_	
46-21	7940-7946	family	_	
46-22	7947-7953	income	_	
46-23	7954-7962	brackets	_	
46-24	7963-7964	(	_	
46-25	7964-7968	unit	_	
46-26	7968-7969	:	_	
46-27	7970-7978	Canadian	_	
46-28	7979-7985	dollar	_	
46-29	7985-7986	,	_	
46-30	7987-7988	8	_	
46-31	7989-7997	brackets	_	
46-32	7998-8002	from	_	
46-33	8003-8004	“	_	
46-34	8004-8009	under	_	
46-35	8010-8017	$25,000	_	
46-36	8017-8018	″	_	
46-37	8019-8021	to	_	
46-38	8022-8023	“	_	
46-39	8023-8027	over	_	
46-40	8028-8036	$175,000	_	
46-41	8036-8037	″	_	
46-42	8037-8038	)	_	
46-43	8038-8039	,	_	
46-44	8040-8044	full	http://maven.renci.org/NeuroBridge/neurobridge#FullScaleIntelligenceQuotient[7]	
46-45	8045-8050	scale	http://maven.renci.org/NeuroBridge/neurobridge#FullScaleIntelligenceQuotient[7]	
46-46	8051-8063	intelligence	http://maven.renci.org/NeuroBridge/neurobridge#FullScaleIntelligenceQuotient[7]	
46-47	8064-8072	quotient	http://maven.renci.org/NeuroBridge/neurobridge#FullScaleIntelligenceQuotient[7]	
46-48	8073-8074	(	http://maven.renci.org/NeuroBridge/neurobridge#FullScaleIntelligenceQuotient[7]	
46-49	8074-8078	FSIQ	http://maven.renci.org/NeuroBridge/neurobridge#FullScaleIntelligenceQuotient[7]	
46-50	8078-8079	)	http://maven.renci.org/NeuroBridge/neurobridge#FullScaleIntelligenceQuotient[7]	
46-51	8079-8080	,	_	
46-52	8081-8085	head	_	
46-53	8086-8092	motion	_	
46-54	8093-8094	(	_	
46-55	8094-8101	average	_	
46-56	8102-8110	relative	_	
46-57	8111-8121	frame-wise	_	
46-58	8122-8134	displacement	_	
46-59	8134-8135	)	_	
46-60	8135-8136	,	_	
46-61	8137-8140	and	_	
46-62	8141-8144	the	_	
46-63	8145-8151	number	_	
46-64	8152-8154	of	_	
46-65	8155-8167	participants	_	
46-66	8168-8171	who	_	
46-67	8172-8175	had	_	
46-68	8176-8184	multiple	_	
46-69	8185-8190	scans	_	
46-70	8190-8191	.	_	

#Text=Age, family income, and FSIQ were significantly different between the two groups (age: PAE > Control, t = 3.27, p = 0.002; family income: PAE < Control, t = −6.06, p = 2.49E-08; FSIQ: PAE < Control, t = −5.28, p = 1.05E-06).
47-1	8192-8195	Age	_	
47-2	8195-8196	,	_	
47-3	8197-8203	family	_	
47-4	8204-8210	income	_	
47-5	8210-8211	,	_	
47-6	8212-8215	and	_	
47-7	8216-8220	FSIQ	_	
47-8	8221-8225	were	_	
47-9	8226-8239	significantly	_	
47-10	8240-8249	different	_	
47-11	8250-8257	between	_	
47-12	8258-8261	the	_	
47-13	8262-8265	two	_	
47-14	8266-8272	groups	_	
47-15	8273-8274	(	_	
47-16	8274-8277	age	_	
47-17	8277-8278	:	_	
47-18	8279-8282	PAE	_	
47-19	8283-8284	>	_	
47-20	8285-8292	Control	_	
47-21	8292-8293	,	_	
47-22	8294-8295	t	_	
47-23	8295-8296	 	_	
47-24	8296-8297	=	_	
47-25	8297-8298	 	_	
47-26	8298-8302	3.27	_	
47-27	8302-8303	,	_	
47-28	8304-8305	p	_	
47-29	8305-8306	 	_	
47-30	8306-8307	=	_	
47-31	8307-8308	 	_	
47-32	8308-8313	0.002	_	
47-33	8313-8314	;	_	
47-34	8315-8321	family	_	
47-35	8322-8328	income	_	
47-36	8328-8329	:	_	
47-37	8330-8333	PAE	_	
47-38	8334-8335	<	_	
47-39	8336-8343	Control	_	
47-40	8343-8344	,	_	
47-41	8345-8346	t	_	
47-42	8346-8347	 	_	
47-43	8347-8348	=	_	
47-44	8348-8349	 	_	
47-45	8349-8350	−	_	
47-46	8350-8354	6.06	_	
47-47	8354-8355	,	_	
47-48	8356-8357	p	_	
47-49	8357-8358	 	_	
47-50	8358-8359	=	_	
47-51	8359-8360	 	_	
47-52	8360-8365	2.49E	_	
47-53	8365-8366	-	_	
47-54	8366-8368	08	_	
47-55	8368-8369	;	_	
47-56	8370-8374	FSIQ	_	
47-57	8374-8375	:	_	
47-58	8376-8379	PAE	_	
47-59	8380-8381	<	_	
47-60	8382-8389	Control	_	
47-61	8389-8390	,	_	
47-62	8391-8392	t	_	
47-63	8392-8393	 	_	
47-64	8393-8394	=	_	
47-65	8394-8395	 	_	
47-66	8395-8396	−	_	
47-67	8396-8400	5.28	_	
47-68	8400-8401	,	_	
47-69	8402-8403	p	_	
47-70	8403-8404	 	_	
47-71	8404-8405	=	_	
47-72	8405-8406	 	_	
47-73	8406-8411	1.05E	_	
47-74	8411-8412	-	_	
47-75	8412-8414	06	_	
47-76	8414-8415	)	_	
47-77	8415-8416	.	_	

#Text=Table 1\t \t
#Text=Demographics of the datasets included in the current study\t \t\tControls\tPAE\tAll Participants\t \tNumber of participants\t87 (45 female)\t26 (15 female)\t113 (60 female)\t \tAge*\t4.86 ± 1.21\t5.57 ± 0.95\t4.96 ± 1.20\t \tAge range\t3.35 - 6.97\t1.97 - 8.00\t1.97 - 8.00\t \tFamily income (median bracket)*\t$125,000–149,999/year\t$75,000–99,999/year\t$125,000–149,999/year\t \tFSIQ*\t109 ± 12\t93 ± 12\t104 ± 14\t \tHead Motion (mm)\t0.21 ± 0.18\t0.24 ± 0.29\t0.22 ± 0.20\t \tOne Scan\t38 (44%)\t19 (73%)\t57 (50%)\t \tTwo Scans\t12 (14%)\t6 (23%)\t18 (16%)\t \tThree Scans\t14 (16%)\t1 (4%)\t15 (13%)\t \tFour Scans\t11 (13%)\t/\t11 (10%)\t \tFive Scans\t7 (8%)\t/\t7 (6%)\t \tSix Scans\t3 (3%)\t/\t3 (3%)\t \tSeven Scans\t2 (2%)\t/\t2 (2%)\t \tTotal Scans\t215\t34\t249\t \t
#Text=The study was originally planned with a longitudinal design, and all participants’ families were invited to return for subsequent scans approximately every six months before school age, and annually thereafter.
48-1	8417-8422	Table	_	
48-2	8423-8424	1	_	
48-3	8428-8440	Demographics	_	
48-4	8441-8443	of	_	
48-5	8444-8447	the	_	
48-6	8448-8456	datasets	_	
48-7	8457-8465	included	_	
48-8	8466-8468	in	_	
48-9	8469-8472	the	_	
48-10	8473-8480	current	_	
48-11	8481-8486	study	_	
48-12	8490-8498	Controls	_	
48-13	8499-8502	PAE	_	
48-14	8503-8506	All	_	
48-15	8507-8519	Participants	_	
48-16	8522-8528	Number	_	
48-17	8529-8531	of	_	
48-18	8532-8544	participants	_	
48-19	8545-8547	87	_	
48-20	8548-8549	(	_	
48-21	8549-8551	45	_	
48-22	8552-8558	female	_	
48-23	8558-8559	)	_	
48-24	8560-8562	26	_	
48-25	8563-8564	(	_	
48-26	8564-8566	15	_	
48-27	8567-8573	female	_	
48-28	8573-8574	)	_	
48-29	8575-8578	113	_	
48-30	8579-8580	(	_	
48-31	8580-8582	60	_	
48-32	8583-8589	female	_	
48-33	8589-8590	)	_	
48-34	8593-8596	Age	_	
48-35	8596-8597	*	_	
48-36	8598-8602	4.86	_	
48-37	8602-8603	 	_	
48-38	8603-8604	±	_	
48-39	8604-8605	 	_	
48-40	8605-8609	1.21	_	
48-41	8610-8614	5.57	_	
48-42	8614-8615	 	_	
48-43	8615-8616	±	_	
48-44	8616-8617	 	_	
48-45	8617-8621	0.95	_	
48-46	8622-8626	4.96	_	
48-47	8626-8627	 	_	
48-48	8627-8628	±	_	
48-49	8628-8629	 	_	
48-50	8629-8633	1.20	_	
48-51	8636-8639	Age	_	
48-52	8640-8645	range	_	
48-53	8646-8650	3.35	_	
48-54	8651-8652	-	_	
48-55	8653-8657	6.97	_	
48-56	8658-8662	1.97	_	
48-57	8663-8664	-	_	
48-58	8665-8669	8.00	_	
48-59	8670-8674	1.97	_	
48-60	8675-8676	-	_	
48-61	8677-8681	8.00	_	
48-62	8684-8690	Family	_	
48-63	8691-8697	income	_	
48-64	8698-8699	(	_	
48-65	8699-8705	median	_	
48-66	8706-8713	bracket	_	
48-67	8713-8714	)	_	
48-68	8714-8715	*	_	
48-69	8716-8724	$125,000	_	
48-70	8724-8725	–	_	
48-71	8725-8732	149,999	_	
48-72	8732-8733	/	_	
48-73	8733-8737	year	_	
48-74	8738-8745	$75,000	_	
48-75	8745-8746	–	_	
48-76	8746-8752	99,999	_	
48-77	8752-8753	/	_	
48-78	8753-8757	year	_	
48-79	8758-8766	$125,000	_	
48-80	8766-8767	–	_	
48-81	8767-8774	149,999	_	
48-82	8774-8775	/	_	
48-83	8775-8779	year	_	
48-84	8782-8786	FSIQ	_	
48-85	8786-8787	*	_	
48-86	8788-8791	109	_	
48-87	8792-8793	±	_	
48-88	8793-8794	 	_	
48-89	8794-8796	12	_	
48-90	8797-8799	93	_	
48-91	8800-8801	±	_	
48-92	8801-8802	 	_	
48-93	8802-8804	12	_	
48-94	8805-8808	104	_	
48-95	8809-8810	±	_	
48-96	8810-8811	 	_	
48-97	8811-8813	14	_	
48-98	8816-8820	Head	_	
48-99	8821-8827	Motion	_	
48-100	8828-8829	(	_	
48-101	8829-8831	mm	_	
48-102	8831-8832	)	_	
48-103	8833-8837	0.21	_	
48-104	8837-8838	 	_	
48-105	8838-8839	±	_	
48-106	8839-8840	 	_	
48-107	8840-8844	0.18	_	
48-108	8845-8849	0.24	_	
48-109	8849-8850	 	_	
48-110	8850-8851	±	_	
48-111	8851-8852	 	_	
48-112	8852-8856	0.29	_	
48-113	8857-8861	0.22	_	
48-114	8861-8862	 	_	
48-115	8862-8863	±	_	
48-116	8863-8864	 	_	
48-117	8864-8868	0.20	_	
48-118	8871-8874	One	_	
48-119	8875-8879	Scan	_	
48-120	8880-8882	38	_	
48-121	8883-8884	(	_	
48-122	8884-8887	44%	_	
48-123	8887-8888	)	_	
48-124	8889-8891	19	_	
48-125	8892-8893	(	_	
48-126	8893-8896	73%	_	
48-127	8896-8897	)	_	
48-128	8898-8900	57	_	
48-129	8901-8902	(	_	
48-130	8902-8905	50%	_	
48-131	8905-8906	)	_	
48-132	8909-8912	Two	_	
48-133	8913-8918	Scans	_	
48-134	8919-8921	12	_	
48-135	8922-8923	(	_	
48-136	8923-8926	14%	_	
48-137	8926-8927	)	_	
48-138	8928-8929	6	_	
48-139	8930-8931	(	_	
48-140	8931-8934	23%	_	
48-141	8934-8935	)	_	
48-142	8936-8938	18	_	
48-143	8939-8940	(	_	
48-144	8940-8943	16%	_	
48-145	8943-8944	)	_	
48-146	8947-8952	Three	_	
48-147	8953-8958	Scans	_	
48-148	8959-8961	14	_	
48-149	8962-8963	(	_	
48-150	8963-8966	16%	_	
48-151	8966-8967	)	_	
48-152	8968-8969	1	_	
48-153	8970-8971	(	_	
48-154	8971-8973	4%	_	
48-155	8973-8974	)	_	
48-156	8975-8977	15	_	
48-157	8978-8979	(	_	
48-158	8979-8982	13%	_	
48-159	8982-8983	)	_	
48-160	8986-8990	Four	_	
48-161	8991-8996	Scans	_	
48-162	8997-8999	11	_	
48-163	9000-9001	(	_	
48-164	9001-9004	13%	_	
48-165	9004-9005	)	_	
48-166	9006-9007	/	_	
48-167	9008-9010	11	_	
48-168	9011-9012	(	_	
48-169	9012-9015	10%	_	
48-170	9015-9016	)	_	
48-171	9019-9023	Five	_	
48-172	9024-9029	Scans	_	
48-173	9030-9031	7	_	
48-174	9032-9033	(	_	
48-175	9033-9035	8%	_	
48-176	9035-9036	)	_	
48-177	9037-9038	/	_	
48-178	9039-9040	7	_	
48-179	9041-9042	(	_	
48-180	9042-9044	6%	_	
48-181	9044-9045	)	_	
48-182	9048-9051	Six	_	
48-183	9052-9057	Scans	_	
48-184	9058-9059	3	_	
48-185	9060-9061	(	_	
48-186	9061-9063	3%	_	
48-187	9063-9064	)	_	
48-188	9065-9066	/	_	
48-189	9067-9068	3	_	
48-190	9069-9070	(	_	
48-191	9070-9072	3%	_	
48-192	9072-9073	)	_	
48-193	9076-9081	Seven	_	
48-194	9082-9087	Scans	_	
48-195	9088-9089	2	_	
48-196	9090-9091	(	_	
48-197	9091-9093	2%	_	
48-198	9093-9094	)	_	
48-199	9095-9096	/	_	
48-200	9097-9098	2	_	
48-201	9099-9100	(	_	
48-202	9100-9102	2%	_	
48-203	9102-9103	)	_	
48-204	9106-9111	Total	_	
48-205	9112-9117	Scans	_	
48-206	9118-9121	215	_	
48-207	9122-9124	34	_	
48-208	9125-9128	249	_	
48-209	9132-9135	The	_	
48-210	9136-9141	study	_	
48-211	9142-9145	was	_	
48-212	9146-9156	originally	_	
48-213	9157-9164	planned	_	
48-214	9165-9169	with	_	
48-215	9170-9171	a	_	
48-216	9172-9184	longitudinal	_	
48-217	9185-9191	design	_	
48-218	9191-9192	,	_	
48-219	9193-9196	and	_	
48-220	9197-9200	all	_	
48-221	9201-9213	participants	_	
48-222	9213-9214	’	_	
48-223	9215-9223	families	_	
48-224	9224-9228	were	_	
48-225	9229-9236	invited	_	
48-226	9237-9239	to	_	
48-227	9240-9246	return	_	
48-228	9247-9250	for	_	
48-229	9251-9261	subsequent	_	
48-230	9262-9267	scans	_	
48-231	9268-9281	approximately	_	
48-232	9282-9287	every	_	
48-233	9288-9291	six	_	
48-234	9292-9298	months	_	
48-235	9299-9305	before	_	
48-236	9306-9312	school	_	
48-237	9313-9316	age	_	
48-238	9316-9317	,	_	
48-239	9318-9321	and	_	
48-240	9322-9330	annually	_	
48-241	9331-9341	thereafter	_	
48-242	9341-9342	.	_	

#Text=After removing scans with severe head motion (see details in Data preprocessing), unfinished scans (any fMRI scans with < 250 vol), and scans where participants were asleep, a total of 249 fMRI datasets (215 datasets from 87 control participants, 34 datasets from 26 participants with PAE, less head motion, non-sleep and full 250 vol) were included in the present study (Table 1).
49-1	9343-9348	After	_	
49-2	9349-9357	removing	_	
49-3	9358-9363	scans	_	
49-4	9364-9368	with	_	
49-5	9369-9375	severe	_	
49-6	9376-9380	head	_	
49-7	9381-9387	motion	_	
49-8	9388-9389	(	_	
49-9	9389-9392	see	_	
49-10	9393-9400	details	_	
49-11	9401-9403	in	_	
49-12	9404-9408	Data	_	
49-13	9409-9422	preprocessing	_	
49-14	9422-9423	)	_	
49-15	9423-9424	,	_	
49-16	9425-9435	unfinished	_	
49-17	9436-9441	scans	_	
49-18	9442-9443	(	_	
49-19	9443-9446	any	_	
49-20	9447-9451	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging	
49-21	9452-9457	scans	_	
49-22	9458-9462	with	_	
49-23	9463-9464	<	_	
49-24	9465-9468	250	_	
49-25	9469-9472	vol	_	
49-26	9472-9473	)	_	
49-27	9473-9474	,	_	
49-28	9475-9478	and	_	
49-29	9479-9484	scans	_	
49-30	9485-9490	where	_	
49-31	9491-9503	participants	_	
49-32	9504-9508	were	_	
49-33	9509-9515	asleep	_	
49-34	9515-9516	,	_	
49-35	9517-9518	a	_	
49-36	9519-9524	total	_	
49-37	9525-9527	of	_	
49-38	9528-9531	249	_	
49-39	9532-9536	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging	
49-40	9537-9545	datasets	_	
49-41	9546-9547	(	_	
49-42	9547-9550	215	_	
49-43	9551-9559	datasets	_	
49-44	9560-9564	from	_	
49-45	9565-9567	87	_	
49-46	9568-9575	control	_	
49-47	9576-9588	participants	_	
49-48	9588-9589	,	_	
49-49	9590-9592	34	_	
49-50	9593-9601	datasets	_	
49-51	9602-9606	from	_	
49-52	9607-9609	26	_	
49-53	9610-9622	participants	_	
49-54	9623-9627	with	_	
49-55	9628-9631	PAE	_	
49-56	9631-9632	,	_	
49-57	9633-9637	less	_	
49-58	9638-9642	head	_	
49-59	9643-9649	motion	_	
49-60	9649-9650	,	_	
49-61	9651-9660	non-sleep	_	
49-62	9661-9664	and	_	
49-63	9665-9669	full	_	
49-64	9670-9673	250	_	
49-65	9674-9677	vol	_	
49-66	9677-9678	)	_	
49-67	9679-9683	were	_	
49-68	9684-9692	included	_	
49-69	9693-9695	in	_	
49-70	9696-9699	the	_	
49-71	9700-9707	present	_	
49-72	9708-9713	study	_	
49-73	9714-9715	(	_	
49-74	9715-9720	Table	_	
49-75	9720-9721	 	_	
49-76	9721-9722	1	_	
49-77	9722-9723	)	_	
49-78	9723-9724	.	_	

#Text=Because data collection from the children with PAE began after the control data collection, fewer participants with PAE had multiple scans.
50-1	9725-9732	Because	_	
50-2	9733-9737	data	_	
50-3	9738-9748	collection	_	
50-4	9749-9753	from	_	
50-5	9754-9757	the	_	
50-6	9758-9766	children	_	
50-7	9767-9771	with	_	
50-8	9772-9775	PAE	_	
50-9	9776-9781	began	_	
50-10	9782-9787	after	_	
50-11	9788-9791	the	_	
50-12	9792-9799	control	_	
50-13	9800-9804	data	_	
50-14	9805-9815	collection	_	
50-15	9815-9816	,	_	
50-16	9817-9822	fewer	_	
50-17	9823-9835	participants	_	
50-18	9836-9840	with	_	
50-19	9841-9844	PAE	_	
50-20	9845-9848	had	_	
50-21	9849-9857	multiple	_	
50-22	9858-9863	scans	_	
50-23	9863-9864	.	_	

#Text=Parents or legal guardians of all participants provided written informed consent, and all participants provided verbal assent.
51-1	9865-9872	Parents	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
51-2	9873-9875	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
51-3	9876-9881	legal	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
51-4	9882-9891	guardians	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
51-5	9892-9894	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
51-6	9895-9898	all	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
51-7	9899-9911	participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
51-8	9912-9920	provided	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
51-9	9921-9928	written	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
51-10	9929-9937	informed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
51-11	9938-9945	consent	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
51-12	9945-9946	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
51-13	9947-9950	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
51-14	9951-9954	all	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
51-15	9955-9967	participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
51-16	9968-9976	provided	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
51-17	9977-9983	verbal	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
51-18	9984-9990	assent	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
51-19	9990-9991	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	

#Text=The study was approved by the conjoint health research ethics board at the University of Calgary.
52-1	9992-9995	The	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
52-2	9996-10001	study	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
52-3	10002-10005	was	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
52-4	10006-10014	approved	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
52-5	10015-10017	by	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
52-6	10018-10021	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
52-7	10022-10030	conjoint	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
52-8	10031-10037	health	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
52-9	10038-10046	research	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
52-10	10047-10053	ethics	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
52-11	10054-10059	board	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
52-12	10060-10062	at	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
52-13	10063-10066	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
52-14	10067-10077	University	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
52-15	10078-10080	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
52-16	10081-10088	Calgary	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
52-17	10088-10089	.	_	

#Text=MRI parameters
#Text=Imaging was conducted on a GE 3T MR750w (General Electric, Waukesha, WI) scanner equipped with a 32-channel head-coil at the Alberta Children’s Hospital in Calgary, Canada.
53-1	10090-10093	MRI	_	
53-2	10094-10104	parameters	_	
53-3	10105-10112	Imaging	_	
53-4	10113-10116	was	_	
53-5	10117-10126	conducted	_	
53-6	10127-10129	on	_	
53-7	10130-10131	a	_	
53-8	10132-10134	GE	_	
53-9	10135-10137	3T	_	
53-10	10138-10144	MR750w	_	
53-11	10145-10146	(	_	
53-12	10146-10153	General	_	
53-13	10154-10162	Electric	_	
53-14	10162-10163	,	_	
53-15	10164-10172	Waukesha	_	
53-16	10172-10173	,	_	
53-17	10174-10176	WI	_	
53-18	10176-10177	)	_	
53-19	10178-10185	scanner	_	
53-20	10186-10194	equipped	_	
53-21	10195-10199	with	_	
53-22	10200-10201	a	_	
53-23	10202-10204	32	_	
53-24	10204-10205	-	_	
53-25	10205-10212	channel	_	
53-26	10213-10222	head-coil	_	
53-27	10223-10225	at	_	
53-28	10226-10229	the	_	
53-29	10230-10237	Alberta	_	
53-30	10238-10246	Children	_	
53-31	10246-10247	’	_	
53-32	10247-10248	s	_	
53-33	10249-10257	Hospital	_	
53-34	10258-10260	in	_	
53-35	10261-10268	Calgary	_	
53-36	10268-10269	,	_	
53-37	10270-10276	Canada	_	
53-38	10276-10277	.	_	

#Text=Children were not sedated, and were watching a movie of their choice for the entire duration of the MRI scan.
54-1	10278-10286	Children	_	
54-2	10287-10291	were	_	
54-3	10292-10295	not	_	
54-4	10296-10303	sedated	_	
54-5	10303-10304	,	_	
54-6	10305-10308	and	_	
54-7	10309-10313	were	_	
54-8	10314-10322	watching	_	
54-9	10323-10324	a	_	
54-10	10325-10330	movie	_	
54-11	10331-10333	of	_	
54-12	10334-10339	their	_	
54-13	10340-10346	choice	_	
54-14	10347-10350	for	_	
54-15	10351-10354	the	_	
54-16	10355-10361	entire	_	
54-17	10362-10370	duration	_	
54-18	10371-10373	of	_	
54-19	10374-10377	the	_	
54-20	10378-10381	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging	
54-21	10382-10386	scan	_	
54-22	10386-10387	.	_	

#Text=Headphones were equipped to receive movie audio and to communicate with scanning staff.
55-1	10388-10398	Headphones	_	
55-2	10399-10403	were	_	
55-3	10404-10412	equipped	_	
55-4	10413-10415	to	_	
55-5	10416-10423	receive	_	
55-6	10424-10429	movie	_	
55-7	10430-10435	audio	_	
55-8	10436-10439	and	_	
55-9	10440-10442	to	_	
55-10	10443-10454	communicate	_	
55-11	10455-10459	with	_	
55-12	10460-10468	scanning	_	
55-13	10469-10474	staff	_	
55-14	10474-10475	.	_	

#Text=T1-weighted data acquisition used an FSPGR BRAVO sequence with flip angle = 12º, 210 slices, TR = 8.23 ms, TE = 3.76 ms, voxel size = 0.9 × 0.9 × 0.9 mm, matrix size = 512 × 512, inversion time = 540 ms.
56-1	10476-10478	T1	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[10]	
56-2	10478-10479	-	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[10]	
56-3	10479-10487	weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[10]	
56-4	10488-10492	data	_	
56-5	10493-10504	acquisition	_	
56-6	10505-10509	used	_	
56-7	10510-10512	an	_	
56-8	10513-10518	FSPGR	_	
56-9	10519-10524	BRAVO	_	
56-10	10525-10533	sequence	_	
56-11	10534-10538	with	_	
56-12	10539-10543	flip	_	
56-13	10544-10549	angle	_	
56-14	10549-10550	 	_	
56-15	10550-10551	=	_	
56-16	10551-10552	 	_	
56-17	10552-10555	12º	_	
56-18	10555-10556	,	_	
56-19	10557-10560	210	_	
56-20	10561-10567	slices	_	
56-21	10567-10568	,	_	
56-22	10569-10571	TR	_	
56-23	10571-10572	 	_	
56-24	10572-10573	=	_	
56-25	10573-10574	 	_	
56-26	10574-10578	8.23	_	
56-27	10578-10579	 	_	
56-28	10579-10581	ms	_	
56-29	10581-10582	,	_	
56-30	10583-10585	TE	_	
56-31	10585-10586	 	_	
56-32	10586-10587	=	_	
56-33	10587-10588	 	_	
56-34	10588-10592	3.76	_	
56-35	10592-10593	 	_	
56-36	10593-10595	ms	_	
56-37	10595-10596	,	_	
56-38	10597-10602	voxel	_	
56-39	10603-10607	size	_	
56-40	10607-10608	 	_	
56-41	10608-10609	=	_	
56-42	10609-10610	 	_	
56-43	10610-10613	0.9	_	
56-44	10613-10614	 	_	
56-45	10614-10615	×	_	
56-46	10615-10616	 	_	
56-47	10616-10619	0.9	_	
56-48	10619-10620	 	_	
56-49	10620-10621	×	_	
56-50	10621-10622	 	_	
56-51	10622-10625	0.9	_	
56-52	10625-10626	 	_	
56-53	10626-10628	mm	_	
56-54	10628-10629	,	_	
56-55	10630-10636	matrix	_	
56-56	10637-10641	size	_	
56-57	10641-10642	 	_	
56-58	10642-10643	=	_	
56-59	10643-10644	 	_	
56-60	10644-10647	512	_	
56-61	10647-10648	 	_	
56-62	10648-10649	×	_	
56-63	10649-10650	 	_	
56-64	10650-10653	512	_	
56-65	10653-10654	,	_	
56-66	10655-10664	inversion	_	
56-67	10665-10669	time	_	
56-68	10669-10670	 	_	
56-69	10670-10671	=	_	
56-70	10671-10672	 	_	
56-71	10672-10675	540	_	
56-72	10675-10676	 	_	
56-73	10676-10678	ms	_	
56-74	10678-10679	.	_	

#Text=Data acquisition for fMRI used a gradient- echo-planar imaging (EPI) sequence with TR = 2 s, TE = 30 ms, flip angle = 60º, 36 slices, voxel size = 3.59 × 3.59 × 3.6 mm, matrix size = 64 × 64, 250 vol, total scan time 8:10 min.
57-1	10680-10684	Data	_	
57-2	10685-10696	acquisition	_	
57-3	10697-10700	for	_	
57-4	10701-10705	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging	
57-5	10706-10710	used	_	
57-6	10711-10712	a	_	
57-7	10713-10721	gradient	_	
57-8	10721-10722	-	_	
57-9	10723-10734	echo-planar	_	
57-10	10735-10742	imaging	_	
57-11	10743-10744	(	_	
57-12	10744-10747	EPI	_	
57-13	10747-10748	)	_	
57-14	10749-10757	sequence	_	
57-15	10758-10762	with	_	
57-16	10763-10765	TR	_	
57-17	10765-10766	 	_	
57-18	10766-10767	=	_	
57-19	10767-10768	 	_	
57-20	10768-10769	2	_	
57-21	10769-10770	 	_	
57-22	10770-10771	s	_	
57-23	10771-10772	,	_	
57-24	10773-10775	TE	_	
57-25	10775-10776	 	_	
57-26	10776-10777	=	_	
57-27	10777-10778	 	_	
57-28	10778-10780	30	_	
57-29	10780-10781	 	_	
57-30	10781-10783	ms	_	
57-31	10783-10784	,	_	
57-32	10785-10789	flip	_	
57-33	10790-10795	angle	_	
57-34	10795-10796	 	_	
57-35	10796-10797	=	_	
57-36	10797-10798	 	_	
57-37	10798-10801	60º	_	
57-38	10801-10802	,	_	
57-39	10803-10805	36	_	
57-40	10806-10812	slices	_	
57-41	10812-10813	,	_	
57-42	10814-10819	voxel	_	
57-43	10820-10824	size	_	
57-44	10824-10825	 	_	
57-45	10825-10826	=	_	
57-46	10826-10827	 	_	
57-47	10827-10831	3.59	_	
57-48	10831-10832	 	_	
57-49	10832-10833	×	_	
57-50	10833-10834	 	_	
57-51	10834-10838	3.59	_	
57-52	10838-10839	 	_	
57-53	10839-10840	×	_	
57-54	10840-10841	 	_	
57-55	10841-10844	3.6	_	
57-56	10844-10845	 	_	
57-57	10845-10847	mm	_	
57-58	10847-10848	,	_	
57-59	10849-10855	matrix	_	
57-60	10856-10860	size	_	
57-61	10860-10861	 	_	
57-62	10861-10862	=	_	
57-63	10862-10863	 	_	
57-64	10863-10865	64	_	
57-65	10865-10866	 	_	
57-66	10866-10867	×	_	
57-67	10867-10868	 	_	
57-68	10868-10870	64	_	
57-69	10870-10871	,	_	
57-70	10872-10875	250	_	
57-71	10876-10879	vol	_	
57-72	10879-10880	,	_	
57-73	10881-10886	total	_	
57-74	10887-10891	scan	_	
57-75	10892-10896	time	_	
57-76	10897-10898	8	_	
57-77	10898-10899	:	_	
57-78	10899-10901	10	_	
57-79	10901-10902	 	_	
57-80	10902-10905	min	_	
57-81	10905-10906	.	_	

#Text=The entire protocol including other modalities lasted 45–60 min, depending on whether sequences needed to be repeated.
58-1	10907-10910	The	_	
58-2	10911-10917	entire	_	
58-3	10918-10926	protocol	_	
58-4	10927-10936	including	_	
58-5	10937-10942	other	_	
58-6	10943-10953	modalities	_	
58-7	10954-10960	lasted	_	
58-8	10961-10963	45	_	
58-9	10963-10964	–	_	
58-10	10964-10966	60	_	
58-11	10966-10967	 	_	
58-12	10967-10970	min	_	
58-13	10970-10971	,	_	
58-14	10972-10981	depending	_	
58-15	10982-10984	on	_	
58-16	10985-10992	whether	_	
58-17	10993-11002	sequences	_	
58-18	11003-11009	needed	_	
58-19	11010-11012	to	_	
58-20	11013-11015	be	_	
58-21	11016-11024	repeated	_	
58-22	11024-11025	.	_	

#Text=In some cases, children requested that the scan be stopped, or they were moving too much to collect high quality data, and the scan was stopped early.
59-1	11026-11028	In	_	
59-2	11029-11033	some	_	
59-3	11034-11039	cases	_	
59-4	11039-11040	,	_	
59-5	11041-11049	children	_	
59-6	11050-11059	requested	_	
59-7	11060-11064	that	_	
59-8	11065-11068	the	_	
59-9	11069-11073	scan	_	
59-10	11074-11076	be	_	
59-11	11077-11084	stopped	_	
59-12	11084-11085	,	_	
59-13	11086-11088	or	_	
59-14	11089-11093	they	_	
59-15	11094-11098	were	_	
59-16	11099-11105	moving	_	
59-17	11106-11109	too	_	
59-18	11110-11114	much	_	
59-19	11115-11117	to	_	
59-20	11118-11125	collect	_	
59-21	11126-11130	high	_	
59-22	11131-11138	quality	_	
59-23	11139-11143	data	_	
59-24	11143-11144	,	_	
59-25	11145-11148	and	_	
59-26	11149-11152	the	_	
59-27	11153-11157	scan	_	
59-28	11158-11161	was	_	
59-29	11162-11169	stopped	_	
59-30	11170-11175	early	_	
59-31	11175-11176	.	_	

#Text=Data preprocessing
#Text=Data preprocessing was completed in AFNI and FSL.
60-1	11177-11181	Data	_	
60-2	11182-11195	preprocessing	_	
60-3	11196-11200	Data	_	
60-4	11201-11214	preprocessing	_	
60-5	11215-11218	was	_	
60-6	11219-11228	completed	_	
60-7	11229-11231	in	_	
60-8	11232-11236	AFNI	_	
60-9	11237-11240	and	_	
60-10	11241-11244	FSL	_	
60-11	11244-11245	.	_	

#Text=Each participant's T1-weighted image was skull stripped and segmented into gray matter, white matter, and cerebrospinal fluid (CSF) images and co-registered to their individual fMRI space.
61-1	11246-11250	Each	_	
61-2	11251-11264	participant's	_	
61-3	11265-11267	T1	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[11]	
61-4	11267-11268	-	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[11]	
61-5	11268-11276	weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[11]	
61-6	11277-11282	image	_	
61-7	11283-11286	was	_	
61-8	11287-11292	skull	_	
61-9	11293-11301	stripped	_	
61-10	11302-11305	and	_	
61-11	11306-11315	segmented	_	
61-12	11316-11320	into	_	
61-13	11321-11325	gray	_	
61-14	11326-11332	matter	_	
61-15	11332-11333	,	_	
61-16	11334-11339	white	_	
61-17	11340-11346	matter	_	
61-18	11346-11347	,	_	
61-19	11348-11351	and	_	
61-20	11352-11365	cerebrospinal	_	
61-21	11366-11371	fluid	_	
61-22	11372-11373	(	_	
61-23	11373-11376	CSF	_	
61-24	11376-11377	)	_	
61-25	11378-11384	images	_	
61-26	11385-11388	and	_	
61-27	11389-11402	co-registered	_	
61-28	11403-11405	to	_	
61-29	11406-11411	their	_	
61-30	11412-11422	individual	_	
61-31	11423-11427	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging	
61-32	11428-11433	space	_	
61-33	11433-11434	.	_	

#Text=Total brain volume was calculated as the sum of gray and white matter volumes and used as a covariate due to its potential effect on the graph measures.
62-1	11435-11440	Total	_	
62-2	11441-11446	brain	_	
62-3	11447-11453	volume	_	
62-4	11454-11457	was	_	
62-5	11458-11468	calculated	_	
62-6	11469-11471	as	_	
62-7	11472-11475	the	_	
62-8	11476-11479	sum	_	
62-9	11480-11482	of	_	
62-10	11483-11487	gray	_	
62-11	11488-11491	and	_	
62-12	11492-11497	white	_	
62-13	11498-11504	matter	_	
62-14	11505-11512	volumes	_	
62-15	11513-11516	and	_	
62-16	11517-11521	used	_	
62-17	11522-11524	as	_	
62-18	11525-11526	a	_	
62-19	11527-11536	covariate	_	
62-20	11537-11540	due	_	
62-21	11541-11543	to	_	
62-22	11544-11547	its	_	
62-23	11548-11557	potential	_	
62-24	11558-11564	effect	_	
62-25	11565-11567	on	_	
62-26	11568-11571	the	_	
62-27	11572-11577	graph	_	
62-28	11578-11586	measures	_	
62-29	11586-11587	.	_	

#Text=The first 10 volumes of the passive viewing fMRI data were removed to allow for environmental adaptation and signal stabilization; 240 volumes remained.
63-1	11588-11591	The	_	
63-2	11592-11597	first	_	
63-3	11598-11600	10	_	
63-4	11601-11608	volumes	_	
63-5	11609-11611	of	_	
63-6	11612-11615	the	_	
63-7	11616-11623	passive	_	
63-8	11624-11631	viewing	_	
63-9	11632-11636	fMRI	_	
63-10	11637-11641	data	_	
63-11	11642-11646	were	_	
63-12	11647-11654	removed	_	
63-13	11655-11657	to	_	
63-14	11658-11663	allow	_	
63-15	11664-11667	for	_	
63-16	11668-11681	environmental	_	
63-17	11682-11692	adaptation	_	
63-18	11693-11696	and	_	
63-19	11697-11703	signal	_	
63-20	11704-11717	stabilization	_	
63-21	11717-11718	;	_	
63-22	11719-11722	240	_	
63-23	11723-11730	volumes	_	
63-24	11731-11739	remained	_	
63-25	11739-11740	.	_	

#Text=Correction of slice timing and head motion were performed.
64-1	11741-11751	Correction	_	
64-2	11752-11754	of	_	
64-3	11755-11760	slice	_	
64-4	11761-11767	timing	_	
64-5	11768-11771	and	_	
64-6	11772-11776	head	_	
64-7	11777-11783	motion	_	
64-8	11784-11788	were	_	
64-9	11789-11798	performed	_	
64-10	11798-11799	.	_	

#Text=The averaged relative frame-wise displacement (FD) was calculated for further analysis.
65-1	11800-11803	The	_	
65-2	11804-11812	averaged	_	
65-3	11813-11821	relative	_	
65-4	11822-11832	frame-wise	_	
65-5	11833-11845	displacement	_	
65-6	11846-11847	(	_	
65-7	11847-11849	FD	_	
65-8	11849-11850	)	_	
65-9	11851-11854	was	_	
65-10	11855-11865	calculated	_	
65-11	11866-11869	for	_	
65-12	11870-11877	further	_	
65-13	11878-11886	analysis	_	
65-14	11886-11887	.	_	

#Text=A 36-parameter matrix was created from the averaged signals from the individual whole brain mask, CSF mask, white matter mask, the six head motion parameters, and their temporal derivatives and quadratic term signals.
66-1	11888-11889	A	_	
66-2	11890-11892	36	_	
66-3	11892-11893	-	_	
66-4	11893-11902	parameter	_	
66-5	11903-11909	matrix	_	
66-6	11910-11913	was	_	
66-7	11914-11921	created	_	
66-8	11922-11926	from	_	
66-9	11927-11930	the	_	
66-10	11931-11939	averaged	_	
66-11	11940-11947	signals	_	
66-12	11948-11952	from	_	
66-13	11953-11956	the	_	
66-14	11957-11967	individual	_	
66-15	11968-11973	whole	_	
66-16	11974-11979	brain	_	
66-17	11980-11984	mask	_	
66-18	11984-11985	,	_	
66-19	11986-11989	CSF	_	
66-20	11990-11994	mask	_	
66-21	11994-11995	,	_	
66-22	11996-12001	white	_	
66-23	12002-12008	matter	_	
66-24	12009-12013	mask	_	
66-25	12013-12014	,	_	
66-26	12015-12018	the	_	
66-27	12019-12022	six	_	
66-28	12023-12027	head	_	
66-29	12028-12034	motion	_	
66-30	12035-12045	parameters	_	
66-31	12045-12046	,	_	
66-32	12047-12050	and	_	
66-33	12051-12056	their	_	
66-34	12057-12065	temporal	_	
66-35	12066-12077	derivatives	_	
66-36	12078-12081	and	_	
66-37	12082-12091	quadratic	_	
66-38	12092-12096	term	_	
66-39	12097-12104	signals	_	
66-40	12104-12105	.	_	

#Text=A spike matrix was created from volumes that had high relative FD (> 0.3 mm).
67-1	12106-12107	A	_	
67-2	12108-12113	spike	_	
67-3	12114-12120	matrix	_	
67-4	12121-12124	was	_	
67-5	12125-12132	created	_	
67-6	12133-12137	from	_	
67-7	12138-12145	volumes	_	
67-8	12146-12150	that	_	
67-9	12151-12154	had	_	
67-10	12155-12159	high	_	
67-11	12160-12168	relative	_	
67-12	12169-12171	FD	_	
67-13	12172-12173	(	_	
67-14	12173-12174	>	_	
67-15	12175-12178	0.3	_	
67-16	12178-12179	 	_	
67-17	12179-12181	mm	_	
67-18	12181-12182	)	_	
67-19	12182-12183	.	_	

#Text=Then the combination of the 36-parameter matrix and the spike matrix were regressed out of the fMRI signals.
68-1	12184-12188	Then	_	
68-2	12189-12192	the	_	
68-3	12193-12204	combination	_	
68-4	12205-12207	of	_	
68-5	12208-12211	the	_	
68-6	12212-12214	36	_	
68-7	12214-12215	-	_	
68-8	12215-12224	parameter	_	
68-9	12225-12231	matrix	_	
68-10	12232-12235	and	_	
68-11	12236-12239	the	_	
68-12	12240-12245	spike	_	
68-13	12246-12252	matrix	_	
68-14	12253-12257	were	_	
68-15	12258-12267	regressed	_	
68-16	12268-12271	out	_	
68-17	12272-12274	of	_	
68-18	12275-12278	the	_	
68-19	12279-12283	fMRI	_	
68-20	12284-12291	signals	_	
68-21	12291-12292	.	_	

#Text=Datasets with spike volumes longer than 4 min (i.e., less than 4 min of low-motion data) were excluded from the study.
69-1	12293-12301	Datasets	_	
69-2	12302-12306	with	_	
69-3	12307-12312	spike	_	
69-4	12313-12320	volumes	_	
69-5	12321-12327	longer	_	
69-6	12328-12332	than	_	
69-7	12333-12334	4	_	
69-8	12334-12335	 	_	
69-9	12335-12338	min	_	
69-10	12339-12340	(	_	
69-11	12340-12343	i.e	_	
69-12	12343-12344	.	_	
69-13	12344-12345	,	_	
69-14	12346-12350	less	_	
69-15	12351-12355	than	_	
69-16	12356-12357	4	_	
69-17	12357-12358	 	_	
69-18	12358-12361	min	_	
69-19	12362-12364	of	_	
69-20	12365-12375	low-motion	_	
69-21	12376-12380	data	_	
69-22	12380-12381	)	_	
69-23	12382-12386	were	_	
69-24	12387-12395	excluded	_	
69-25	12396-12400	from	_	
69-26	12401-12404	the	_	
69-27	12405-12410	study	_	
69-28	12410-12411	.	_	

#Text=Finally, the residual fMRI signals were band-pass filtered (0.009 to 0.08 Hz), underwent linear-trend removal, spatially transformed to MNI standard space using a pediatric template aged from 4.5 to 8.5 years, and spatially smoothed with a 4 mm full width at half maximum kernel.
70-1	12412-12419	Finally	_	
70-2	12419-12420	,	_	
70-3	12421-12424	the	_	
70-4	12425-12433	residual	_	
70-5	12434-12438	fMRI	_	
70-6	12439-12446	signals	_	
70-7	12447-12451	were	_	
70-8	12452-12461	band-pass	_	
70-9	12462-12470	filtered	_	
70-10	12471-12472	(	_	
70-11	12472-12477	0.009	_	
70-12	12478-12480	to	_	
70-13	12481-12485	0.08	_	
70-14	12485-12486	 	_	
70-15	12486-12488	Hz	_	
70-16	12488-12489	)	_	
70-17	12489-12490	,	_	
70-18	12491-12500	underwent	_	
70-19	12501-12513	linear-trend	_	
70-20	12514-12521	removal	_	
70-21	12521-12522	,	_	
70-22	12523-12532	spatially	_	
70-23	12533-12544	transformed	_	
70-24	12545-12547	to	_	
70-25	12548-12551	MNI	_	
70-26	12552-12560	standard	_	
70-27	12561-12566	space	_	
70-28	12567-12572	using	_	
70-29	12573-12574	a	_	
70-30	12575-12584	pediatric	_	
70-31	12585-12593	template	_	
70-32	12594-12598	aged	_	
70-33	12599-12603	from	_	
70-34	12604-12607	4.5	_	
70-35	12608-12610	to	_	
70-36	12611-12614	8.5	_	
70-37	12615-12620	years	_	
70-38	12620-12621	,	_	
70-39	12622-12625	and	_	
70-40	12626-12635	spatially	_	
70-41	12636-12644	smoothed	_	
70-42	12645-12649	with	_	
70-43	12650-12651	a	_	
70-44	12652-12653	4	_	
70-45	12653-12654	 	_	
70-46	12654-12656	mm	_	
70-47	12657-12661	full	_	
70-48	12662-12667	width	_	
70-49	12668-12670	at	_	
70-50	12671-12675	half	_	
70-51	12676-12683	maximum	_	
70-52	12684-12690	kernel	_	
70-53	12690-12691	.	_	

#Text=Slice timing, head motion correction, T1-weighted image segmentation, head motion outlier detection, co-registration, and spatial normalization and smoothing were done in FSL.
71-1	12692-12697	Slice	_	
71-2	12698-12704	timing	_	
71-3	12704-12705	,	_	
71-4	12706-12710	head	_	
71-5	12711-12717	motion	_	
71-6	12718-12728	correction	_	
71-7	12728-12729	,	_	
71-8	12730-12732	T1	_	
71-9	12732-12733	-	_	
71-10	12733-12741	weighted	_	
71-11	12742-12747	image	_	
71-12	12748-12760	segmentation	_	
71-13	12760-12761	,	_	
71-14	12762-12766	head	_	
71-15	12767-12773	motion	_	
71-16	12774-12781	outlier	_	
71-17	12782-12791	detection	_	
71-18	12791-12792	,	_	
71-19	12793-12808	co-registration	_	
71-20	12808-12809	,	_	
71-21	12810-12813	and	_	
71-22	12814-12821	spatial	_	
71-23	12822-12835	normalization	_	
71-24	12836-12839	and	_	
71-25	12840-12849	smoothing	_	
71-26	12850-12854	were	_	
71-27	12855-12859	done	_	
71-28	12860-12862	in	_	
71-29	12863-12866	FSL	_	
71-30	12866-12867	.	_	

#Text=Regression of the nuisance signals, band-pass filtering and linear trend removal were done using AFNI version AFNI_17.3.03.
72-1	12868-12878	Regression	_	
72-2	12879-12881	of	_	
72-3	12882-12885	the	_	
72-4	12886-12894	nuisance	_	
72-5	12895-12902	signals	_	
72-6	12902-12903	,	_	
72-7	12904-12913	band-pass	_	
72-8	12914-12923	filtering	_	
72-9	12924-12927	and	_	
72-10	12928-12934	linear	_	
72-11	12935-12940	trend	_	
72-12	12941-12948	removal	_	
72-13	12949-12953	were	_	
72-14	12954-12958	done	_	
72-15	12959-12964	using	_	
72-16	12965-12969	AFNI	_	
72-17	12970-12977	version	_	
72-18	12978-12982	AFNI	_	
72-19	12982-12983	_	_	
72-20	12983-12990	17.3.03	_	
72-21	12990-12991	.	_	

#Text=Functional connectome constructions
#Text=Schematic showing the functional connectome analysis pipeline. a) 90×90 connectivity matrices based on the AAL template were calculated for each participant based on the entire fMRI dataset, then the first half and the second half of each dataset separately.
73-1	12992-13002	Functional	_	
73-2	13003-13013	connectome	_	
73-3	13014-13027	constructions	_	
73-4	13028-13037	Schematic	_	
73-5	13038-13045	showing	_	
73-6	13046-13049	the	_	
73-7	13050-13060	functional	_	
73-8	13061-13071	connectome	_	
73-9	13072-13080	analysis	_	
73-10	13081-13089	pipeline	_	
73-11	13089-13090	.	_	
73-12	13091-13092	a	_	
73-13	13092-13093	)	_	
73-14	13094-13096	90	_	
73-15	13096-13097	×	_	
73-16	13097-13099	90	_	
73-17	13100-13112	connectivity	_	
73-18	13113-13121	matrices	_	
73-19	13122-13127	based	_	
73-20	13128-13130	on	_	
73-21	13131-13134	the	_	
73-22	13135-13138	AAL	_	
73-23	13139-13147	template	_	
73-24	13148-13152	were	_	
73-25	13153-13163	calculated	_	
73-26	13164-13167	for	_	
73-27	13168-13172	each	_	
73-28	13173-13184	participant	_	
73-29	13185-13190	based	_	
73-30	13191-13193	on	_	
73-31	13194-13197	the	_	
73-32	13198-13204	entire	_	
73-33	13205-13209	fMRI	_	
73-34	13210-13217	dataset	_	
73-35	13217-13218	,	_	
73-36	13219-13223	then	_	
73-37	13224-13227	the	_	
73-38	13228-13233	first	_	
73-39	13234-13238	half	_	
73-40	13239-13242	and	_	
73-41	13243-13246	the	_	
73-42	13247-13253	second	_	
73-43	13254-13258	half	_	
73-44	13259-13261	of	_	
73-45	13262-13266	each	_	
73-46	13267-13274	dataset	_	
73-47	13275-13285	separately	_	
73-48	13285-13286	.	_	

#Text=Intra-participant stability was calculated as the correlation between connectivity matrices from the first and the second half of the data.
74-1	13287-13304	Intra-participant	_	
74-2	13305-13314	stability	_	
74-3	13315-13318	was	_	
74-4	13319-13329	calculated	_	
74-5	13330-13332	as	_	
74-6	13333-13336	the	_	
74-7	13337-13348	correlation	_	
74-8	13349-13356	between	_	
74-9	13357-13369	connectivity	_	
74-10	13370-13378	matrices	_	
74-11	13379-13383	from	_	
74-12	13384-13387	the	_	
74-13	13388-13393	first	_	
74-14	13394-13397	and	_	
74-15	13398-13401	the	_	
74-16	13402-13408	second	_	
74-17	13409-13413	half	_	
74-18	13414-13416	of	_	
74-19	13417-13420	the	_	
74-20	13421-13425	data	_	
74-21	13425-13426	.	_	

#Text=Correlations between intra-participant stability and age were examined for the PAE and control groups. c) To evaluate inter-individual stability, cross-correlation analysis was performed between entire dataset connectivity matrices for each participant within the same group, e.g., control group in the figure, and averaged to create one value per participant.
75-1	13427-13439	Correlations	_	
75-2	13440-13447	between	_	
75-3	13448-13465	intra-participant	_	
75-4	13466-13475	stability	_	
75-5	13476-13479	and	_	
75-6	13480-13483	age	_	
75-7	13484-13488	were	_	
75-8	13489-13497	examined	_	
75-9	13498-13501	for	_	
75-10	13502-13505	the	_	
75-11	13506-13509	PAE	_	
75-12	13510-13513	and	_	
75-13	13514-13521	control	_	
75-14	13522-13528	groups	_	
75-15	13528-13529	.	_	
75-16	13530-13531	c	_	
75-17	13531-13532	)	_	
75-18	13533-13535	To	_	
75-19	13536-13544	evaluate	_	
75-20	13545-13561	inter-individual	_	
75-21	13562-13571	stability	_	
75-22	13571-13572	,	_	
75-23	13573-13590	cross-correlation	_	
75-24	13591-13599	analysis	_	
75-25	13600-13603	was	_	
75-26	13604-13613	performed	_	
75-27	13614-13621	between	_	
75-28	13622-13628	entire	_	
75-29	13629-13636	dataset	_	
75-30	13637-13649	connectivity	_	
75-31	13650-13658	matrices	_	
75-32	13659-13662	for	_	
75-33	13663-13667	each	_	
75-34	13668-13679	participant	_	
75-35	13680-13686	within	_	
75-36	13687-13690	the	_	
75-37	13691-13695	same	_	
75-38	13696-13701	group	_	
75-39	13701-13702	,	_	
75-40	13703-13706	e.g	_	
75-41	13706-13707	.	_	
75-42	13707-13708	,	_	
75-43	13709-13716	control	_	
75-44	13717-13722	group	_	
75-45	13723-13725	in	_	
75-46	13726-13729	the	_	
75-47	13730-13736	figure	_	
75-48	13736-13737	,	_	
75-49	13738-13741	and	_	
75-50	13742-13750	averaged	_	
75-51	13751-13753	to	_	
75-52	13754-13760	create	_	
75-53	13761-13764	one	_	
75-54	13765-13770	value	_	
75-55	13771-13774	per	_	
75-56	13775-13786	participant	_	
75-57	13786-13787	.	_	

#Text=These were examined for correlations with age in each group.
76-1	13788-13793	These	_	
76-2	13794-13798	were	_	
76-3	13799-13807	examined	_	
76-4	13808-13811	for	_	
76-5	13812-13824	correlations	_	
76-6	13825-13829	with	_	
76-7	13830-13833	age	_	
76-8	13834-13836	in	_	
76-9	13837-13841	each	_	
76-10	13842-13847	group	_	
76-11	13847-13848	.	_	

#Text=Fig. 1
#Text=We used an adapted version of the stability analysis performed by Vanderwal and colleagues to investigate intra-individual stability of the functional connectome.
77-1	13849-13852	Fig	_	
77-2	13852-13853	.	_	
77-3	13854-13855	1	_	
77-4	13856-13858	We	_	
77-5	13859-13863	used	_	
77-6	13864-13866	an	_	
77-7	13867-13874	adapted	_	
77-8	13875-13882	version	_	
77-9	13883-13885	of	_	
77-10	13886-13889	the	_	
77-11	13890-13899	stability	_	
77-12	13900-13908	analysis	_	
77-13	13909-13918	performed	_	
77-14	13919-13921	by	_	
77-15	13922-13931	Vanderwal	_	
77-16	13932-13935	and	_	
77-17	13936-13946	colleagues	_	
77-18	13947-13949	to	_	
77-19	13950-13961	investigate	_	
77-20	13962-13978	intra-individual	_	
77-21	13979-13988	stability	_	
77-22	13989-13991	of	_	
77-23	13992-13995	the	_	
77-24	13996-14006	functional	_	
77-25	14007-14017	connectome	_	
77-26	14017-14018	.	_	

#Text=This analysis involved splitting the fMRI signal into two halves for each participant and comparing the similarity between halves.
78-1	14019-14023	This	_	
78-2	14024-14032	analysis	_	
78-3	14033-14041	involved	_	
78-4	14042-14051	splitting	_	
78-5	14052-14055	the	_	
78-6	14056-14060	fMRI	_	
78-7	14061-14067	signal	_	
78-8	14068-14072	into	_	
78-9	14073-14076	two	_	
78-10	14077-14083	halves	_	
78-11	14084-14087	for	_	
78-12	14088-14092	each	_	
78-13	14093-14104	participant	_	
78-14	14105-14108	and	_	
78-15	14109-14118	comparing	_	
78-16	14119-14122	the	_	
78-17	14123-14133	similarity	_	
78-18	14134-14141	between	_	
78-19	14142-14148	halves	_	
78-20	14148-14149	.	_	

#Text=To complete this, each participant's fMRI time series was split into two equal datasets with 120 time points each.
79-1	14150-14152	To	_	
79-2	14153-14161	complete	_	
79-3	14162-14166	this	_	
79-4	14166-14167	,	_	
79-5	14168-14172	each	_	
79-6	14173-14186	participant's	_	
79-7	14187-14191	fMRI	_	
79-8	14192-14196	time	_	
79-9	14197-14203	series	_	
79-10	14204-14207	was	_	
79-11	14208-14213	split	_	
79-12	14214-14218	into	_	
79-13	14219-14222	two	_	
79-14	14223-14228	equal	_	
79-15	14229-14237	datasets	_	
79-16	14238-14242	with	_	
79-17	14243-14246	120	_	
79-18	14247-14251	time	_	
79-19	14252-14258	points	_	
79-20	14259-14263	each	_	
79-21	14263-14264	.	_	

#Text=Each half of the dataset, as well as the entire dataset (all time points), were separately run through the following functional connectome analysis in AFNI.
80-1	14265-14269	Each	_	
80-2	14270-14274	half	_	
80-3	14275-14277	of	_	
80-4	14278-14281	the	_	
80-5	14282-14289	dataset	_	
80-6	14289-14290	,	_	
80-7	14291-14293	as	_	
80-8	14294-14298	well	_	
80-9	14299-14301	as	_	
80-10	14302-14305	the	_	
80-11	14306-14312	entire	_	
80-12	14313-14320	dataset	_	
80-13	14321-14322	(	_	
80-14	14322-14325	all	_	
80-15	14326-14330	time	_	
80-16	14331-14337	points	_	
80-17	14337-14338	)	_	
80-18	14338-14339	,	_	
80-19	14340-14344	were	_	
80-20	14345-14355	separately	_	
80-21	14356-14359	run	_	
80-22	14360-14367	through	_	
80-23	14368-14371	the	_	
80-24	14372-14381	following	_	
80-25	14382-14392	functional	_	
80-26	14393-14403	connectome	_	
80-27	14404-14412	analysis	_	
80-28	14413-14415	in	_	
80-29	14416-14420	AFNI	_	
80-30	14420-14421	.	_	

#Text=The Automated Anatomical Labeling (AAL) template was used to subdivide each participant's brain into 90 regions excluding the cerebellum.
81-1	14422-14425	The	_	
81-2	14426-14435	Automated	_	
81-3	14436-14446	Anatomical	_	
81-4	14447-14455	Labeling	_	
81-5	14456-14457	(	_	
81-6	14457-14460	AAL	_	
81-7	14460-14461	)	_	
81-8	14462-14470	template	_	
81-9	14471-14474	was	_	
81-10	14475-14479	used	_	
81-11	14480-14482	to	_	
81-12	14483-14492	subdivide	_	
81-13	14493-14497	each	_	
81-14	14498-14511	participant's	_	
81-15	14512-14517	brain	_	
81-16	14518-14522	into	_	
81-17	14523-14525	90	_	
81-18	14526-14533	regions	_	
81-19	14534-14543	excluding	_	
81-20	14544-14547	the	_	
81-21	14548-14558	cerebellum	_	
81-22	14558-14559	.	_	

#Text=The average time series was calculated within each AAL region, and then Pearson's correlation coefficients were calculated between the averaged time series of each pair of AAL regions and transformed to Fisher's z scores to create a 90 × 90 connectivity matrix for each dataset (Fig. 1a).
82-1	14560-14563	The	_	
82-2	14564-14571	average	_	
82-3	14572-14576	time	_	
82-4	14577-14583	series	_	
82-5	14584-14587	was	_	
82-6	14588-14598	calculated	_	
82-7	14599-14605	within	_	
82-8	14606-14610	each	_	
82-9	14611-14614	AAL	_	
82-10	14615-14621	region	_	
82-11	14621-14622	,	_	
82-12	14623-14626	and	_	
82-13	14627-14631	then	_	
82-14	14632-14641	Pearson's	_	
82-15	14642-14653	correlation	_	
82-16	14654-14666	coefficients	_	
82-17	14667-14671	were	_	
82-18	14672-14682	calculated	_	
82-19	14683-14690	between	_	
82-20	14691-14694	the	_	
82-21	14695-14703	averaged	_	
82-22	14704-14708	time	_	
82-23	14709-14715	series	_	
82-24	14716-14718	of	_	
82-25	14719-14723	each	_	
82-26	14724-14728	pair	_	
82-27	14729-14731	of	_	
82-28	14732-14735	AAL	_	
82-29	14736-14743	regions	_	
82-30	14744-14747	and	_	
82-31	14748-14759	transformed	_	
82-32	14760-14762	to	_	
82-33	14763-14771	Fisher's	_	
82-34	14772-14773	z	_	
82-35	14774-14780	scores	_	
82-36	14781-14783	to	_	
82-37	14784-14790	create	_	
82-38	14791-14792	a	_	
82-39	14793-14795	90	_	
82-40	14795-14796	 	_	
82-41	14796-14797	×	_	
82-42	14797-14798	 	_	
82-43	14798-14800	90	_	
82-44	14801-14813	connectivity	_	
82-45	14814-14820	matrix	_	
82-46	14821-14824	for	_	
82-47	14825-14829	each	_	
82-48	14830-14837	dataset	_	
82-49	14838-14839	(	_	
82-50	14839-14842	Fig	_	
82-51	14842-14843	.	_	
82-52	14843-14844	 	_	
82-53	14844-14846	1a	_	
82-54	14846-14847	)	_	
82-55	14847-14848	.	_	

#Text=Thus, three connectivity matrices were produced for each participant: one on the first half of their data, one on the second half, and one for the entire dataset.
83-1	14849-14853	Thus	_	
83-2	14853-14854	,	_	
83-3	14855-14860	three	_	
83-4	14861-14873	connectivity	_	
83-5	14874-14882	matrices	_	
83-6	14883-14887	were	_	
83-7	14888-14896	produced	_	
83-8	14897-14900	for	_	
83-9	14901-14905	each	_	
83-10	14906-14917	participant	_	
83-11	14917-14918	:	_	
83-12	14919-14922	one	_	
83-13	14923-14925	on	_	
83-14	14926-14929	the	_	
83-15	14930-14935	first	_	
83-16	14936-14940	half	_	
83-17	14941-14943	of	_	
83-18	14944-14949	their	_	
83-19	14950-14954	data	_	
83-20	14954-14955	,	_	
83-21	14956-14959	one	_	
83-22	14960-14962	on	_	
83-23	14963-14966	the	_	
83-24	14967-14973	second	_	
83-25	14974-14978	half	_	
83-26	14978-14979	,	_	
83-27	14980-14983	and	_	
83-28	14984-14987	one	_	
83-29	14988-14991	for	_	
83-30	14992-14995	the	_	
83-31	14996-15002	entire	_	
83-32	15003-15010	dataset	_	
83-33	15010-15011	.	_	

#Text=Analysis of the functional connectome
#Text=First, we examined intra-participant stability during movie watching by correlating connectivity matrices from the first and the second halves of the dataset for each participant (Fig. 1a).
84-1	15012-15020	Analysis	_	
84-2	15021-15023	of	_	
84-3	15024-15027	the	_	
84-4	15028-15038	functional	_	
84-5	15039-15049	connectome	_	
84-6	15050-15055	First	_	
84-7	15055-15056	,	_	
84-8	15057-15059	we	_	
84-9	15060-15068	examined	_	
84-10	15069-15086	intra-participant	_	
84-11	15087-15096	stability	_	
84-12	15097-15103	during	_	
84-13	15104-15109	movie	_	
84-14	15110-15118	watching	_	
84-15	15119-15121	by	_	
84-16	15122-15133	correlating	_	
84-17	15134-15146	connectivity	_	
84-18	15147-15155	matrices	_	
84-19	15156-15160	from	_	
84-20	15161-15164	the	_	
84-21	15165-15170	first	_	
84-22	15171-15174	and	_	
84-23	15175-15178	the	_	
84-24	15179-15185	second	_	
84-25	15186-15192	halves	_	
84-26	15193-15195	of	_	
84-27	15196-15199	the	_	
84-28	15200-15207	dataset	_	
84-29	15208-15211	for	_	
84-30	15212-15216	each	_	
84-31	15217-15228	participant	_	
84-32	15229-15230	(	_	
84-33	15230-15233	Fig	_	
84-34	15233-15234	.	_	
84-35	15234-15235	 	_	
84-36	15235-15237	1a	_	
84-37	15237-15238	)	_	
84-38	15238-15239	.	_	

#Text=Correlation coefficients were transformed to Fisher's z scores and a permutation comparison test was performed between the PAE and control groups.
85-1	15240-15251	Correlation	_	
85-2	15252-15264	coefficients	_	
85-3	15265-15269	were	_	
85-4	15270-15281	transformed	_	
85-5	15282-15284	to	_	
85-6	15285-15293	Fisher's	_	
85-7	15294-15295	z	_	
85-8	15296-15302	scores	_	
85-9	15303-15306	and	_	
85-10	15307-15308	a	_	
85-11	15309-15320	permutation	_	
85-12	15321-15331	comparison	_	
85-13	15332-15336	test	_	
85-14	15337-15340	was	_	
85-15	15341-15350	performed	_	
85-16	15351-15358	between	_	
85-17	15359-15362	the	_	
85-18	15363-15366	PAE	_	
85-19	15367-15370	and	_	
85-20	15371-15378	control	_	
85-21	15379-15385	groups	_	
85-22	15385-15386	.	_	

#Text=Age, sex, head motion (i.e., averaged relative FD), and total brain volume were included as covariates.
86-1	15387-15390	Age	_	
86-2	15390-15391	,	_	
86-3	15392-15395	sex	_	
86-4	15395-15396	,	_	
86-5	15397-15401	head	_	
86-6	15402-15408	motion	_	
86-7	15409-15410	(	_	
86-8	15410-15413	i.e	_	
86-9	15413-15414	.	_	
86-10	15414-15415	,	_	
86-11	15416-15424	averaged	_	
86-12	15425-15433	relative	_	
86-13	15434-15436	FD	_	
86-14	15436-15437	)	_	
86-15	15437-15438	,	_	
86-16	15439-15442	and	_	
86-17	15443-15448	total	_	
86-18	15449-15454	brain	_	
86-19	15455-15461	volume	_	
86-20	15462-15466	were	_	
86-21	15467-15475	included	_	
86-22	15476-15478	as	_	
86-23	15479-15489	covariates	_	
86-24	15489-15490	.	_	

#Text=Linear correlations between age and the intra-participant stability metric were calculated for each group with sex, head motion, and total brain volume as covariates.
87-1	15491-15497	Linear	_	
87-2	15498-15510	correlations	_	
87-3	15511-15518	between	_	
87-4	15519-15522	age	_	
87-5	15523-15526	and	_	
87-6	15527-15530	the	_	
87-7	15531-15548	intra-participant	_	
87-8	15549-15558	stability	_	
87-9	15559-15565	metric	_	
87-10	15566-15570	were	_	
87-11	15571-15581	calculated	_	
87-12	15582-15585	for	_	
87-13	15586-15590	each	_	
87-14	15591-15596	group	_	
87-15	15597-15601	with	_	
87-16	15602-15605	sex	_	
87-17	15605-15606	,	_	
87-18	15607-15611	head	_	
87-19	15612-15618	motion	_	
87-20	15618-15619	,	_	
87-21	15620-15623	and	_	
87-22	15624-15629	total	_	
87-23	15630-15635	brain	_	
87-24	15636-15642	volume	_	
87-25	15643-15645	as	_	
87-26	15646-15656	covariates	_	
87-27	15656-15657	.	_	

#Text=Second, inter-individual stability was examined within each group (Fig. 1b).
88-1	15658-15664	Second	_	
88-2	15664-15665	,	_	
88-3	15666-15682	inter-individual	_	
88-4	15683-15692	stability	_	
88-5	15693-15696	was	_	
88-6	15697-15705	examined	_	
88-7	15706-15712	within	_	
88-8	15713-15717	each	_	
88-9	15718-15723	group	_	
88-10	15724-15725	(	_	
88-11	15725-15728	Fig	_	
88-12	15728-15729	.	_	
88-13	15729-15730	 	_	
88-14	15730-15732	1b	_	
88-15	15732-15733	)	_	
88-16	15733-15734	.	_	

#Text=Pearson's correlation coefficients were calculated between each subject's whole connectivity matrix and that of every other participant in the same group (i.e., PAE or controls).
89-1	15735-15744	Pearson's	_	
89-2	15745-15756	correlation	_	
89-3	15757-15769	coefficients	_	
89-4	15770-15774	were	_	
89-5	15775-15785	calculated	_	
89-6	15786-15793	between	_	
89-7	15794-15798	each	_	
89-8	15799-15808	subject's	_	
89-9	15809-15814	whole	_	
89-10	15815-15827	connectivity	_	
89-11	15828-15834	matrix	_	
89-12	15835-15838	and	_	
89-13	15839-15843	that	_	
89-14	15844-15846	of	_	
89-15	15847-15852	every	_	
89-16	15853-15858	other	_	
89-17	15859-15870	participant	_	
89-18	15871-15873	in	_	
89-19	15874-15877	the	_	
89-20	15878-15882	same	_	
89-21	15883-15888	group	_	
89-22	15889-15890	(	_	
89-23	15890-15893	i.e	_	
89-24	15893-15894	.	_	
89-25	15894-15895	,	_	
89-26	15896-15899	PAE	_	
89-27	15900-15902	or	_	
89-28	15903-15911	controls	_	
89-29	15911-15912	)	_	
89-30	15912-15913	.	_	

#Text=Then a 215 × 215 correlation matrix for the unexposed control group and a 34 × 34 correlation matrix for the PAE group were generated, and the average value of each row was calculated to generate an inter-individual stability value for each person in each dataset.
90-1	15914-15918	Then	_	
90-2	15919-15920	a	_	
90-3	15921-15924	215	_	
90-4	15924-15925	 	_	
90-5	15925-15926	×	_	
90-6	15926-15927	 	_	
90-7	15927-15930	215	_	
90-8	15931-15942	correlation	_	
90-9	15943-15949	matrix	_	
90-10	15950-15953	for	_	
90-11	15954-15957	the	_	
90-12	15958-15967	unexposed	_	
90-13	15968-15975	control	_	
90-14	15976-15981	group	_	
90-15	15982-15985	and	_	
90-16	15986-15987	a	_	
90-17	15988-15990	34	_	
90-18	15990-15991	 	_	
90-19	15991-15992	×	_	
90-20	15992-15993	 	_	
90-21	15993-15995	34	_	
90-22	15996-16007	correlation	_	
90-23	16008-16014	matrix	_	
90-24	16015-16018	for	_	
90-25	16019-16022	the	_	
90-26	16023-16026	PAE	_	
90-27	16027-16032	group	_	
90-28	16033-16037	were	_	
90-29	16038-16047	generated	_	
90-30	16047-16048	,	_	
90-31	16049-16052	and	_	
90-32	16053-16056	the	_	
90-33	16057-16064	average	_	
90-34	16065-16070	value	_	
90-35	16071-16073	of	_	
90-36	16074-16078	each	_	
90-37	16079-16082	row	_	
90-38	16083-16086	was	_	
90-39	16087-16097	calculated	_	
90-40	16098-16100	to	_	
90-41	16101-16109	generate	_	
90-42	16110-16112	an	_	
90-43	16113-16129	inter-individual	_	
90-44	16130-16139	stability	_	
90-45	16140-16145	value	_	
90-46	16146-16149	for	_	
90-47	16150-16154	each	_	
90-48	16155-16161	person	_	
90-49	16162-16164	in	_	
90-50	16165-16169	each	_	
90-51	16170-16177	dataset	_	
90-52	16177-16178	.	_	

#Text=A permutation comparison test was performed between the inter-individual stability of two groups with age, sex, head motion, and total brain volume as covariates.
91-1	16179-16180	A	_	
91-2	16181-16192	permutation	_	
91-3	16193-16203	comparison	_	
91-4	16204-16208	test	_	
91-5	16209-16212	was	_	
91-6	16213-16222	performed	_	
91-7	16223-16230	between	_	
91-8	16231-16234	the	_	
91-9	16235-16251	inter-individual	_	
91-10	16252-16261	stability	_	
91-11	16262-16264	of	_	
91-12	16265-16268	two	_	
91-13	16269-16275	groups	_	
91-14	16276-16280	with	_	
91-15	16281-16284	age	_	
91-16	16284-16285	,	_	
91-17	16286-16289	sex	_	
91-18	16289-16290	,	_	
91-19	16291-16295	head	_	
91-20	16296-16302	motion	_	
91-21	16302-16303	,	_	
91-22	16304-16307	and	_	
91-23	16308-16313	total	_	
91-24	16314-16319	brain	_	
91-25	16320-16326	volume	_	
91-26	16327-16329	as	_	
91-27	16330-16340	covariates	_	
91-28	16340-16341	.	_	

#Text=The relationship between inter-individual stability and age was examined with sex, head motion, and total brain volume as covariates.
92-1	16342-16345	The	_	
92-2	16346-16358	relationship	_	
92-3	16359-16366	between	_	
92-4	16367-16383	inter-individual	_	
92-5	16384-16393	stability	_	
92-6	16394-16397	and	_	
92-7	16398-16401	age	_	
92-8	16402-16405	was	_	
92-9	16406-16414	examined	_	
92-10	16415-16419	with	_	
92-11	16420-16423	sex	_	
92-12	16423-16424	,	_	
92-13	16425-16429	head	_	
92-14	16430-16436	motion	_	
92-15	16436-16437	,	_	
92-16	16438-16441	and	_	
92-17	16442-16447	total	_	
92-18	16448-16453	brain	_	
92-19	16454-16460	volume	_	
92-20	16461-16463	as	_	
92-21	16464-16474	covariates	_	
92-22	16474-16475	.	_	

#Text=Graph-theory based metrics calculation
#Text=As in previous studies, the graph theoretical measurements were calculated for the thresholded and binarized individual connectivity matrix of the whole time series.
93-1	16476-16488	Graph-theory	_	
93-2	16489-16494	based	_	
93-3	16495-16502	metrics	_	
93-4	16503-16514	calculation	_	
93-5	16515-16517	As	_	
93-6	16518-16520	in	_	
93-7	16521-16529	previous	_	
93-8	16530-16537	studies	_	
93-9	16537-16538	,	_	
93-10	16539-16542	the	_	
93-11	16543-16548	graph	_	
93-12	16549-16560	theoretical	_	
93-13	16561-16573	measurements	_	
93-14	16574-16578	were	_	
93-15	16579-16589	calculated	_	
93-16	16590-16593	for	_	
93-17	16594-16597	the	_	
93-18	16598-16609	thresholded	_	
93-19	16610-16613	and	_	
93-20	16614-16623	binarized	_	
93-21	16624-16634	individual	_	
93-22	16635-16647	connectivity	_	
93-23	16648-16654	matrix	_	
93-24	16655-16657	of	_	
93-25	16658-16661	the	_	
93-26	16662-16667	whole	_	
93-27	16668-16672	time	_	
93-28	16673-16679	series	_	
93-29	16679-16680	.	_	

#Text=The threshold of the matrix was set at r = 0.17 as p < 0.01.
94-1	16681-16684	The	_	
94-2	16685-16694	threshold	_	
94-3	16695-16697	of	_	
94-4	16698-16701	the	_	
94-5	16702-16708	matrix	_	
94-6	16709-16712	was	_	
94-7	16713-16716	set	_	
94-8	16717-16719	at	_	
94-9	16720-16721	r	_	
94-10	16721-16722	 	_	
94-11	16722-16723	=	_	
94-12	16723-16724	 	_	
94-13	16724-16728	0.17	_	
94-14	16729-16731	as	_	
94-15	16732-16733	p	_	
94-16	16734-16735	<	_	
94-17	16736-16740	0.01	_	
94-18	16740-16741	.	_	

#Text=The graph theoretic metrics (global and nodal level of clustering coefficient, shortest path length, small-worldness, local efficiency, global efficiency, betweenness centrality and network degree centrality) were calculated for each binary matrix using the GRETNA toolbox.
95-1	16742-16745	The	_	
95-2	16746-16751	graph	_	
95-3	16752-16761	theoretic	_	
95-4	16762-16769	metrics	_	
95-5	16770-16771	(	_	
95-6	16771-16777	global	_	
95-7	16778-16781	and	_	
95-8	16782-16787	nodal	_	
95-9	16788-16793	level	_	
95-10	16794-16796	of	_	
95-11	16797-16807	clustering	_	
95-12	16808-16819	coefficient	_	
95-13	16819-16820	,	_	
95-14	16821-16829	shortest	_	
95-15	16830-16834	path	_	
95-16	16835-16841	length	_	
95-17	16841-16842	,	_	
95-18	16843-16858	small-worldness	_	
95-19	16858-16859	,	_	
95-20	16860-16865	local	_	
95-21	16866-16876	efficiency	_	
95-22	16876-16877	,	_	
95-23	16878-16884	global	_	
95-24	16885-16895	efficiency	_	
95-25	16895-16896	,	_	
95-26	16897-16908	betweenness	_	
95-27	16909-16919	centrality	_	
95-28	16920-16923	and	_	
95-29	16924-16931	network	_	
95-30	16932-16938	degree	_	
95-31	16939-16949	centrality	_	
95-32	16949-16950	)	_	
95-33	16951-16955	were	_	
95-34	16956-16966	calculated	_	
95-35	16967-16970	for	_	
95-36	16971-16975	each	_	
95-37	16976-16982	binary	_	
95-38	16983-16989	matrix	_	
95-39	16990-16995	using	_	
95-40	16996-16999	the	_	
95-41	17000-17006	GRETNA	_	
95-42	17007-17014	toolbox	_	
95-43	17014-17015	.	_	

#Text=Clustering coefficient measures the connection density among all neighbors of each node; shortest path length measures the fastest pathway to transfer information between any pair of nodes; sigma characterizes the ratio between clustering coefficient and shortest path length compared with the random networks; local efficiency measures the efficiency of transferring information from each node and its neighbors; global efficiency measures the efficiency of transferring information from each node to all other nodes in the whole graph, with higher efficiency indicating that fewer pathways are required to reach to other nodes in the network; betweenness centrality measures the intensity of the shortest pathway that passes each node; degree centrality measures the number of the connections of each node.
96-1	17016-17026	Clustering	_	
96-2	17027-17038	coefficient	_	
96-3	17039-17047	measures	_	
96-4	17048-17051	the	_	
96-5	17052-17062	connection	_	
96-6	17063-17070	density	_	
96-7	17071-17076	among	_	
96-8	17077-17080	all	_	
96-9	17081-17090	neighbors	_	
96-10	17091-17093	of	_	
96-11	17094-17098	each	_	
96-12	17099-17103	node	_	
96-13	17103-17104	;	_	
96-14	17105-17113	shortest	_	
96-15	17114-17118	path	_	
96-16	17119-17125	length	_	
96-17	17126-17134	measures	_	
96-18	17135-17138	the	_	
96-19	17139-17146	fastest	_	
96-20	17147-17154	pathway	_	
96-21	17155-17157	to	_	
96-22	17158-17166	transfer	_	
96-23	17167-17178	information	_	
96-24	17179-17186	between	_	
96-25	17187-17190	any	_	
96-26	17191-17195	pair	_	
96-27	17196-17198	of	_	
96-28	17199-17204	nodes	_	
96-29	17204-17205	;	_	
96-30	17206-17211	sigma	_	
96-31	17212-17225	characterizes	_	
96-32	17226-17229	the	_	
96-33	17230-17235	ratio	_	
96-34	17236-17243	between	_	
96-35	17244-17254	clustering	_	
96-36	17255-17266	coefficient	_	
96-37	17267-17270	and	_	
96-38	17271-17279	shortest	_	
96-39	17280-17284	path	_	
96-40	17285-17291	length	_	
96-41	17292-17300	compared	_	
96-42	17301-17305	with	_	
96-43	17306-17309	the	_	
96-44	17310-17316	random	_	
96-45	17317-17325	networks	_	
96-46	17325-17326	;	_	
96-47	17327-17332	local	_	
96-48	17333-17343	efficiency	_	
96-49	17344-17352	measures	_	
96-50	17353-17356	the	_	
96-51	17357-17367	efficiency	_	
96-52	17368-17370	of	_	
96-53	17371-17383	transferring	_	
96-54	17384-17395	information	_	
96-55	17396-17400	from	_	
96-56	17401-17405	each	_	
96-57	17406-17410	node	_	
96-58	17411-17414	and	_	
96-59	17415-17418	its	_	
96-60	17419-17428	neighbors	_	
96-61	17428-17429	;	_	
96-62	17430-17436	global	_	
96-63	17437-17447	efficiency	_	
96-64	17448-17456	measures	_	
96-65	17457-17460	the	_	
96-66	17461-17471	efficiency	_	
96-67	17472-17474	of	_	
96-68	17475-17487	transferring	_	
96-69	17488-17499	information	_	
96-70	17500-17504	from	_	
96-71	17505-17509	each	_	
96-72	17510-17514	node	_	
96-73	17515-17517	to	_	
96-74	17518-17521	all	_	
96-75	17522-17527	other	_	
96-76	17528-17533	nodes	_	
96-77	17534-17536	in	_	
96-78	17537-17540	the	_	
96-79	17541-17546	whole	_	
96-80	17547-17552	graph	_	
96-81	17552-17553	,	_	
96-82	17554-17558	with	_	
96-83	17559-17565	higher	_	
96-84	17566-17576	efficiency	_	
96-85	17577-17587	indicating	_	
96-86	17588-17592	that	_	
96-87	17593-17598	fewer	_	
96-88	17599-17607	pathways	_	
96-89	17608-17611	are	_	
96-90	17612-17620	required	_	
96-91	17621-17623	to	_	
96-92	17624-17629	reach	_	
96-93	17630-17632	to	_	
96-94	17633-17638	other	_	
96-95	17639-17644	nodes	_	
96-96	17645-17647	in	_	
96-97	17648-17651	the	_	
96-98	17652-17659	network	_	
96-99	17659-17660	;	_	
96-100	17661-17672	betweenness	_	
96-101	17673-17683	centrality	_	
96-102	17684-17692	measures	_	
96-103	17693-17696	the	_	
96-104	17697-17706	intensity	_	
96-105	17707-17709	of	_	
96-106	17710-17713	the	_	
96-107	17714-17722	shortest	_	
96-108	17723-17730	pathway	_	
96-109	17731-17735	that	_	
96-110	17736-17742	passes	_	
96-111	17743-17747	each	_	
96-112	17748-17752	node	_	
96-113	17752-17753	;	_	
96-114	17754-17760	degree	_	
96-115	17761-17771	centrality	_	
96-116	17772-17780	measures	_	
96-117	17781-17784	the	_	
96-118	17785-17791	number	_	
96-119	17792-17794	of	_	
96-120	17795-17798	the	_	
96-121	17799-17810	connections	_	
96-122	17811-17813	of	_	
96-123	17814-17818	each	_	
96-124	17819-17823	node	_	
96-125	17823-17824	.	_	

#Text=Permutation tests between the two groups for each metric were performed controlling for age, sex, head motion, and total brain volume.
97-1	17825-17836	Permutation	_	
97-2	17837-17842	tests	_	
97-3	17843-17850	between	_	
97-4	17851-17854	the	_	
97-5	17855-17858	two	_	
97-6	17859-17865	groups	_	
97-7	17866-17869	for	_	
97-8	17870-17874	each	_	
97-9	17875-17881	metric	_	
97-10	17882-17886	were	_	
97-11	17887-17896	performed	_	
97-12	17897-17908	controlling	_	
97-13	17909-17912	for	_	
97-14	17913-17916	age	_	
97-15	17916-17917	,	_	
97-16	17918-17921	sex	_	
97-17	17921-17922	,	_	
97-18	17923-17927	head	_	
97-19	17928-17934	motion	_	
97-20	17934-17935	,	_	
97-21	17936-17939	and	_	
97-22	17940-17945	total	_	
97-23	17946-17951	brain	_	
97-24	17952-17958	volume	_	
97-25	17958-17959	.	_	

#Text=The threshold for nodal metrics was set at p < 0.05.
98-1	17960-17963	The	_	
98-2	17964-17973	threshold	_	
98-3	17974-17977	for	_	
98-4	17978-17983	nodal	_	
98-5	17984-17991	metrics	_	
98-6	17992-17995	was	_	
98-7	17996-17999	set	_	
98-8	18000-18002	at	_	
98-9	18003-18004	p	_	
98-10	18005-18006	<	_	
98-11	18007-18011	0.05	_	
98-12	18011-18012	.	_	

#Text=For completeness, we report results both uncorrected and corrected using false discovery rate (FDR) for multiple comparisons.
99-1	18013-18016	For	_	
99-2	18017-18029	completeness	_	
99-3	18029-18030	,	_	
99-4	18031-18033	we	_	
99-5	18034-18040	report	_	
99-6	18041-18048	results	_	
99-7	18049-18053	both	_	
99-8	18054-18065	uncorrected	_	
99-9	18066-18069	and	_	
99-10	18070-18079	corrected	_	
99-11	18080-18085	using	_	
99-12	18086-18091	false	_	
99-13	18092-18101	discovery	_	
99-14	18102-18106	rate	_	
99-15	18107-18108	(	_	
99-16	18108-18111	FDR	_	
99-17	18111-18112	)	_	
99-18	18113-18116	for	_	
99-19	18117-18125	multiple	_	
99-20	18126-18137	comparisons	_	
99-21	18137-18138	.	_	

#Text=We also analyzed metrics for linear correlations with age, and for group-age interactions.
100-1	18139-18141	We	_	
100-2	18142-18146	also	_	
100-3	18147-18155	analyzed	_	
100-4	18156-18163	metrics	_	
100-5	18164-18167	for	_	
100-6	18168-18174	linear	_	
100-7	18175-18187	correlations	_	
100-8	18188-18192	with	_	
100-9	18193-18196	age	_	
100-10	18196-18197	,	_	
100-11	18198-18201	and	_	
100-12	18202-18205	for	_	
100-13	18206-18215	group-age	_	
100-14	18216-18228	interactions	_	
100-15	18228-18229	.	_	

#Text=All permutation tests were performed in the GRETNA toolbox.
101-1	18230-18233	All	_	
101-2	18234-18245	permutation	_	
101-3	18246-18251	tests	_	
101-4	18252-18256	were	_	
101-5	18257-18266	performed	_	
101-6	18267-18269	in	_	
101-7	18270-18273	the	_	
101-8	18274-18280	GRETNA	_	
101-9	18281-18288	toolbox	_	
101-10	18288-18289	.	_	

#Text=The nodal level results were displayed by BrainNet Viewer toolbox.
102-1	18290-18293	The	_	
102-2	18294-18299	nodal	_	
102-3	18300-18305	level	_	
102-4	18306-18313	results	_	
102-5	18314-18318	were	_	
102-6	18319-18328	displayed	_	
102-7	18329-18331	by	_	
102-8	18332-18340	BrainNet	_	
102-9	18341-18347	Viewer	_	
102-10	18348-18355	toolbox	_	
102-11	18355-18356	.	_	

#Text=Results
#Text=Children with PAE had significantly smaller total brain volume than controls: mean(PAE) = 1.08 × 106 mm3, mean(Controls) = 1.14 × 106 mm3; t = 2.70, p = 0.007.
#Text=a) The PAE group (blue), but not typical controls (black), had significant age-related increases of intra-participant stability during movie viewing fMRI. b) Controls (black) had significant age-related increases in inter-participant stability, but the PAE group (blue) did not.
103-1	18357-18364	Results	_	
103-2	18365-18373	Children	_	
103-3	18374-18378	with	_	
103-4	18379-18382	PAE	_	
103-5	18383-18386	had	_	
103-6	18387-18400	significantly	_	
103-7	18401-18408	smaller	_	
103-8	18409-18414	total	_	
103-9	18415-18420	brain	_	
103-10	18421-18427	volume	_	
103-11	18428-18432	than	_	
103-12	18433-18441	controls	_	
103-13	18441-18442	:	_	
103-14	18443-18447	mean	_	
103-15	18447-18448	(	_	
103-16	18448-18451	PAE	_	
103-17	18451-18452	)	_	
103-18	18452-18453	 	_	
103-19	18453-18454	=	_	
103-20	18454-18455	 	_	
103-21	18455-18459	1.08	_	
103-22	18459-18460	 	_	
103-23	18460-18461	×	_	
103-24	18461-18462	 	_	
103-25	18462-18465	106	_	
103-26	18465-18466	 	_	
103-27	18466-18469	mm3	_	
103-28	18469-18470	,	_	
103-29	18471-18475	mean	_	
103-30	18475-18476	(	_	
103-31	18476-18484	Controls	_	
103-32	18484-18485	)	_	
103-33	18485-18486	 	_	
103-34	18486-18487	=	_	
103-35	18487-18488	 	_	
103-36	18488-18492	1.14	_	
103-37	18492-18493	 	_	
103-38	18493-18494	×	_	
103-39	18494-18495	 	_	
103-40	18495-18498	106	_	
103-41	18498-18499	 	_	
103-42	18499-18502	mm3	_	
103-43	18502-18503	;	_	
103-44	18504-18505	t	_	
103-45	18505-18506	 	_	
103-46	18506-18507	=	_	
103-47	18507-18508	 	_	
103-48	18508-18512	2.70	_	
103-49	18512-18513	,	_	
103-50	18514-18515	p	_	
103-51	18515-18516	 	_	
103-52	18516-18517	=	_	
103-53	18517-18518	 	_	
103-54	18518-18523	0.007	_	
103-55	18523-18524	.	_	
103-56	18525-18526	a	_	
103-57	18526-18527	)	_	
103-58	18528-18531	The	_	
103-59	18532-18535	PAE	_	
103-60	18536-18541	group	_	
103-61	18542-18543	(	_	
103-62	18543-18547	blue	_	
103-63	18547-18548	)	_	
103-64	18548-18549	,	_	
103-65	18550-18553	but	_	
103-66	18554-18557	not	_	
103-67	18558-18565	typical	_	
103-68	18566-18574	controls	_	
103-69	18575-18576	(	_	
103-70	18576-18581	black	_	
103-71	18581-18582	)	_	
103-72	18582-18583	,	_	
103-73	18584-18587	had	_	
103-74	18588-18599	significant	_	
103-75	18600-18611	age-related	_	
103-76	18612-18621	increases	_	
103-77	18622-18624	of	_	
103-78	18625-18642	intra-participant	_	
103-79	18643-18652	stability	_	
103-80	18653-18659	during	_	
103-81	18660-18665	movie	_	
103-82	18666-18673	viewing	_	
103-83	18674-18678	fMRI	_	
103-84	18678-18679	.	_	
103-85	18680-18681	b	_	
103-86	18681-18682	)	_	
103-87	18683-18691	Controls	_	
103-88	18692-18693	(	_	
103-89	18693-18698	black	_	
103-90	18698-18699	)	_	
103-91	18700-18703	had	_	
103-92	18704-18715	significant	_	
103-93	18716-18727	age-related	_	
103-94	18728-18737	increases	_	
103-95	18738-18740	in	_	
103-96	18741-18758	inter-participant	_	
103-97	18759-18768	stability	_	
103-98	18768-18769	,	_	
103-99	18770-18773	but	_	
103-100	18774-18777	the	_	
103-101	18778-18781	PAE	_	
103-102	18782-18787	group	_	
103-103	18788-18789	(	_	
103-104	18789-18793	blue	_	
103-105	18793-18794	)	_	
103-106	18795-18798	did	_	
103-107	18799-18802	not	_	
103-108	18802-18803	.	_	

#Text=(For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
104-1	18804-18805	(	_	
104-2	18805-18808	For	_	
104-3	18809-18823	interpretation	_	
104-4	18824-18826	of	_	
104-5	18827-18830	the	_	
104-6	18831-18841	references	_	
104-7	18842-18844	to	_	
104-8	18845-18850	color	_	
104-9	18851-18853	in	_	
104-10	18854-18858	this	_	
104-11	18859-18865	figure	_	
104-12	18866-18872	legend	_	
104-13	18872-18873	,	_	
104-14	18874-18877	the	_	
104-15	18878-18884	reader	_	
104-16	18885-18887	is	_	
104-17	18888-18896	referred	_	
104-18	18897-18899	to	_	
104-19	18900-18903	the	_	
104-20	18904-18907	web	_	
104-21	18908-18915	version	_	
104-22	18916-18918	of	_	
104-23	18919-18923	this	_	
104-24	18924-18931	article	_	
104-25	18931-18932	.	_	
104-26	18932-18933	)	_	

#Text=Fig. 2
#Text=Intra-participant stability between the first half and the second half of the data was high in both groups: z(PAE) = 0.82 ± 0.11; z(Controls) = 0.80 ± 0.11, and no significant difference was found between groups (p = 0.37).
105-1	18934-18937	Fig	_	
105-2	18937-18938	.	_	
105-3	18939-18940	2	_	
105-4	18941-18958	Intra-participant	_	
105-5	18959-18968	stability	_	
105-6	18969-18976	between	_	
105-7	18977-18980	the	_	
105-8	18981-18986	first	_	
105-9	18987-18991	half	_	
105-10	18992-18995	and	_	
105-11	18996-18999	the	_	
105-12	19000-19006	second	_	
105-13	19007-19011	half	_	
105-14	19012-19014	of	_	
105-15	19015-19018	the	_	
105-16	19019-19023	data	_	
105-17	19024-19027	was	_	
105-18	19028-19032	high	_	
105-19	19033-19035	in	_	
105-20	19036-19040	both	_	
105-21	19041-19047	groups	_	
105-22	19047-19048	:	_	
105-23	19049-19050	z	_	
105-24	19050-19051	(	_	
105-25	19051-19054	PAE	_	
105-26	19054-19055	)	_	
105-27	19055-19056	 	_	
105-28	19056-19057	=	_	
105-29	19057-19058	 	_	
105-30	19058-19062	0.82	_	
105-31	19062-19063	 	_	
105-32	19063-19064	±	_	
105-33	19064-19065	 	_	
105-34	19065-19069	0.11	_	
105-35	19069-19070	;	_	
105-36	19071-19072	z	_	
105-37	19072-19073	(	_	
105-38	19073-19081	Controls	_	
105-39	19081-19082	)	_	
105-40	19082-19083	 	_	
105-41	19083-19084	=	_	
105-42	19084-19085	 	_	
105-43	19085-19089	0.80	_	
105-44	19089-19090	 	_	
105-45	19090-19091	±	_	
105-46	19091-19092	 	_	
105-47	19092-19096	0.11	_	
105-48	19096-19097	,	_	
105-49	19098-19101	and	_	
105-50	19102-19104	no	_	
105-51	19105-19116	significant	_	
105-52	19117-19127	difference	_	
105-53	19128-19131	was	_	
105-54	19132-19137	found	_	
105-55	19138-19145	between	_	
105-56	19146-19152	groups	_	
105-57	19153-19154	(	_	
105-58	19154-19155	p	_	
105-59	19155-19156	 	_	
105-60	19156-19157	=	_	
105-61	19157-19158	 	_	
105-62	19158-19162	0.37	_	
105-63	19162-19163	)	_	
105-64	19163-19164	.	_	

#Text=Intra-participant stability increased significantly with age only in the PAE group: r(PAE) = 0.36, p = 0.05; r(Controls) = 0.08, p = 0.27, and PAE > Controls at p = 0.12 (Fig. 2a).
106-1	19165-19182	Intra-participant	_	
106-2	19183-19192	stability	_	
106-3	19193-19202	increased	_	
106-4	19203-19216	significantly	_	
106-5	19217-19221	with	_	
106-6	19222-19225	age	_	
106-7	19226-19230	only	_	
106-8	19231-19233	in	_	
106-9	19234-19237	the	_	
106-10	19238-19241	PAE	_	
106-11	19242-19247	group	_	
106-12	19247-19248	:	_	
106-13	19249-19250	r	_	
106-14	19250-19251	(	_	
106-15	19251-19254	PAE	_	
106-16	19254-19255	)	_	
106-17	19255-19256	 	_	
106-18	19256-19257	=	_	
106-19	19257-19258	 	_	
106-20	19258-19262	0.36	_	
106-21	19262-19263	,	_	
106-22	19264-19265	p	_	
106-23	19265-19266	 	_	
106-24	19266-19267	=	_	
106-25	19267-19268	 	_	
106-26	19268-19272	0.05	_	
106-27	19272-19273	;	_	
106-28	19274-19275	r	_	
106-29	19275-19276	(	_	
106-30	19276-19284	Controls	_	
106-31	19284-19285	)	_	
106-32	19285-19286	 	_	
106-33	19286-19287	=	_	
106-34	19287-19288	 	_	
106-35	19288-19292	0.08	_	
106-36	19292-19293	,	_	
106-37	19294-19295	p	_	
106-38	19295-19296	 	_	
106-39	19296-19297	=	_	
106-40	19297-19298	 	_	
106-41	19298-19302	0.27	_	
106-42	19302-19303	,	_	
106-43	19304-19307	and	_	
106-44	19308-19311	PAE	_	
106-45	19312-19313	>	_	
106-46	19314-19322	Controls	_	
106-47	19323-19325	at	_	
106-48	19326-19327	p	_	
106-49	19327-19328	 	_	
106-50	19328-19329	=	_	
106-51	19329-19330	 	_	
106-52	19330-19334	0.12	_	
106-53	19335-19336	(	_	
106-54	19336-19339	Fig	_	
106-55	19339-19340	.	_	
106-56	19340-19341	 	_	
106-57	19341-19343	2a	_	
106-58	19343-19344	)	_	
106-59	19344-19345	.	_	

#Text=Inter-individual stability was not significantly different between groups (p = 0.12): PAE = 0.40 ± 0.06; Controls = 0.39 ± 0.05.
107-1	19346-19362	Inter-individual	_	
107-2	19363-19372	stability	_	
107-3	19373-19376	was	_	
107-4	19377-19380	not	_	
107-5	19381-19394	significantly	_	
107-6	19395-19404	different	_	
107-7	19405-19412	between	_	
107-8	19413-19419	groups	_	
107-9	19420-19421	(	_	
107-10	19421-19422	p	_	
107-11	19422-19423	 	_	
107-12	19423-19424	=	_	
107-13	19424-19425	 	_	
107-14	19425-19429	0.12	_	
107-15	19429-19430	)	_	
107-16	19430-19431	:	_	
107-17	19432-19435	PAE	_	
107-18	19435-19436	 	_	
107-19	19436-19437	=	_	
107-20	19437-19438	 	_	
107-21	19438-19442	0.40	_	
107-22	19442-19443	 	_	
107-23	19443-19444	±	_	
107-24	19444-19445	 	_	
107-25	19445-19449	0.06	_	
107-26	19449-19450	;	_	
107-27	19451-19459	Controls	_	
107-28	19459-19460	 	_	
107-29	19460-19461	=	_	
107-30	19461-19462	 	_	
107-31	19462-19466	0.39	_	
107-32	19466-19467	 	_	
107-33	19467-19468	±	_	
107-34	19468-19469	 	_	
107-35	19469-19473	0.05	_	
107-36	19473-19474	.	_	

#Text=Inter-individual stability increased significantly with age in controls, but in not the PAE group: r(PAE) = 0.14, p < 0.44; r(Controls) = 0.16, p < 0.02; PAE < Controls at p = 0.91 (Fig. 2b).
108-1	19475-19491	Inter-individual	_	
108-2	19492-19501	stability	_	
108-3	19502-19511	increased	_	
108-4	19512-19525	significantly	_	
108-5	19526-19530	with	_	
108-6	19531-19534	age	_	
108-7	19535-19537	in	_	
108-8	19538-19546	controls	_	
108-9	19546-19547	,	_	
108-10	19548-19551	but	_	
108-11	19552-19554	in	_	
108-12	19555-19558	not	_	
108-13	19559-19562	the	_	
108-14	19563-19566	PAE	_	
108-15	19567-19572	group	_	
108-16	19572-19573	:	_	
108-17	19574-19575	r	_	
108-18	19575-19576	(	_	
108-19	19576-19579	PAE	_	
108-20	19579-19580	)	_	
108-21	19580-19581	 	_	
108-22	19581-19582	=	_	
108-23	19582-19583	 	_	
108-24	19583-19587	0.14	_	
108-25	19587-19588	,	_	
108-26	19589-19590	p	_	
108-27	19591-19592	<	_	
108-28	19593-19597	0.44	_	
108-29	19597-19598	;	_	
108-30	19599-19600	r	_	
108-31	19600-19601	(	_	
108-32	19601-19609	Controls	_	
108-33	19609-19610	)	_	
108-34	19610-19611	 	_	
108-35	19611-19612	=	_	
108-36	19612-19613	 	_	
108-37	19613-19617	0.16	_	
108-38	19617-19618	,	_	
108-39	19619-19620	p	_	
108-40	19621-19622	<	_	
108-41	19623-19627	0.02	_	
108-42	19627-19628	;	_	
108-43	19629-19632	PAE	_	
108-44	19633-19634	<	_	
108-45	19635-19643	Controls	_	
108-46	19644-19646	at	_	
108-47	19647-19648	p	_	
108-48	19648-19649	 	_	
108-49	19649-19650	=	_	
108-50	19650-19651	 	_	
108-51	19651-19655	0.91	_	
108-52	19656-19657	(	_	
108-53	19657-19660	Fig	_	
108-54	19660-19661	.	_	
108-55	19661-19662	 	_	
108-56	19662-19664	2b	_	
108-57	19664-19665	)	_	
108-58	19665-19666	.	_	

#Text=Group comparisons for whole brain graph theoretical measurements.
109-1	19667-19672	Group	_	
109-2	19673-19684	comparisons	_	
109-3	19685-19688	for	_	
109-4	19689-19694	whole	_	
109-5	19695-19700	brain	_	
109-6	19701-19706	graph	_	
109-7	19707-19718	theoretical	_	
109-8	19719-19731	measurements	_	
109-9	19731-19732	.	_	

#Text=Table 2\t \t
#Text=Metrics\tPAE\tControls\tP value\t \tClustering coefficient\t0.59 ± 0.05\t0.59 ± 0.06\t0.27\t \tShortest path length\t1.58 ± 0.04\t1.58 ± 0.04\t0.26\t \tSmall-worldness\t0.87 ± 0.03\t0.87 ± 0.02\t0.26\t \tLocal efficiency\t0.79 ± 0.03\t0.79 ± 0.03\t0.27\t \tGlobal efficiency\t0.64 ± 0.02\t0.63 ± 0.02\t0.25\t \tBetweenness centrality\t35.67 ± 1.93\t35.84 ± 1.88\t0.48\t \tDegree centrality\t27.26 ± 2.92\t27.35 ± 3.32\t0.17\t \t
#Text=No significant differences were detected in the global graph theoretical measurements between two groups (Table 2).
110-1	19733-19738	Table	_	
110-2	19739-19740	2	_	
110-3	19744-19751	Metrics	_	
110-4	19752-19755	PAE	_	
110-5	19756-19764	Controls	_	
110-6	19765-19766	P	_	
110-7	19767-19772	value	_	
110-8	19775-19785	Clustering	_	
110-9	19786-19797	coefficient	_	
110-10	19798-19802	0.59	_	
110-11	19802-19803	 	_	
110-12	19803-19804	±	_	
110-13	19804-19805	 	_	
110-14	19805-19809	0.05	_	
110-15	19810-19814	0.59	_	
110-16	19814-19815	 	_	
110-17	19815-19816	±	_	
110-18	19816-19817	 	_	
110-19	19817-19821	0.06	_	
110-20	19822-19826	0.27	_	
110-21	19829-19837	Shortest	_	
110-22	19838-19842	path	_	
110-23	19843-19849	length	_	
110-24	19850-19854	1.58	_	
110-25	19854-19855	 	_	
110-26	19855-19856	±	_	
110-27	19856-19857	 	_	
110-28	19857-19861	0.04	_	
110-29	19862-19866	1.58	_	
110-30	19866-19867	 	_	
110-31	19867-19868	±	_	
110-32	19868-19869	 	_	
110-33	19869-19873	0.04	_	
110-34	19874-19878	0.26	_	
110-35	19881-19896	Small-worldness	_	
110-36	19897-19901	0.87	_	
110-37	19901-19902	 	_	
110-38	19902-19903	±	_	
110-39	19903-19904	 	_	
110-40	19904-19908	0.03	_	
110-41	19909-19913	0.87	_	
110-42	19913-19914	 	_	
110-43	19914-19915	±	_	
110-44	19915-19916	 	_	
110-45	19916-19920	0.02	_	
110-46	19921-19925	0.26	_	
110-47	19928-19933	Local	_	
110-48	19934-19944	efficiency	_	
110-49	19945-19949	0.79	_	
110-50	19949-19950	 	_	
110-51	19950-19951	±	_	
110-52	19951-19952	 	_	
110-53	19952-19956	0.03	_	
110-54	19957-19961	0.79	_	
110-55	19961-19962	 	_	
110-56	19962-19963	±	_	
110-57	19963-19964	 	_	
110-58	19964-19968	0.03	_	
110-59	19969-19973	0.27	_	
110-60	19976-19982	Global	_	
110-61	19983-19993	efficiency	_	
110-62	19994-19998	0.64	_	
110-63	19998-19999	 	_	
110-64	19999-20000	±	_	
110-65	20000-20001	 	_	
110-66	20001-20005	0.02	_	
110-67	20006-20010	0.63	_	
110-68	20010-20011	 	_	
110-69	20011-20012	±	_	
110-70	20012-20013	 	_	
110-71	20013-20017	0.02	_	
110-72	20018-20022	0.25	_	
110-73	20025-20036	Betweenness	_	
110-74	20037-20047	centrality	_	
110-75	20048-20053	35.67	_	
110-76	20053-20054	 	_	
110-77	20054-20055	±	_	
110-78	20055-20056	 	_	
110-79	20056-20060	1.93	_	
110-80	20061-20066	35.84	_	
110-81	20066-20067	 	_	
110-82	20067-20068	±	_	
110-83	20068-20069	 	_	
110-84	20069-20073	1.88	_	
110-85	20074-20078	0.48	_	
110-86	20081-20087	Degree	_	
110-87	20088-20098	centrality	_	
110-88	20099-20104	27.26	_	
110-89	20104-20105	 	_	
110-90	20105-20106	±	_	
110-91	20106-20107	 	_	
110-92	20107-20111	2.92	_	
110-93	20112-20117	27.35	_	
110-94	20117-20118	 	_	
110-95	20118-20119	±	_	
110-96	20119-20120	 	_	
110-97	20120-20124	3.32	_	
110-98	20125-20129	0.17	_	
110-99	20133-20135	No	_	
110-100	20136-20147	significant	_	
110-101	20148-20159	differences	_	
110-102	20160-20164	were	_	
110-103	20165-20173	detected	_	
110-104	20174-20176	in	_	
110-105	20177-20180	the	_	
110-106	20181-20187	global	_	
110-107	20188-20193	graph	_	
110-108	20194-20205	theoretical	_	
110-109	20206-20218	measurements	_	
110-110	20219-20226	between	_	
110-111	20227-20230	two	_	
110-112	20231-20237	groups	_	
110-113	20238-20239	(	_	
110-114	20239-20244	Table	_	
110-115	20244-20245	 	_	
110-116	20245-20246	2	_	
110-117	20246-20247	)	_	
110-118	20247-20248	.	_	

#Text=Nodal level analysis detected distributed differences between groups, though none of the results survived FDR correction at p<0.05 (Fig. 1S, Table 1 and 2 in Supplementary materials).
111-1	20249-20254	Nodal	_	
111-2	20255-20260	level	_	
111-3	20261-20269	analysis	_	
111-4	20270-20278	detected	_	
111-5	20279-20290	distributed	_	
111-6	20291-20302	differences	_	
111-7	20303-20310	between	_	
111-8	20311-20317	groups	_	
111-9	20317-20318	,	_	
111-10	20319-20325	though	_	
111-11	20326-20330	none	_	
111-12	20331-20333	of	_	
111-13	20334-20337	the	_	
111-14	20338-20345	results	_	
111-15	20346-20354	survived	_	
111-16	20355-20358	FDR	_	
111-17	20359-20369	correction	_	
111-18	20370-20372	at	_	
111-19	20373-20374	p	_	
111-20	20374-20375	<	_	
111-21	20375-20379	0.05	_	
111-22	20380-20381	(	_	
111-23	20381-20384	Fig	_	
111-24	20384-20385	.	_	
111-25	20385-20386	 	_	
111-26	20386-20388	1S	_	
111-27	20388-20389	,	_	
111-28	20390-20395	Table	_	
111-29	20395-20396	 	_	
111-30	20396-20397	1	_	
111-31	20398-20401	and	_	
111-32	20402-20403	2	_	
111-33	20404-20406	in	_	
111-34	20407-20420	Supplementary	_	
111-35	20421-20430	materials	_	
111-36	20430-20431	)	_	
111-37	20431-20432	.	_	

#Text=Because of the significant age difference between the groups, the graph theory analysis was repeated on the full PAE group compared to a subset of control participants who were closely age- and sex-matched (n = 34; age: 5.57 ± 0.95); group differences remained non-significant (all uncorrected p-values >0.07).
112-1	20433-20440	Because	_	
112-2	20441-20443	of	_	
112-3	20444-20447	the	_	
112-4	20448-20459	significant	_	
112-5	20460-20463	age	_	
112-6	20464-20474	difference	_	
112-7	20475-20482	between	_	
112-8	20483-20486	the	_	
112-9	20487-20493	groups	_	
112-10	20493-20494	,	_	
112-11	20495-20498	the	_	
112-12	20499-20504	graph	_	
112-13	20505-20511	theory	_	
112-14	20512-20520	analysis	_	
112-15	20521-20524	was	_	
112-16	20525-20533	repeated	_	
112-17	20534-20536	on	_	
112-18	20537-20540	the	_	
112-19	20541-20545	full	_	
112-20	20546-20549	PAE	_	
112-21	20550-20555	group	_	
112-22	20556-20564	compared	_	
112-23	20565-20567	to	_	
112-24	20568-20569	a	_	
112-25	20570-20576	subset	_	
112-26	20577-20579	of	_	
112-27	20580-20587	control	_	
112-28	20588-20600	participants	_	
112-29	20601-20604	who	_	
112-30	20605-20609	were	_	
112-31	20610-20617	closely	_	
112-32	20618-20621	age	_	
112-33	20621-20622	-	_	
112-34	20623-20626	and	_	
112-35	20627-20638	sex-matched	_	
112-36	20639-20640	(	_	
112-37	20640-20641	n	_	
112-38	20641-20642	 	_	
112-39	20642-20643	=	_	
112-40	20643-20644	 	_	
112-41	20644-20646	34	_	
112-42	20646-20647	;	_	
112-43	20648-20651	age	_	
112-44	20651-20652	:	_	
112-45	20653-20657	5.57	_	
112-46	20657-20658	 	_	
112-47	20658-20659	±	_	
112-48	20659-20660	 	_	
112-49	20660-20664	0.95	_	
112-50	20664-20665	)	_	
112-51	20665-20666	;	_	
112-52	20667-20672	group	_	
112-53	20673-20684	differences	_	
112-54	20685-20693	remained	_	
112-55	20694-20709	non-significant	_	
112-56	20710-20711	(	_	
112-57	20711-20714	all	_	
112-58	20715-20726	uncorrected	_	
112-59	20727-20735	p-values	_	
112-60	20736-20737	>	_	
112-61	20737-20741	0.07	_	
112-62	20741-20742	)	_	
112-63	20742-20743	.	_	

#Text=Discussion
#Text=In this study of young children with PAE, we used graph theory methods to investigate functional network features.
113-1	20744-20754	Discussion	_	
113-2	20755-20757	In	_	
113-3	20758-20762	this	_	
113-4	20763-20768	study	_	
113-5	20769-20771	of	_	
113-6	20772-20777	young	_	
113-7	20778-20786	children	_	
113-8	20787-20791	with	_	
113-9	20792-20795	PAE	_	
113-10	20795-20796	,	_	
113-11	20797-20799	we	_	
113-12	20800-20804	used	_	
113-13	20805-20810	graph	_	
113-14	20811-20817	theory	_	
113-15	20818-20825	methods	_	
113-16	20826-20828	to	_	
113-17	20829-20840	investigate	_	
113-18	20841-20851	functional	_	
113-19	20852-20859	network	_	
113-20	20860-20868	features	_	
113-21	20868-20869	.	_	

#Text=Our data showed similar network metrics as well as intra-participant and inter-participant stability of the functional connectome in children with PAE compared to controls.
114-1	20870-20873	Our	_	
114-2	20874-20878	data	_	
114-3	20879-20885	showed	_	
114-4	20886-20893	similar	_	
114-5	20894-20901	network	_	
114-6	20902-20909	metrics	_	
114-7	20910-20912	as	_	
114-8	20913-20917	well	_	
114-9	20918-20920	as	_	
114-10	20921-20938	intra-participant	_	
114-11	20939-20942	and	_	
114-12	20943-20960	inter-participant	_	
114-13	20961-20970	stability	_	
114-14	20971-20973	of	_	
114-15	20974-20977	the	_	
114-16	20978-20988	functional	_	
114-17	20989-20999	connectome	_	
114-18	21000-21002	in	_	
114-19	21003-21011	children	_	
114-20	21012-21016	with	_	
114-21	21017-21020	PAE	_	
114-22	21021-21029	compared	_	
114-23	21030-21032	to	_	
114-24	21033-21041	controls	_	
114-25	21041-21042	.	_	

#Text=Children with PAE, but not controls, showed increasing intra-participant stability with age, but lacked the age-related increases in inter-participant stability seen in controls.
115-1	21043-21051	Children	_	
115-2	21052-21056	with	_	
115-3	21057-21060	PAE	_	
115-4	21060-21061	,	_	
115-5	21062-21065	but	_	
115-6	21066-21069	not	_	
115-7	21070-21078	controls	_	
115-8	21078-21079	,	_	
115-9	21080-21086	showed	_	
115-10	21087-21097	increasing	_	
115-11	21098-21115	intra-participant	_	
115-12	21116-21125	stability	_	
115-13	21126-21130	with	_	
115-14	21131-21134	age	_	
115-15	21134-21135	,	_	
115-16	21136-21139	but	_	
115-17	21140-21146	lacked	_	
115-18	21147-21150	the	_	
115-19	21151-21162	age-related	_	
115-20	21163-21172	increases	_	
115-21	21173-21175	in	_	
115-22	21176-21193	inter-participant	_	
115-23	21194-21203	stability	_	
115-24	21204-21208	seen	_	
115-25	21209-21211	in	_	
115-26	21212-21220	controls	_	
115-27	21220-21221	.	_	

#Text=Our results provide important context for previous findings of atypical connectome metrics across older children with PAE group, suggesting that increased variability originates in early childhood.
116-1	21222-21225	Our	_	
116-2	21226-21233	results	_	
116-3	21234-21241	provide	_	
116-4	21242-21251	important	_	
116-5	21252-21259	context	_	
116-6	21260-21263	for	_	
116-7	21264-21272	previous	_	
116-8	21273-21281	findings	_	
116-9	21282-21284	of	_	
116-10	21285-21293	atypical	_	
116-11	21294-21304	connectome	_	
116-12	21305-21312	metrics	_	
116-13	21313-21319	across	_	
116-14	21320-21325	older	_	
116-15	21326-21334	children	_	
116-16	21335-21339	with	_	
116-17	21340-21343	PAE	_	
116-18	21344-21349	group	_	
116-19	21349-21350	,	_	
116-20	21351-21361	suggesting	_	
116-21	21362-21366	that	_	
116-22	21367-21376	increased	_	
116-23	21377-21388	variability	_	
116-24	21389-21399	originates	_	
116-25	21400-21402	in	_	
116-26	21403-21408	early	_	
116-27	21409-21418	childhood	_	
116-28	21418-21419	.	_	

#Text=Stability of functional connectome during passive viewing
#Text=Intra-participant stability of the functional connectome was high (r = ~ 0.67) in both PAE and control groups during passive viewing fMRI.
117-1	21420-21429	Stability	_	
117-2	21430-21432	of	_	
117-3	21433-21443	functional	_	
117-4	21444-21454	connectome	_	
117-5	21455-21461	during	_	
117-6	21462-21469	passive	_	
117-7	21470-21477	viewing	_	
117-8	21478-21495	Intra-participant	_	
117-9	21496-21505	stability	_	
117-10	21506-21508	of	_	
117-11	21509-21512	the	_	
117-12	21513-21523	functional	_	
117-13	21524-21534	connectome	_	
117-14	21535-21538	was	_	
117-15	21539-21543	high	_	
117-16	21544-21545	(	_	
117-17	21545-21546	r	_	
117-18	21546-21547	 	_	
117-19	21547-21548	=	_	
117-20	21548-21549	 	_	
117-21	21549-21550	~	_	
117-22	21551-21555	0.67	_	
117-23	21555-21556	)	_	
117-24	21557-21559	in	_	
117-25	21560-21564	both	_	
117-26	21565-21568	PAE	_	
117-27	21569-21572	and	_	
117-28	21573-21580	control	_	
117-29	21581-21587	groups	_	
117-30	21588-21594	during	_	
117-31	21595-21602	passive	_	
117-32	21603-21610	viewing	_	
117-33	21611-21615	fMRI	_	
117-34	21615-21616	.	_	

#Text=This level of stability is similar to a previous study in older typically-developing children, which found correlations of functional connectivity matrices between the first and the second half of the data were approximately 0.60 when watching video clips.
118-1	21617-21621	This	_	
118-2	21622-21627	level	_	
118-3	21628-21630	of	_	
118-4	21631-21640	stability	_	
118-5	21641-21643	is	_	
118-6	21644-21651	similar	_	
118-7	21652-21654	to	_	
118-8	21655-21656	a	_	
118-9	21657-21665	previous	_	
118-10	21666-21671	study	_	
118-11	21672-21674	in	_	
118-12	21675-21680	older	_	
118-13	21681-21701	typically-developing	_	
118-14	21702-21710	children	_	
118-15	21710-21711	,	_	
118-16	21712-21717	which	_	
118-17	21718-21723	found	_	
118-18	21724-21736	correlations	_	
118-19	21737-21739	of	_	
118-20	21740-21750	functional	_	
118-21	21751-21763	connectivity	_	
118-22	21764-21772	matrices	_	
118-23	21773-21780	between	_	
118-24	21781-21784	the	_	
118-25	21785-21790	first	_	
118-26	21791-21794	and	_	
118-27	21795-21798	the	_	
118-28	21799-21805	second	_	
118-29	21806-21810	half	_	
118-30	21811-21813	of	_	
118-31	21814-21817	the	_	
118-32	21818-21822	data	_	
118-33	21823-21827	were	_	
118-34	21828-21841	approximately	_	
118-35	21842-21846	0.60	_	
118-36	21847-21851	when	_	
118-37	21852-21860	watching	_	
118-38	21861-21866	video	_	
118-39	21867-21872	clips	_	
118-40	21872-21873	.	_	

#Text=The high intra-participant stability in the PAE group was unexpected because children with PAE often have behavioral challenges, atypical neurocognitive responses to visual, auditory, and emotional stimuli, as well as altered functional connectivity among brain regions.
119-1	21874-21877	The	_	
119-2	21878-21882	high	_	
119-3	21883-21900	intra-participant	_	
119-4	21901-21910	stability	_	
119-5	21911-21913	in	_	
119-6	21914-21917	the	_	
119-7	21918-21921	PAE	_	
119-8	21922-21927	group	_	
119-9	21928-21931	was	_	
119-10	21932-21942	unexpected	_	
119-11	21943-21950	because	_	
119-12	21951-21959	children	_	
119-13	21960-21964	with	_	
119-14	21965-21968	PAE	_	
119-15	21969-21974	often	_	
119-16	21975-21979	have	_	
119-17	21980-21990	behavioral	_	
119-18	21991-22001	challenges	_	
119-19	22001-22002	,	_	
119-20	22003-22011	atypical	_	
119-21	22012-22026	neurocognitive	_	
119-22	22027-22036	responses	_	
119-23	22037-22039	to	_	
119-24	22040-22046	visual	_	
119-25	22046-22047	,	_	
119-26	22048-22056	auditory	_	
119-27	22056-22057	,	_	
119-28	22058-22061	and	_	
119-29	22062-22071	emotional	_	
119-30	22072-22079	stimuli	_	
119-31	22079-22080	,	_	
119-32	22081-22083	as	_	
119-33	22084-22088	well	_	
119-34	22089-22091	as	_	
119-35	22092-22099	altered	_	
119-36	22100-22110	functional	_	
119-37	22111-22123	connectivity	_	
119-38	22124-22129	among	_	
119-39	22130-22135	brain	_	
119-40	22136-22143	regions	_	
119-41	22143-22144	.	_	

#Text=It may be that movie viewing, as opposed to behavioral tasks, moderates the intra-individual variability in children with PAE and leads to higher stability.
120-1	22145-22147	It	_	
120-2	22148-22151	may	_	
120-3	22152-22154	be	_	
120-4	22155-22159	that	_	
120-5	22160-22165	movie	_	
120-6	22166-22173	viewing	_	
120-7	22173-22174	,	_	
120-8	22175-22177	as	_	
120-9	22178-22185	opposed	_	
120-10	22186-22188	to	_	
120-11	22189-22199	behavioral	_	
120-12	22200-22205	tasks	_	
120-13	22205-22206	,	_	
120-14	22207-22216	moderates	_	
120-15	22217-22220	the	_	
120-16	22221-22237	intra-individual	_	
120-17	22238-22249	variability	_	
120-18	22250-22252	in	_	
120-19	22253-22261	children	_	
120-20	22262-22266	with	_	
120-21	22267-22270	PAE	_	
120-22	22271-22274	and	_	
120-23	22275-22280	leads	_	
120-24	22281-22283	to	_	
120-25	22284-22290	higher	_	
120-26	22291-22300	stability	_	
120-27	22300-22301	.	_	

#Text=More challenging behavioral tasks may elicit more variable responses in children with PAE, while passive viewing is not sufficiently challenging to elicit high variability.
121-1	22302-22306	More	_	
121-2	22307-22318	challenging	_	
121-3	22319-22329	behavioral	_	
121-4	22330-22335	tasks	_	
121-5	22336-22339	may	_	
121-6	22340-22346	elicit	_	
121-7	22347-22351	more	_	
121-8	22352-22360	variable	_	
121-9	22361-22370	responses	_	
121-10	22371-22373	in	_	
121-11	22374-22382	children	_	
121-12	22383-22387	with	_	
121-13	22388-22391	PAE	_	
121-14	22391-22392	,	_	
121-15	22393-22398	while	_	
121-16	22399-22406	passive	_	
121-17	22407-22414	viewing	_	
121-18	22415-22417	is	_	
121-19	22418-22421	not	_	
121-20	22422-22434	sufficiently	_	
121-21	22435-22446	challenging	_	
121-22	22447-22449	to	_	
121-23	22450-22456	elicit	_	
121-24	22457-22461	high	_	
121-25	22462-22473	variability	_	
121-26	22473-22474	.	_	

#Text=This high stability of brain function suggests that naturalistic viewing fMRI could be a reliable paradigm for resting neuroimaging studies in young children, even those with PAE.
122-1	22475-22479	This	_	
122-2	22480-22484	high	_	
122-3	22485-22494	stability	_	
122-4	22495-22497	of	_	
122-5	22498-22503	brain	_	
122-6	22504-22512	function	_	
122-7	22513-22521	suggests	_	
122-8	22522-22526	that	_	
122-9	22527-22539	naturalistic	_	
122-10	22540-22547	viewing	_	
122-11	22548-22552	fMRI	_	
122-12	22553-22558	could	_	
122-13	22559-22561	be	_	
122-14	22562-22563	a	_	
122-15	22564-22572	reliable	_	
122-16	22573-22581	paradigm	_	
122-17	22582-22585	for	_	
122-18	22586-22593	resting	_	
122-19	22594-22606	neuroimaging	_	
122-20	22607-22614	studies	_	
122-21	22615-22617	in	_	
122-22	22618-22623	young	_	
122-23	22624-22632	children	_	
122-24	22632-22633	,	_	
122-25	22634-22638	even	_	
122-26	22639-22644	those	_	
122-27	22645-22649	with	_	
122-28	22650-22653	PAE	_	
122-29	22653-22654	.	_	

#Text=Previous resting-state fMRI studies in PAE instructed participants to close their eyes, or acquired data during natural sleep in infants, and found significant between-group differences in functional connectivity compared to unexposed controls.
123-1	22655-22663	Previous	_	
123-2	22664-22677	resting-state	_	
123-3	22678-22682	fMRI	_	
123-4	22683-22690	studies	_	
123-5	22691-22693	in	_	
123-6	22694-22697	PAE	_	
123-7	22698-22708	instructed	_	
123-8	22709-22721	participants	_	
123-9	22722-22724	to	_	
123-10	22725-22730	close	_	
123-11	22731-22736	their	_	
123-12	22737-22741	eyes	_	
123-13	22741-22742	,	_	
123-14	22743-22745	or	_	
123-15	22746-22754	acquired	_	
123-16	22755-22759	data	_	
123-17	22760-22766	during	_	
123-18	22767-22774	natural	_	
123-19	22775-22780	sleep	_	
123-20	22781-22783	in	_	
123-21	22784-22791	infants	_	
123-22	22791-22792	,	_	
123-23	22793-22796	and	_	
123-24	22797-22802	found	_	
123-25	22803-22814	significant	_	
123-26	22815-22828	between-group	_	
123-27	22829-22840	differences	_	
123-28	22841-22843	in	_	
123-29	22844-22854	functional	_	
123-30	22855-22867	connectivity	_	
123-31	22868-22876	compared	_	
123-32	22877-22879	to	_	
123-33	22880-22889	unexposed	_	
123-34	22890-22898	controls	_	
123-35	22898-22899	.	_	

#Text=It is possible that the passive viewing status here, with its relatively high intra-individual stability, may be less taxing on the brain and thus may not show differences evident in more difficult cognitive tasks.
124-1	22900-22902	It	_	
124-2	22903-22905	is	_	
124-3	22906-22914	possible	_	
124-4	22915-22919	that	_	
124-5	22920-22923	the	_	
124-6	22924-22931	passive	_	
124-7	22932-22939	viewing	_	
124-8	22940-22946	status	_	
124-9	22947-22951	here	_	
124-10	22951-22952	,	_	
124-11	22953-22957	with	_	
124-12	22958-22961	its	_	
124-13	22962-22972	relatively	_	
124-14	22973-22977	high	_	
124-15	22978-22994	intra-individual	_	
124-16	22995-23004	stability	_	
124-17	23004-23005	,	_	
124-18	23006-23009	may	_	
124-19	23010-23012	be	_	
124-20	23013-23017	less	_	
124-21	23018-23024	taxing	_	
124-22	23025-23027	on	_	
124-23	23028-23031	the	_	
124-24	23032-23037	brain	_	
124-25	23038-23041	and	_	
124-26	23042-23046	thus	_	
124-27	23047-23050	may	_	
124-28	23051-23054	not	_	
124-29	23055-23059	show	_	
124-30	23060-23071	differences	_	
124-31	23072-23079	evident	_	
124-32	23080-23082	in	_	
124-33	23083-23087	more	_	
124-34	23088-23097	difficult	_	
124-35	23098-23107	cognitive	_	
124-36	23108-23113	tasks	_	
124-37	23113-23114	.	_	

#Text=Alternatively, there may be fewer differences in the brain's functional connectivity at the younger ages studied here.
125-1	23115-23128	Alternatively	_	
125-2	23128-23129	,	_	
125-3	23130-23135	there	_	
125-4	23136-23139	may	_	
125-5	23140-23142	be	_	
125-6	23143-23148	fewer	_	
125-7	23149-23160	differences	_	
125-8	23161-23163	in	_	
125-9	23164-23167	the	_	
125-10	23168-23175	brain's	_	
125-11	23176-23186	functional	_	
125-12	23187-23199	connectivity	_	
125-13	23200-23202	at	_	
125-14	23203-23206	the	_	
125-15	23207-23214	younger	_	
125-16	23215-23219	ages	_	
125-17	23220-23227	studied	_	
125-18	23228-23232	here	_	
125-19	23232-23233	.	_	

#Text=Intra-participant connectome stability increased significantly with age in children with PAE, suggesting ongoing adjustment of functional networks during childhood.
126-1	23234-23251	Intra-participant	_	
126-2	23252-23262	connectome	_	
126-3	23263-23272	stability	_	
126-4	23273-23282	increased	_	
126-5	23283-23296	significantly	_	
126-6	23297-23301	with	_	
126-7	23302-23305	age	_	
126-8	23306-23308	in	_	
126-9	23309-23317	children	_	
126-10	23318-23322	with	_	
126-11	23323-23326	PAE	_	
126-12	23326-23327	,	_	
126-13	23328-23338	suggesting	_	
126-14	23339-23346	ongoing	_	
126-15	23347-23357	adjustment	_	
126-16	23358-23360	of	_	
126-17	23361-23371	functional	_	
126-18	23372-23380	networks	_	
126-19	23381-23387	during	_	
126-20	23388-23397	childhood	_	
126-21	23397-23398	.	_	

#Text=The unexposed controls, however, presented a flat trend of intra-participant stability.
127-1	23399-23402	The	_	
127-2	23403-23412	unexposed	_	
127-3	23413-23421	controls	_	
127-4	23421-23422	,	_	
127-5	23423-23430	however	_	
127-6	23430-23431	,	_	
127-7	23432-23441	presented	_	
127-8	23442-23443	a	_	
127-9	23444-23448	flat	_	
127-10	23449-23454	trend	_	
127-11	23455-23457	of	_	
127-12	23458-23475	intra-participant	_	
127-13	23476-23485	stability	_	
127-14	23485-23486	.	_	

#Text=Increasing intra-individual stability with age in children with PAE may reflect decreased variability in cognitive processing during passive viewing.
128-1	23487-23497	Increasing	_	
128-2	23498-23514	intra-individual	_	
128-3	23515-23524	stability	_	
128-4	23525-23529	with	_	
128-5	23530-23533	age	_	
128-6	23534-23536	in	_	
128-7	23537-23545	children	_	
128-8	23546-23550	with	_	
128-9	23551-23554	PAE	_	
128-10	23555-23558	may	_	
128-11	23559-23566	reflect	_	
128-12	23567-23576	decreased	_	
128-13	23577-23588	variability	_	
128-14	23589-23591	in	_	
128-15	23592-23601	cognitive	_	
128-16	23602-23612	processing	_	
128-17	23613-23619	during	_	
128-18	23620-23627	passive	_	
128-19	23628-23635	viewing	_	
128-20	23635-23636	.	_	

#Text=Electroencephalography (EEG) studies have shown that signal variability increases with age from childhood to adulthood in typically-developing individuals, and that higher variability (i.e., decreased stability) is associated with better task performance.
129-1	23637-23659	Electroencephalography	_	
129-2	23660-23661	(	_	
129-3	23661-23664	EEG	_	
129-4	23664-23665	)	_	
129-5	23666-23673	studies	_	
129-6	23674-23678	have	_	
129-7	23679-23684	shown	_	
129-8	23685-23689	that	_	
129-9	23690-23696	signal	_	
129-10	23697-23708	variability	_	
129-11	23709-23718	increases	_	
129-12	23719-23723	with	_	
129-13	23724-23727	age	_	
129-14	23728-23732	from	_	
129-15	23733-23742	childhood	_	
129-16	23743-23745	to	_	
129-17	23746-23755	adulthood	_	
129-18	23756-23758	in	_	
129-19	23759-23779	typically-developing	_	
129-20	23780-23791	individuals	_	
129-21	23791-23792	,	_	
129-22	23793-23796	and	_	
129-23	23797-23801	that	_	
129-24	23802-23808	higher	_	
129-25	23809-23820	variability	_	
129-26	23821-23822	(	_	
129-27	23822-23825	i.e	_	
129-28	23825-23826	.	_	
129-29	23826-23827	,	_	
129-30	23828-23837	decreased	_	
129-31	23838-23847	stability	_	
129-32	23847-23848	)	_	
129-33	23849-23851	is	_	
129-34	23852-23862	associated	_	
129-35	23863-23867	with	_	
129-36	23868-23874	better	_	
129-37	23875-23879	task	_	
129-38	23880-23891	performance	_	
129-39	23891-23892	.	_	

#Text=This suggests that variability in neuronal responses is essential to appropriate cognitive processing and the relative lack of variability may underlie impaired cognitive processing in children with PAE.
130-1	23893-23897	This	_	
130-2	23898-23906	suggests	_	
130-3	23907-23911	that	_	
130-4	23912-23923	variability	_	
130-5	23924-23926	in	_	
130-6	23927-23935	neuronal	_	
130-7	23936-23945	responses	_	
130-8	23946-23948	is	_	
130-9	23949-23958	essential	_	
130-10	23959-23961	to	_	
130-11	23962-23973	appropriate	_	
130-12	23974-23983	cognitive	_	
130-13	23984-23994	processing	_	
130-14	23995-23998	and	_	
130-15	23999-24002	the	_	
130-16	24003-24011	relative	_	
130-17	24012-24016	lack	_	
130-18	24017-24019	of	_	
130-19	24020-24031	variability	_	
130-20	24032-24035	may	_	
130-21	24036-24044	underlie	_	
130-22	24045-24053	impaired	_	
130-23	24054-24063	cognitive	_	
130-24	24064-24074	processing	_	
130-25	24075-24077	in	_	
130-26	24078-24086	children	_	
130-27	24087-24091	with	_	
130-28	24092-24095	PAE	_	
130-29	24095-24096	.	_	

#Text=Dramatic changes in cognition and behavior occur across childhood, skills that may be impaired in children with PAE.
131-1	24097-24105	Dramatic	_	
131-2	24106-24113	changes	_	
131-3	24114-24116	in	_	
131-4	24117-24126	cognition	_	
131-5	24127-24130	and	_	
131-6	24131-24139	behavior	_	
131-7	24140-24145	occur	_	
131-8	24146-24152	across	_	
131-9	24153-24162	childhood	_	
131-10	24162-24163	,	_	
131-11	24164-24170	skills	_	
131-12	24171-24175	that	_	
131-13	24176-24179	may	_	
131-14	24180-24182	be	_	
131-15	24183-24191	impaired	_	
131-16	24192-24194	in	_	
131-17	24195-24203	children	_	
131-18	24204-24208	with	_	
131-19	24209-24212	PAE	_	
131-20	24212-24213	.	_	

#Text=Thus, network reorganization related to increasing intra-participant stability may reflect abnormal brain development underlying cognitive and behavioral difficulties in this population.
132-1	24214-24218	Thus	_	
132-2	24218-24219	,	_	
132-3	24220-24227	network	_	
132-4	24228-24242	reorganization	_	
132-5	24243-24250	related	_	
132-6	24251-24253	to	_	
132-7	24254-24264	increasing	_	
132-8	24265-24282	intra-participant	_	
132-9	24283-24292	stability	_	
132-10	24293-24296	may	_	
132-11	24297-24304	reflect	_	
132-12	24305-24313	abnormal	_	
132-13	24314-24319	brain	_	
132-14	24320-24331	development	_	
132-15	24332-24342	underlying	_	
132-16	24343-24352	cognitive	_	
132-17	24353-24356	and	_	
132-18	24357-24367	behavioral	_	
132-19	24368-24380	difficulties	_	
132-20	24381-24383	in	_	
132-21	24384-24388	this	_	
132-22	24389-24399	population	_	
132-23	24399-24400	.	_	

#Text=Inter-participant stability of functional connectome
#Text=Using cross-correlations between connectivity matrices, we found similar inter-individual stability in children with PAE and unexposed controls, but inter-individual stability in the PAE group did not show the age-related increases observed in controls.
133-1	24401-24418	Inter-participant	_	
133-2	24419-24428	stability	_	
133-3	24429-24431	of	_	
133-4	24432-24442	functional	_	
133-5	24443-24453	connectome	_	
133-6	24454-24459	Using	_	
133-7	24460-24478	cross-correlations	_	
133-8	24479-24486	between	_	
133-9	24487-24499	connectivity	_	
133-10	24500-24508	matrices	_	
133-11	24508-24509	,	_	
133-12	24510-24512	we	_	
133-13	24513-24518	found	_	
133-14	24519-24526	similar	_	
133-15	24527-24543	inter-individual	_	
133-16	24544-24553	stability	_	
133-17	24554-24556	in	_	
133-18	24557-24565	children	_	
133-19	24566-24570	with	_	
133-20	24571-24574	PAE	_	
133-21	24575-24578	and	_	
133-22	24579-24588	unexposed	_	
133-23	24589-24597	controls	_	
133-24	24597-24598	,	_	
133-25	24599-24602	but	_	
133-26	24603-24619	inter-individual	_	
133-27	24620-24629	stability	_	
133-28	24630-24632	in	_	
133-29	24633-24636	the	_	
133-30	24637-24640	PAE	_	
133-31	24641-24646	group	_	
133-32	24647-24650	did	_	
133-33	24651-24654	not	_	
133-34	24655-24659	show	_	
133-35	24660-24663	the	_	
133-36	24664-24675	age-related	_	
133-37	24676-24685	increases	_	
133-38	24686-24694	observed	_	
133-39	24695-24697	in	_	
133-40	24698-24706	controls	_	
133-41	24706-24707	.	_	

#Text=This may suggest that children with PAE have highly variable development rates, with some children showing faster brain development than others, perhaps associated with the extent of PAE.
134-1	24708-24712	This	_	
134-2	24713-24716	may	_	
134-3	24717-24724	suggest	_	
134-4	24725-24729	that	_	
134-5	24730-24738	children	_	
134-6	24739-24743	with	_	
134-7	24744-24747	PAE	_	
134-8	24748-24752	have	_	
134-9	24753-24759	highly	_	
134-10	24760-24768	variable	_	
134-11	24769-24780	development	_	
134-12	24781-24786	rates	_	
134-13	24786-24787	,	_	
134-14	24788-24792	with	_	
134-15	24793-24797	some	_	
134-16	24798-24806	children	_	
134-17	24807-24814	showing	_	
134-18	24815-24821	faster	_	
134-19	24822-24827	brain	_	
134-20	24828-24839	development	_	
134-21	24840-24844	than	_	
134-22	24845-24851	others	_	
134-23	24851-24852	,	_	
134-24	24853-24860	perhaps	_	
134-25	24861-24871	associated	_	
134-26	24872-24876	with	_	
134-27	24877-24880	the	_	
134-28	24881-24887	extent	_	
134-29	24888-24890	of	_	
134-30	24891-24894	PAE	_	
134-31	24894-24895	.	_	

#Text=More similar development rates in controls would lead to increasing inter-individual stability, while more variable rates of brain development in children with PAE would keep inter-individual stability low relative to controls.
135-1	24896-24900	More	_	
135-2	24901-24908	similar	_	
135-3	24909-24920	development	_	
135-4	24921-24926	rates	_	
135-5	24927-24929	in	_	
135-6	24930-24938	controls	_	
135-7	24939-24944	would	_	
135-8	24945-24949	lead	_	
135-9	24950-24952	to	_	
135-10	24953-24963	increasing	_	
135-11	24964-24980	inter-individual	_	
135-12	24981-24990	stability	_	
135-13	24990-24991	,	_	
135-14	24992-24997	while	_	
135-15	24998-25002	more	_	
135-16	25003-25011	variable	_	
135-17	25012-25017	rates	_	
135-18	25018-25020	of	_	
135-19	25021-25026	brain	_	
135-20	25027-25038	development	_	
135-21	25039-25041	in	_	
135-22	25042-25050	children	_	
135-23	25051-25055	with	_	
135-24	25056-25059	PAE	_	
135-25	25060-25065	would	_	
135-26	25066-25070	keep	_	
135-27	25071-25087	inter-individual	_	
135-28	25088-25097	stability	_	
135-29	25098-25101	low	_	
135-30	25102-25110	relative	_	
135-31	25111-25113	to	_	
135-32	25114-25122	controls	_	
135-33	25122-25123	.	_	

#Text=Higher inter-individual variability in the human brain has been detected in other neurodevelopmental disorders, including adults with ASD and young adults with attention deficit hyperactivity disorder.
136-1	25124-25130	Higher	_	
136-2	25131-25147	inter-individual	_	
136-3	25148-25159	variability	_	
136-4	25160-25162	in	_	
136-5	25163-25166	the	_	
136-6	25167-25172	human	_	
136-7	25173-25178	brain	_	
136-8	25179-25182	has	_	
136-9	25183-25187	been	_	
136-10	25188-25196	detected	_	
136-11	25197-25199	in	_	
136-12	25200-25205	other	_	
136-13	25206-25224	neurodevelopmental	_	
136-14	25225-25234	disorders	_	
136-15	25234-25235	,	_	
136-16	25236-25245	including	_	
136-17	25246-25252	adults	_	
136-18	25253-25257	with	_	
136-19	25258-25261	ASD	_	
136-20	25262-25265	and	_	
136-21	25266-25271	young	_	
136-22	25272-25278	adults	_	
136-23	25279-25283	with	_	
136-24	25284-25293	attention	_	
136-25	25294-25301	deficit	_	
136-26	25302-25315	hyperactivity	_	
136-27	25316-25324	disorder	_	
136-28	25324-25325	.	_	

#Text=One study in older children with PAE showed more atypical functional connectome metrics in PAE compared to controls.
137-1	25326-25329	One	_	
137-2	25330-25335	study	_	
137-3	25336-25338	in	_	
137-4	25339-25344	older	_	
137-5	25345-25353	children	_	
137-6	25354-25358	with	_	
137-7	25359-25362	PAE	_	
137-8	25363-25369	showed	_	
137-9	25370-25374	more	_	
137-10	25375-25383	atypical	_	
137-11	25384-25394	functional	_	
137-12	25395-25405	connectome	_	
137-13	25406-25413	metrics	_	
137-14	25414-25416	in	_	
137-15	25417-25420	PAE	_	
137-16	25421-25429	compared	_	
137-17	25430-25432	to	_	
137-18	25433-25441	controls	_	
137-19	25441-25442	.	_	

#Text=For comparison purposes, we applied a similar analysis testing how many participants with PAE were >1 standard deviation from the mean of the whole sample.
138-1	25443-25446	For	_	
138-2	25447-25457	comparison	_	
138-3	25458-25466	purposes	_	
138-4	25466-25467	,	_	
138-5	25468-25470	we	_	
138-6	25471-25478	applied	_	
138-7	25479-25480	a	_	
138-8	25481-25488	similar	_	
138-9	25489-25497	analysis	_	
138-10	25498-25505	testing	_	
138-11	25506-25509	how	_	
138-12	25510-25514	many	_	
138-13	25515-25527	participants	_	
138-14	25528-25532	with	_	
138-15	25533-25536	PAE	_	
138-16	25537-25541	were	_	
138-17	25542-25543	>	_	
138-18	25543-25544	1	_	
138-19	25545-25553	standard	_	
138-20	25554-25563	deviation	_	
138-21	25564-25568	from	_	
138-22	25569-25572	the	_	
138-23	25573-25577	mean	_	
138-24	25578-25580	of	_	
138-25	25581-25584	the	_	
138-26	25585-25590	whole	_	
138-27	25591-25597	sample	_	
138-28	25597-25598	.	_	

#Text=We found that 15% of the children with PAE in our study had atypical global functional connectome metrics (local and global efficiency, clustering coefficient and shortest path length), considerably lower than the 50% observed in older children and adolescents with PAE.
139-1	25599-25601	We	_	
139-2	25602-25607	found	_	
139-3	25608-25612	that	_	
139-4	25613-25616	15%	_	
139-5	25617-25619	of	_	
139-6	25620-25623	the	_	
139-7	25624-25632	children	_	
139-8	25633-25637	with	_	
139-9	25638-25641	PAE	_	
139-10	25642-25644	in	_	
139-11	25645-25648	our	_	
139-12	25649-25654	study	_	
139-13	25655-25658	had	_	
139-14	25659-25667	atypical	_	
139-15	25668-25674	global	_	
139-16	25675-25685	functional	_	
139-17	25686-25696	connectome	_	
139-18	25697-25704	metrics	_	
139-19	25705-25706	(	_	
139-20	25706-25711	local	_	
139-21	25712-25715	and	_	
139-22	25716-25722	global	_	
139-23	25723-25733	efficiency	_	
139-24	25733-25734	,	_	
139-25	25735-25745	clustering	_	
139-26	25746-25757	coefficient	_	
139-27	25758-25761	and	_	
139-28	25762-25770	shortest	_	
139-29	25771-25775	path	_	
139-30	25776-25782	length	_	
139-31	25782-25783	)	_	
139-32	25783-25784	,	_	
139-33	25785-25797	considerably	_	
139-34	25798-25803	lower	_	
139-35	25804-25808	than	_	
139-36	25809-25812	the	_	
139-37	25813-25816	50%	_	
139-38	25817-25825	observed	_	
139-39	25826-25828	in	_	
139-40	25829-25834	older	_	
139-41	25835-25843	children	_	
139-42	25844-25847	and	_	
139-43	25848-25859	adolescents	_	
139-44	25860-25864	with	_	
139-45	25865-25868	PAE	_	
139-46	25868-25869	.	_	

#Text=Our current results showed greater inter-individual variability within the PAE group than in controls, and suggest divergent trajectories in the functional connectome, where stability across individuals increases with age in controls, but these increases are absent in individuals with PAE.
140-1	25870-25873	Our	_	
140-2	25874-25881	current	_	
140-3	25882-25889	results	_	
140-4	25890-25896	showed	_	
140-5	25897-25904	greater	_	
140-6	25905-25921	inter-individual	_	
140-7	25922-25933	variability	_	
140-8	25934-25940	within	_	
140-9	25941-25944	the	_	
140-10	25945-25948	PAE	_	
140-11	25949-25954	group	_	
140-12	25955-25959	than	_	
140-13	25960-25962	in	_	
140-14	25963-25971	controls	_	
140-15	25971-25972	,	_	
140-16	25973-25976	and	_	
140-17	25977-25984	suggest	_	
140-18	25985-25994	divergent	_	
140-19	25995-26007	trajectories	_	
140-20	26008-26010	in	_	
140-21	26011-26014	the	_	
140-22	26015-26025	functional	_	
140-23	26026-26036	connectome	_	
140-24	26036-26037	,	_	
140-25	26038-26043	where	_	
140-26	26044-26053	stability	_	
140-27	26054-26060	across	_	
140-28	26061-26072	individuals	_	
140-29	26073-26082	increases	_	
140-30	26083-26087	with	_	
140-31	26088-26091	age	_	
140-32	26092-26094	in	_	
140-33	26095-26103	controls	_	
140-34	26103-26104	,	_	
140-35	26105-26108	but	_	
140-36	26109-26114	these	_	
140-37	26115-26124	increases	_	
140-38	26125-26128	are	_	
140-39	26129-26135	absent	_	
140-40	26136-26138	in	_	
140-41	26139-26150	individuals	_	
140-42	26151-26155	with	_	
140-43	26156-26159	PAE	_	
140-44	26159-26160	.	_	

#Text=This difference in development may be associated with the higher frequency of atypical functional connectomes in older children and adolescents with PAE.
141-1	26161-26165	This	_	
141-2	26166-26176	difference	_	
141-3	26177-26179	in	_	
141-4	26180-26191	development	_	
141-5	26192-26195	may	_	
141-6	26196-26198	be	_	
141-7	26199-26209	associated	_	
141-8	26210-26214	with	_	
141-9	26215-26218	the	_	
141-10	26219-26225	higher	_	
141-11	26226-26235	frequency	_	
141-12	26236-26238	of	_	
141-13	26239-26247	atypical	_	
141-14	26248-26258	functional	_	
141-15	26259-26270	connectomes	_	
141-16	26271-26273	in	_	
141-17	26274-26279	older	_	
141-18	26280-26288	children	_	
141-19	26289-26292	and	_	
141-20	26293-26304	adolescents	_	
141-21	26305-26309	with	_	
141-22	26310-26313	PAE	_	
141-23	26313-26314	.	_	

#Text=The lack of increasing inter-participant stability in the PAE group may reflect disordered functional network development that becomes more apparent with age as functional demand increases.
142-1	26315-26318	The	_	
142-2	26319-26323	lack	_	
142-3	26324-26326	of	_	
142-4	26327-26337	increasing	_	
142-5	26338-26355	inter-participant	_	
142-6	26356-26365	stability	_	
142-7	26366-26368	in	_	
142-8	26369-26372	the	_	
142-9	26373-26376	PAE	_	
142-10	26377-26382	group	_	
142-11	26383-26386	may	_	
142-12	26387-26394	reflect	_	
142-13	26395-26405	disordered	_	
142-14	26406-26416	functional	_	
142-15	26417-26424	network	_	
142-16	26425-26436	development	_	
142-17	26437-26441	that	_	
142-18	26442-26449	becomes	_	
142-19	26450-26454	more	_	
142-20	26455-26463	apparent	_	
142-21	26464-26468	with	_	
142-22	26469-26472	age	_	
142-23	26473-26475	as	_	
142-24	26476-26486	functional	_	
142-25	26487-26493	demand	_	
142-26	26494-26503	increases	_	
142-27	26503-26504	.	_	

#Text=Indeed, older children with PAE had altered functional brain network connectivity.
143-1	26505-26511	Indeed	_	
143-2	26511-26512	,	_	
143-3	26513-26518	older	_	
143-4	26519-26527	children	_	
143-5	26528-26532	with	_	
143-6	26533-26536	PAE	_	
143-7	26537-26540	had	_	
143-8	26541-26548	altered	_	
143-9	26549-26559	functional	_	
143-10	26560-26565	brain	_	
143-11	26566-26573	network	_	
143-12	26574-26586	connectivity	_	
143-13	26586-26587	.	_	

#Text=The altered development of inter- and intra-individual stability may contribute to diverse cognitive impairments often observed in children with PAE.
144-1	26588-26591	The	_	
144-2	26592-26599	altered	_	
144-3	26600-26611	development	_	
144-4	26612-26614	of	_	
144-5	26615-26620	inter	_	
144-6	26620-26621	-	_	
144-7	26622-26625	and	_	
144-8	26626-26642	intra-individual	_	
144-9	26643-26652	stability	_	
144-10	26653-26656	may	_	
144-11	26657-26667	contribute	_	
144-12	26668-26670	to	_	
144-13	26671-26678	diverse	_	
144-14	26679-26688	cognitive	_	
144-15	26689-26700	impairments	_	
144-16	26701-26706	often	_	
144-17	26707-26715	observed	_	
144-18	26716-26718	in	_	
144-19	26719-26727	children	_	
144-20	26728-26732	with	_	
144-21	26733-26736	PAE	_	
144-22	26736-26737	.	_	

#Text=Though the relationship between network measures and cognitive function was not examined in the current study, previous studies have shown high correlations between network measures (e.g., shortest path length and network efficiency) and cognitive scores in older children with PAE.
145-1	26738-26744	Though	_	
145-2	26745-26748	the	_	
145-3	26749-26761	relationship	_	
145-4	26762-26769	between	_	
145-5	26770-26777	network	_	
145-6	26778-26786	measures	_	
145-7	26787-26790	and	_	
145-8	26791-26800	cognitive	_	
145-9	26801-26809	function	_	
145-10	26810-26813	was	_	
145-11	26814-26817	not	_	
145-12	26818-26826	examined	_	
145-13	26827-26829	in	_	
145-14	26830-26833	the	_	
145-15	26834-26841	current	_	
145-16	26842-26847	study	_	
145-17	26847-26848	,	_	
145-18	26849-26857	previous	_	
145-19	26858-26865	studies	_	
145-20	26866-26870	have	_	
145-21	26871-26876	shown	_	
145-22	26877-26881	high	_	
145-23	26882-26894	correlations	_	
145-24	26895-26902	between	_	
145-25	26903-26910	network	_	
145-26	26911-26919	measures	_	
145-27	26920-26921	(	_	
145-28	26921-26924	e.g	_	
145-29	26924-26925	.	_	
145-30	26925-26926	,	_	
145-31	26927-26935	shortest	_	
145-32	26936-26940	path	_	
145-33	26941-26947	length	_	
145-34	26948-26951	and	_	
145-35	26952-26959	network	_	
145-36	26960-26970	efficiency	_	
145-37	26970-26971	)	_	
145-38	26972-26975	and	_	
145-39	26976-26985	cognitive	_	
145-40	26986-26992	scores	_	
145-41	26993-26995	in	_	
145-42	26996-27001	older	_	
145-43	27002-27010	children	_	
145-44	27011-27015	with	_	
145-45	27016-27019	PAE	_	
145-46	27019-27020	.	_	

#Text=It may be that brain networks of young children with PAE have difficulty reorganizing themselves during development due to impaired underlying structure.
146-1	27021-27023	It	_	
146-2	27024-27027	may	_	
146-3	27028-27030	be	_	
146-4	27031-27035	that	_	
146-5	27036-27041	brain	_	
146-6	27042-27050	networks	_	
146-7	27051-27053	of	_	
146-8	27054-27059	young	_	
146-9	27060-27068	children	_	
146-10	27069-27073	with	_	
146-11	27074-27077	PAE	_	
146-12	27078-27082	have	_	
146-13	27083-27093	difficulty	_	
146-14	27094-27106	reorganizing	_	
146-15	27107-27117	themselves	_	
146-16	27118-27124	during	_	
146-17	27125-27136	development	_	
146-18	27137-27140	due	_	
146-19	27141-27143	to	_	
146-20	27144-27152	impaired	_	
146-21	27153-27163	underlying	_	
146-22	27164-27173	structure	_	
146-23	27173-27174	.	_	

#Text=Widespread structural brain alterations have been reported in children with PAE.
147-1	27175-27185	Widespread	_	
147-2	27186-27196	structural	_	
147-3	27197-27202	brain	_	
147-4	27203-27214	alterations	_	
147-5	27215-27219	have	_	
147-6	27220-27224	been	_	
147-7	27225-27233	reported	_	
147-8	27234-27236	in	_	
147-9	27237-27245	children	_	
147-10	27246-27250	with	_	
147-11	27251-27254	PAE	_	
147-12	27254-27255	.	_	

#Text=Furthermore, altered development of white matter has been observed in older children with PAE, who have differing trajectories of gray matter volume changes which suggest reduced brain plasticity.
148-1	27256-27267	Furthermore	_	
148-2	27267-27268	,	_	
148-3	27269-27276	altered	_	
148-4	27277-27288	development	_	
148-5	27289-27291	of	_	
148-6	27292-27297	white	_	
148-7	27298-27304	matter	_	
148-8	27305-27308	has	_	
148-9	27309-27313	been	_	
148-10	27314-27322	observed	_	
148-11	27323-27325	in	_	
148-12	27326-27331	older	_	
148-13	27332-27340	children	_	
148-14	27341-27345	with	_	
148-15	27346-27349	PAE	_	
148-16	27349-27350	,	_	
148-17	27351-27354	who	_	
148-18	27355-27359	have	_	
148-19	27360-27369	differing	_	
148-20	27370-27382	trajectories	_	
148-21	27383-27385	of	_	
148-22	27386-27390	gray	_	
148-23	27391-27397	matter	_	
148-24	27398-27404	volume	_	
148-25	27405-27412	changes	_	
148-26	27413-27418	which	_	
148-27	27419-27426	suggest	_	
148-28	27427-27434	reduced	_	
148-29	27435-27440	brain	_	
148-30	27441-27451	plasticity	_	
148-31	27451-27452	.	_	

#Text=Structural and functional connectivity both develop quickly in early childhood, though at different rates and with varying relationships to each other.
149-1	27453-27463	Structural	_	
149-2	27464-27467	and	_	
149-3	27468-27478	functional	_	
149-4	27479-27491	connectivity	_	
149-5	27492-27496	both	_	
149-6	27497-27504	develop	_	
149-7	27505-27512	quickly	_	
149-8	27513-27515	in	_	
149-9	27516-27521	early	_	
149-10	27522-27531	childhood	_	
149-11	27531-27532	,	_	
149-12	27533-27539	though	_	
149-13	27540-27542	at	_	
149-14	27543-27552	different	_	
149-15	27553-27558	rates	_	
149-16	27559-27562	and	_	
149-17	27563-27567	with	_	
149-18	27568-27575	varying	_	
149-19	27576-27589	relationships	_	
149-20	27590-27592	to	_	
149-21	27593-27597	each	_	
149-22	27598-27603	other	_	
149-23	27603-27604	.	_	

#Text=The current findings of abnormal development of functional networks in young children with PAE may coincide with altered structural development during this time period.
150-1	27605-27608	The	_	
150-2	27609-27616	current	_	
150-3	27617-27625	findings	_	
150-4	27626-27628	of	_	
150-5	27629-27637	abnormal	_	
150-6	27638-27649	development	_	
150-7	27650-27652	of	_	
150-8	27653-27663	functional	_	
150-9	27664-27672	networks	_	
150-10	27673-27675	in	_	
150-11	27676-27681	young	_	
150-12	27682-27690	children	_	
150-13	27691-27695	with	_	
150-14	27696-27699	PAE	_	
150-15	27700-27703	may	_	
150-16	27704-27712	coincide	_	
150-17	27713-27717	with	_	
150-18	27718-27725	altered	_	
150-19	27726-27736	structural	_	
150-20	27737-27748	development	_	
150-21	27749-27755	during	_	
150-22	27756-27760	this	_	
150-23	27761-27765	time	_	
150-24	27766-27772	period	_	
150-25	27772-27773	.	_	

#Text=Graph theoretical measurements in preschool children with PAE
#Text=We found no significant differences in global functional connectome metrics in children with PAE.
151-1	27774-27779	Graph	_	
151-2	27780-27791	theoretical	_	
151-3	27792-27804	measurements	_	
151-4	27805-27807	in	_	
151-5	27808-27817	preschool	_	
151-6	27818-27826	children	_	
151-7	27827-27831	with	_	
151-8	27832-27835	PAE	_	
151-9	27836-27838	We	_	
151-10	27839-27844	found	_	
151-11	27845-27847	no	_	
151-12	27848-27859	significant	_	
151-13	27860-27871	differences	_	
151-14	27872-27874	in	_	
151-15	27875-27881	global	_	
151-16	27882-27892	functional	_	
151-17	27893-27903	connectome	_	
151-18	27904-27911	metrics	_	
151-19	27912-27914	in	_	
151-20	27915-27923	children	_	
151-21	27924-27928	with	_	
151-22	27929-27932	PAE	_	
151-23	27932-27933	.	_	

#Text=One of the two previous studies on the functional connectome in older children with PAE found significantly decreased global efficiency and increased shortest path length in children and youth with PAE, while the other study found no differences in mean global metrics.
152-1	27934-27937	One	_	
152-2	27938-27940	of	_	
152-3	27941-27944	the	_	
152-4	27945-27948	two	_	
152-5	27949-27957	previous	_	
152-6	27958-27965	studies	_	
152-7	27966-27968	on	_	
152-8	27969-27972	the	_	
152-9	27973-27983	functional	_	
152-10	27984-27994	connectome	_	
152-11	27995-27997	in	_	
152-12	27998-28003	older	_	
152-13	28004-28012	children	_	
152-14	28013-28017	with	_	
152-15	28018-28021	PAE	_	
152-16	28022-28027	found	_	
152-17	28028-28041	significantly	_	
152-18	28042-28051	decreased	_	
152-19	28052-28058	global	_	
152-20	28059-28069	efficiency	_	
152-21	28070-28073	and	_	
152-22	28074-28083	increased	_	
152-23	28084-28092	shortest	_	
152-24	28093-28097	path	_	
152-25	28098-28104	length	_	
152-26	28105-28107	in	_	
152-27	28108-28116	children	_	
152-28	28117-28120	and	_	
152-29	28121-28126	youth	_	
152-30	28127-28131	with	_	
152-31	28132-28135	PAE	_	
152-32	28135-28136	,	_	
152-33	28137-28142	while	_	
152-34	28143-28146	the	_	
152-35	28147-28152	other	_	
152-36	28153-28158	study	_	
152-37	28159-28164	found	_	
152-38	28165-28167	no	_	
152-39	28168-28179	differences	_	
152-40	28180-28182	in	_	
152-41	28183-28187	mean	_	
152-42	28188-28194	global	_	
152-43	28195-28202	metrics	_	
152-44	28202-28203	.	_	

#Text=Our results in young children with PAE are in line with the latter study.
153-1	28204-28207	Our	_	
153-2	28208-28215	results	_	
153-3	28216-28218	in	_	
153-4	28219-28224	young	_	
153-5	28225-28233	children	_	
153-6	28234-28238	with	_	
153-7	28239-28242	PAE	_	
153-8	28243-28246	are	_	
153-9	28247-28249	in	_	
153-10	28250-28254	line	_	
153-11	28255-28259	with	_	
153-12	28260-28263	the	_	
153-13	28264-28270	latter	_	
153-14	28271-28276	study	_	
153-15	28276-28277	.	_	

#Text=Previous studies have demonstrated altered structural connectivty in children aged 5–13 years and infants with PAE, while other studies have shown abnormal functional connectivity in corticostriatal networks during a working-memory task and natural sleep.
154-1	28278-28286	Previous	_	
154-2	28287-28294	studies	_	
154-3	28295-28299	have	_	
154-4	28300-28312	demonstrated	_	
154-5	28313-28320	altered	_	
154-6	28321-28331	structural	_	
154-7	28332-28343	connectivty	_	
154-8	28344-28346	in	_	
154-9	28347-28355	children	_	
154-10	28356-28360	aged	_	
154-11	28361-28362	5	_	
154-12	28362-28363	–	_	
154-13	28363-28365	13	_	
154-14	28366-28371	years	_	
154-15	28372-28375	and	_	
154-16	28376-28383	infants	_	
154-17	28384-28388	with	_	
154-18	28389-28392	PAE	_	
154-19	28392-28393	,	_	
154-20	28394-28399	while	_	
154-21	28400-28405	other	_	
154-22	28406-28413	studies	_	
154-23	28414-28418	have	_	
154-24	28419-28424	shown	_	
154-25	28425-28433	abnormal	_	
154-26	28434-28444	functional	_	
154-27	28445-28457	connectivity	_	
154-28	28458-28460	in	_	
154-29	28461-28476	corticostriatal	_	
154-30	28477-28485	networks	_	
154-31	28486-28492	during	_	
154-32	28493-28494	a	_	
154-33	28495-28509	working-memory	_	
154-34	28510-28514	task	_	
154-35	28515-28518	and	_	
154-36	28519-28526	natural	_	
154-37	28527-28532	sleep	_	
154-38	28532-28533	.	_	

#Text=No previous studies have investigated node-level changes in the functional connectome in PAE.
155-1	28534-28536	No	_	
155-2	28537-28545	previous	_	
155-3	28546-28553	studies	_	
155-4	28554-28558	have	_	
155-5	28559-28571	investigated	_	
155-6	28572-28582	node-level	_	
155-7	28583-28590	changes	_	
155-8	28591-28593	in	_	
155-9	28594-28597	the	_	
155-10	28598-28608	functional	_	
155-11	28609-28619	connectome	_	
155-12	28620-28622	in	_	
155-13	28623-28626	PAE	_	
155-14	28626-28627	.	_	

#Text=We found distributed changes in frontal, motor and occipital cortex, yet none of them survived multiple comparison corrections, suggesting little-to-no difference in functional connectome nodes in youth children with PAE.
156-1	28628-28630	We	_	
156-2	28631-28636	found	_	
156-3	28637-28648	distributed	_	
156-4	28649-28656	changes	_	
156-5	28657-28659	in	_	
156-6	28660-28667	frontal	_	
156-7	28667-28668	,	_	
156-8	28669-28674	motor	_	
156-9	28675-28678	and	_	
156-10	28679-28688	occipital	_	
156-11	28689-28695	cortex	_	
156-12	28695-28696	,	_	
156-13	28697-28700	yet	_	
156-14	28701-28705	none	_	
156-15	28706-28708	of	_	
156-16	28709-28713	them	_	
156-17	28714-28722	survived	_	
156-18	28723-28731	multiple	_	
156-19	28732-28742	comparison	_	
156-20	28743-28754	corrections	_	
156-21	28754-28755	,	_	
156-22	28756-28766	suggesting	_	
156-23	28767-28779	little-to-no	_	
156-24	28780-28790	difference	_	
156-25	28791-28793	in	_	
156-26	28794-28804	functional	_	
156-27	28805-28815	connectome	_	
156-28	28816-28821	nodes	_	
156-29	28822-28824	in	_	
156-30	28825-28830	youth	_	
156-31	28831-28839	children	_	
156-32	28840-28844	with	_	
156-33	28845-28848	PAE	_	
156-34	28848-28849	.	_	

#Text=Limitations
#Text=There were several limitations in our study.
157-1	28850-28861	Limitations	_	
157-2	28862-28867	There	_	
157-3	28868-28872	were	_	
157-4	28873-28880	several	_	
157-5	28881-28892	limitations	_	
157-6	28893-28895	in	_	
157-7	28896-28899	our	_	
157-8	28900-28905	study	_	
157-9	28905-28906	.	_	

#Text=This study used passive viewing fMRI, which can increase compliance relative to fixation on a cross or an eyes closed condition, especially in difficult-to-scan populations such as young children and children with PAE.
158-1	28907-28911	This	_	
158-2	28912-28917	study	_	
158-3	28918-28922	used	_	
158-4	28923-28930	passive	_	
158-5	28931-28938	viewing	_	
158-6	28939-28943	fMRI	_	
158-7	28943-28944	,	_	
158-8	28945-28950	which	_	
158-9	28951-28954	can	_	
158-10	28955-28963	increase	_	
158-11	28964-28974	compliance	_	
158-12	28975-28983	relative	_	
158-13	28984-28986	to	_	
158-14	28987-28995	fixation	_	
158-15	28996-28998	on	_	
158-16	28999-29000	a	_	
158-17	29001-29006	cross	_	
158-18	29007-29009	or	_	
158-19	29010-29012	an	_	
158-20	29013-29017	eyes	_	
158-21	29018-29024	closed	_	
158-22	29025-29034	condition	_	
158-23	29034-29035	,	_	
158-24	29036-29046	especially	_	
158-25	29047-29049	in	_	
158-26	29050-29067	difficult-to-scan	_	
158-27	29068-29079	populations	_	
158-28	29080-29084	such	_	
158-29	29085-29087	as	_	
158-30	29088-29093	young	_	
158-31	29094-29102	children	_	
158-32	29103-29106	and	_	
158-33	29107-29115	children	_	
158-34	29116-29120	with	_	
158-35	29121-29124	PAE	_	
158-36	29124-29125	.	_	

#Text=However, children in our study were watching different movies and the details were not recorded for each scan.
159-1	29126-29133	However	_	
159-2	29133-29134	,	_	
159-3	29135-29143	children	_	
159-4	29144-29146	in	_	
159-5	29147-29150	our	_	
159-6	29151-29156	study	_	
159-7	29157-29161	were	_	
159-8	29162-29170	watching	_	
159-9	29171-29180	different	_	
159-10	29181-29187	movies	_	
159-11	29188-29191	and	_	
159-12	29192-29195	the	_	
159-13	29196-29203	details	_	
159-14	29204-29208	were	_	
159-15	29209-29212	not	_	
159-16	29213-29221	recorded	_	
159-17	29222-29225	for	_	
159-18	29226-29230	each	_	
159-19	29231-29235	scan	_	
159-20	29235-29236	.	_	

#Text=Thus, there may be increased variability between participants compared to passive viewing fMRI studies that use the same clips for all participants.
160-1	29237-29241	Thus	_	
160-2	29241-29242	,	_	
160-3	29243-29248	there	_	
160-4	29249-29252	may	_	
160-5	29253-29255	be	_	
160-6	29256-29265	increased	_	
160-7	29266-29277	variability	_	
160-8	29278-29285	between	_	
160-9	29286-29298	participants	_	
160-10	29299-29307	compared	_	
160-11	29308-29310	to	_	
160-12	29311-29318	passive	_	
160-13	29319-29326	viewing	_	
160-14	29327-29331	fMRI	_	
160-15	29332-29339	studies	_	
160-16	29340-29344	that	_	
160-17	29345-29348	use	_	
160-18	29349-29352	the	_	
160-19	29353-29357	same	_	
160-20	29358-29363	clips	_	
160-21	29364-29367	for	_	
160-22	29368-29371	all	_	
160-23	29372-29384	participants	_	
160-24	29384-29385	.	_	

#Text=The sample size of children with PAE was relatively small with few longitudinal scans, especially compared to the control group, which may reduce the reliability of the findings for the PAE group.
161-1	29386-29389	The	_	
161-2	29390-29396	sample	_	
161-3	29397-29401	size	_	
161-4	29402-29404	of	_	
161-5	29405-29413	children	_	
161-6	29414-29418	with	_	
161-7	29419-29422	PAE	_	
161-8	29423-29426	was	_	
161-9	29427-29437	relatively	_	
161-10	29438-29443	small	_	
161-11	29444-29448	with	_	
161-12	29449-29452	few	_	
161-13	29453-29465	longitudinal	_	
161-14	29466-29471	scans	_	
161-15	29471-29472	,	_	
161-16	29473-29483	especially	_	
161-17	29484-29492	compared	_	
161-18	29493-29495	to	_	
161-19	29496-29499	the	_	
161-20	29500-29507	control	_	
161-21	29508-29513	group	_	
161-22	29513-29514	,	_	
161-23	29515-29520	which	_	
161-24	29521-29524	may	_	
161-25	29525-29531	reduce	_	
161-26	29532-29535	the	_	
161-27	29536-29547	reliability	_	
161-28	29548-29550	of	_	
161-29	29551-29554	the	_	
161-30	29555-29563	findings	_	
161-31	29564-29567	for	_	
161-32	29568-29571	the	_	
161-33	29572-29575	PAE	_	
161-34	29576-29581	group	_	
161-35	29581-29582	.	_	

#Text=The relationship between age and inter-individual stability in control group was significant, but relatively small (r = 0.16); future studies may help clarify whether this represents a meaningful change.
162-1	29583-29586	The	_	
162-2	29587-29599	relationship	_	
162-3	29600-29607	between	_	
162-4	29608-29611	age	_	
162-5	29612-29615	and	_	
162-6	29616-29632	inter-individual	_	
162-7	29633-29642	stability	_	
162-8	29643-29645	in	_	
162-9	29646-29653	control	_	
162-10	29654-29659	group	_	
162-11	29660-29663	was	_	
162-12	29664-29675	significant	_	
162-13	29675-29676	,	_	
162-14	29677-29680	but	_	
162-15	29681-29691	relatively	_	
162-16	29692-29697	small	_	
162-17	29698-29699	(	_	
162-18	29699-29700	r	_	
162-19	29700-29701	 	_	
162-20	29701-29702	=	_	
162-21	29702-29703	 	_	
162-22	29703-29707	0.16	_	
162-23	29707-29708	)	_	
162-24	29708-29709	;	_	
162-25	29710-29716	future	_	
162-26	29717-29724	studies	_	
162-27	29725-29728	may	_	
162-28	29729-29733	help	_	
162-29	29734-29741	clarify	_	
162-30	29742-29749	whether	_	
162-31	29750-29754	this	_	
162-32	29755-29765	represents	_	
162-33	29766-29767	a	_	
162-34	29768-29778	meaningful	_	
162-35	29779-29785	change	_	
162-36	29785-29786	.	_	

#Text=The age range of participants is a strength for the age-related changes analysis, but developmental differences may also obscure group differences that would be apparent in a narrower age group.
163-1	29787-29790	The	_	
163-2	29791-29794	age	_	
163-3	29795-29800	range	_	
163-4	29801-29803	of	_	
163-5	29804-29816	participants	_	
163-6	29817-29819	is	_	
163-7	29820-29821	a	_	
163-8	29822-29830	strength	_	
163-9	29831-29834	for	_	
163-10	29835-29838	the	_	
163-11	29839-29850	age-related	_	
163-12	29851-29858	changes	_	
163-13	29859-29867	analysis	_	
163-14	29867-29868	,	_	
163-15	29869-29872	but	_	
163-16	29873-29886	developmental	_	
163-17	29887-29898	differences	_	
163-18	29899-29902	may	_	
163-19	29903-29907	also	_	
163-20	29908-29915	obscure	_	
163-21	29916-29921	group	_	
163-22	29922-29933	differences	_	
163-23	29934-29938	that	_	
163-24	29939-29944	would	_	
163-25	29945-29947	be	_	
163-26	29948-29956	apparent	_	
163-27	29957-29959	in	_	
163-28	29960-29961	a	_	
163-29	29962-29970	narrower	_	
163-30	29971-29974	age	_	
163-31	29975-29980	group	_	
163-32	29980-29981	.	_	

#Text=Future studies will help clarify functional brain differences in young children with PAE.
164-1	29982-29988	Future	_	
164-2	29989-29996	studies	_	
164-3	29997-30001	will	_	
164-4	30002-30006	help	_	
164-5	30007-30014	clarify	_	
164-6	30015-30025	functional	_	
164-7	30026-30031	brain	_	
164-8	30032-30043	differences	_	
164-9	30044-30046	in	_	
164-10	30047-30052	young	_	
164-11	30053-30061	children	_	
164-12	30062-30066	with	_	
164-13	30067-30070	PAE	_	
164-14	30070-30071	.	_	

#Text=Conclusions
#Text=Here, we used passive-viewing fMRI to describe functional connectome development in young children with PAE.
165-1	30072-30083	Conclusions	_	
165-2	30084-30088	Here	_	
165-3	30088-30089	,	_	
165-4	30090-30092	we	_	
165-5	30093-30097	used	_	
165-6	30098-30113	passive-viewing	_	
165-7	30114-30118	fMRI	_	
165-8	30119-30121	to	_	
165-9	30122-30130	describe	_	
165-10	30131-30141	functional	_	
165-11	30142-30152	connectome	_	
165-12	30153-30164	development	_	
165-13	30165-30167	in	_	
165-14	30168-30173	young	_	
165-15	30174-30182	children	_	
165-16	30183-30187	with	_	
165-17	30188-30191	PAE	_	
165-18	30191-30192	.	_	

#Text=Children with PAE and unexposed controls both showed similar graph theory metrics, as well as intra- and inter-participant stability of their functional connectomes.
166-1	30193-30201	Children	_	
166-2	30202-30206	with	_	
166-3	30207-30210	PAE	_	
166-4	30211-30214	and	_	
166-5	30215-30224	unexposed	_	
166-6	30225-30233	controls	_	
166-7	30234-30238	both	_	
166-8	30239-30245	showed	_	
166-9	30246-30253	similar	_	
166-10	30254-30259	graph	_	
166-11	30260-30266	theory	_	
166-12	30267-30274	metrics	_	
166-13	30274-30275	,	_	
166-14	30276-30278	as	_	
166-15	30279-30283	well	_	
166-16	30284-30286	as	_	
166-17	30287-30292	intra	_	
166-18	30292-30293	-	_	
166-19	30294-30297	and	_	
166-20	30298-30315	inter-participant	_	
166-21	30316-30325	stability	_	
166-22	30326-30328	of	_	
166-23	30329-30334	their	_	
166-24	30335-30345	functional	_	
166-25	30346-30357	connectomes	_	
166-26	30357-30358	.	_	

#Text=Children with PAE showed age-related increases in intra-individual stability of functional connectomes, and no age-related changes in inter-individual stability.
167-1	30359-30367	Children	_	
167-2	30368-30372	with	_	
167-3	30373-30376	PAE	_	
167-4	30377-30383	showed	_	
167-5	30384-30395	age-related	_	
167-6	30396-30405	increases	_	
167-7	30406-30408	in	_	
167-8	30409-30425	intra-individual	_	
167-9	30426-30435	stability	_	
167-10	30436-30438	of	_	
167-11	30439-30449	functional	_	
167-12	30450-30461	connectomes	_	
167-13	30461-30462	,	_	
167-14	30463-30466	and	_	
167-15	30467-30469	no	_	
167-16	30470-30481	age-related	_	
167-17	30482-30489	changes	_	
167-18	30490-30492	in	_	
167-19	30493-30509	inter-individual	_	
167-20	30510-30519	stability	_	
167-21	30519-30520	.	_	

#Text=This suggests early origins of the higher inter-individual variability that exists in older children with PAE and these differences may underlie the altered brain function observed in PAE by resting-state and task-based fMRI studies.
168-1	30521-30525	This	_	
168-2	30526-30534	suggests	_	
168-3	30535-30540	early	_	
168-4	30541-30548	origins	_	
168-5	30549-30551	of	_	
168-6	30552-30555	the	_	
168-7	30556-30562	higher	_	
168-8	30563-30579	inter-individual	_	
168-9	30580-30591	variability	_	
168-10	30592-30596	that	_	
168-11	30597-30603	exists	_	
168-12	30604-30606	in	_	
168-13	30607-30612	older	_	
168-14	30613-30621	children	_	
168-15	30622-30626	with	_	
168-16	30627-30630	PAE	_	
168-17	30631-30634	and	_	
168-18	30635-30640	these	_	
168-19	30641-30652	differences	_	
168-20	30653-30656	may	_	
168-21	30657-30665	underlie	_	
168-22	30666-30669	the	_	
168-23	30670-30677	altered	_	
168-24	30678-30683	brain	_	
168-25	30684-30692	function	_	
168-26	30693-30701	observed	_	
168-27	30702-30704	in	_	
168-28	30705-30708	PAE	_	
168-29	30709-30711	by	_	
168-30	30712-30725	resting-state	_	
168-31	30726-30729	and	_	
168-32	30730-30740	task-based	_	
168-33	30741-30745	fMRI	_	
168-34	30746-30753	studies	_	
168-35	30753-30754	.	_	

#Text=Conflict of Competing Interest
#Text=CL's spouse is an employee of General Electric Healthcare
#Text=References
#Text=A resilient, low-frequency, small-world human brain functional network with highly connected association cortical hubs
#Text=An investigation of intra-individual variability in children with fetal alcohol spectrum disorder (FASD)
#Text=Small-world brain networks
#Text=Brain dynamics in ASD during movie-watching show idiosyncratic functional integration and segregation
#Text=Cortical hubs revealed by intrinsic functional connectivity: mapping, assessment of stability, and relation to Alzheimer's disease
#Text=Complex brain networks: graph theoretical analysis of structural and functional systems
#Text=Developmental connectomics from infancy through early childhood
#Text=Clinical applications of the functional connectome
#Text=Mild cognitive impairment in early life and mental health problems in adulthood
#Text=AFNI: software for analysis and visualization of functional magnetic resonance neuroimages
#Text=Symptom-correlated brain regions in young adults with combined-type ADHD: their organization, variability, and relation to behavioral performance
#Text=Unraveling the miswired connectome: a developmental perspective
#Text=Neuroimaging effects of prenatal alcohol exposure on the developing human brain: a magnetic resonance imaging review
#Text=Interhemispheric functional brain connectivity in neonates with prenatal alcohol exposure: preliminary findings
#Text=Network-level connectivity dynamics of movie watching in 6-year-old children
#Text=Preschool behavioral and social-cognitive problems as predictors of (Pre) adolescent disruptive behavior
#Text=White matter integrity of the cerebellar peduncles as a mediator of effects of prenatal alcohol exposure on eyeblink conditioning
#Text=Localized reductions in resting-state functional connectivity in children with prenatal alcohol exposure
#Text=Unbiased average age-appropriate atlases for pediatric studies
#Text=Association between depression severity and amygdala reactivity during sad face viewing in depressed preschoolers: an fMRI study
#Text=Moment-to-moment brain signal variability: a next frontier in human brain mapping
#Text=Volume changes and brain-behavior relationships in white matter and subcortical gray matter in children with prenatal alcohol exposure
#Text=Imaging structural and functional brain development in early childhood
#Text=Diffusion tensor imaging correlates of saccadic reaction time in children with fetal alcohol spectrum disorder
#Text=Foetal alcohol spectrum disorders and alterations in brain and behaviour
#Text=Out-of-sync: disrupted neural activity in emotional circuitry during film viewing in melancholic depression
#Text=MRI-compatible audio/visual system: impact on pediatric sedation
#Text=Development of human brain structural networks through infancy and childhood
#Text=Cortical patterns of category-selective activation for faces, places and objects in adults with autism
#Text=The brainstem reticular formation is a small-world, not scale-free, network
#Text=Tracking the brain's functional coupling dynamics over development
#Text=Altered functional connectivity during spatial working memory in children with heavy prenatal alcohol exposure
#Text=Effects of prenatal alcohol exposure on child development
#Text=Improved optimization for the robust and accurate linear registration and motion correction of brain images
#Text=FSL
#Text=Mechanisms of connectome development
#Text=The alberta pregnancy outcomes and nutrition (APrON) cohort study: rationale and methods
#Text=Neurocognitive profile in children with fetal alcohol spectrum disorders
#Text=A longitudinal study of the long-term consequences of drinking during pregnancy: heavy in utero alcohol exposure disrupts the normal processes of brain development
#Text=Brain diffusion abnormalities in children with fetal alcohol spectrum disorder
#Text=Imaging the impact of prenatal alcohol exposure on the structure of the developing human brain
#Text=Linking inter-individual variability in functional brain connectivity to cognitive ability in elderly individuals
#Text=Altered functional connectivity observed at rest in children and adolescents prenatally exposed to alcohol
#Text=Age-related functional brain changes in young children
#Text=Sensorimotor network alterations in children and youth with prenatal alcohol exposure
#Text=Intra-individual variability in behavior : links to brain structure, neurotransmission and neuronal activity
#Text=Dynamic functional connectivity of neurocognitive networks in children
#Text=The development of a noisy brain
#Text=Fetal alcohol spectrum disorders: recent neuroimaging findings
#Text=Radiological studies of fetal alcohol spectrum disorders in humans and animal models: an updated comprehensive review
#Text=Deficits in response inhibition correlate with oculomotor control in children with fetal alcohol spectrum disorder and prenatal alcohol exposure
#Text=Diffusion tensor imaging of white matter and correlates to eye movement control and psychometric testing in children with prenatal alcohol exposure
#Text=Emotional understanding in school-aged children with fetal alcohol spectrum disorders: a promising target for intervention
#Text=Methods to detect, characterize, and remove motion artifact in resting state fMRI
#Text=Evidence for hubs in human functional brain networks
#Text=Predicting individual brain maturity using dynamic functional connectivity
#Text=Global and regional white matter development in early childhood
#Text=Fetal alcohol spectrum disorders: an cverview
#Text=Fetal alcohol spectrum disorders: an overview with emphasis on changes in brain and behavior
#Text=Prenatal alcohol exposure is associated with regionally thinner cortex during the preadolescent period
#Text=Functional network integration and attention skills in young children
#Text=Stereotaxic display of brain lesions
#Text=Frontostriatal connectivity in children during working memory and the effects of prenatal methamphetamine, alcohol, and polydrug exposure
#Text=Complex network measures of brain connectivity: uses and interpretations
#Text=Default mode network dysfunction in adults with prenatal alcohol exposure
#Text=An improved framework for confound regression and filtering for control of motion artifact in the preprocessing of resting-state functional connectivity data
#Text=Mapping white matter integrity and neurobehavioral correlates in children with fetal alcohol spectrum disorders
#Text=Abnormal cortical thickness and brain-behavior correlation patterns in individuals with heavy prenatal alcohol exposure
#Text=Delays in auditory processing identified in preschool children with FASD
#Text=Development of large-scale functional brain networks in children
#Text=Development of functional and structural connectivity within the default mode network in young children
#Text=Longitudinal mri reveals altered trajectory of brain development during childhood and adolescence in fetal alcohol spectrum disorders
#Text=Automated anatomical labeling of activations in spm using a macroscopic anatomical parcellation of the MNI MRI single-subject brain
#Text=Typical and atypical development of functional human brain networks: insights from resting-state fMRI
#Text=Future directions for examination of brain networks in neurodevelopmental disorders
#Text=Movies in the magnet: naturalistic paradigms in developmental functional neuroimaging
#Text=Individual differences in functional connectivity during naturalistic viewing conditions
#Text=Inscapes: a movie paradigm to improve compliance in functional magnetic resonance imaging
#Text=GRETNA: a graph theoretical network analysis toolbox for imaging connectomics
#Text=Graph-based network analysis of resting-state functional MRI
#Text=Global functional connectivity abnormalities in children with fetal alcohol spectrum disorders
#Text=Diffusion tensor imaging in children with fetal alcohol spectrum disorders
#Text=Functional connectivity abnormalities and associated cognitive deficits in fetal alcohol spectrum disorders (FASD)
#Text=Inter-Hemispheric functional connectivity disruption in children with prenatal alcohol exposure
#Text=What does diffusion tensor imaging reveal about the brain and cognition in fetal alcohol spectrum disorders
#Text=Microstructural corpus callosum anomalies in children with prenatal alcohol exposure: an extension of previous diffusion tensor imaging findings
#Text=BrainNet viewer: a network visualization tool for human brain connectomics
#Text=Delineating the macroscale areal organization of the macaque cortex in vivo
#Text=Sex- and brain size-related small-world structural cortical networks in young adults: a DTI tractography study
#Text=Abnormal cortical thickness alterations in fetal alcohol spectrum disorders and their relationships with facial dysmorphology
#Text=Resting-state functional MRI studies on infant brains: a decade of gap-filling efforts
#Text=NeuroImage graph theoretical modeling of baby brain networks
#Text=Developmental cortical thinning in fetal alcohol spectrum disorders
#Text=Preserved cortical asymmetry despite thinner cortex in children and adolescents with prenatal alcohol exposure and associated conditions
#Text=Human connectomics across the life span
#Text=Supplementary materials
#Text=Supplementary material associated with this article can be found, in the online version, at doi:10.1016/j.nicl.2019.102082.
169-1	30755-30763	Conflict	_	
169-2	30764-30766	of	_	
169-3	30767-30776	Competing	_	
169-4	30777-30785	Interest	_	
169-5	30786-30790	CL's	_	
169-6	30791-30797	spouse	_	
169-7	30798-30800	is	_	
169-8	30801-30803	an	_	
169-9	30804-30812	employee	_	
169-10	30813-30815	of	_	
169-11	30816-30823	General	_	
169-12	30824-30832	Electric	_	
169-13	30833-30843	Healthcare	_	
169-14	30844-30854	References	_	
169-15	30855-30856	A	_	
169-16	30857-30866	resilient	_	
169-17	30866-30867	,	_	
169-18	30868-30881	low-frequency	_	
169-19	30881-30882	,	_	
169-20	30883-30894	small-world	_	
169-21	30895-30900	human	_	
169-22	30901-30906	brain	_	
169-23	30907-30917	functional	_	
169-24	30918-30925	network	_	
169-25	30926-30930	with	_	
169-26	30931-30937	highly	_	
169-27	30938-30947	connected	_	
169-28	30948-30959	association	_	
169-29	30960-30968	cortical	_	
169-30	30969-30973	hubs	_	
169-31	30974-30976	An	_	
169-32	30977-30990	investigation	_	
169-33	30991-30993	of	_	
169-34	30994-31010	intra-individual	_	
169-35	31011-31022	variability	_	
169-36	31023-31025	in	_	
169-37	31026-31034	children	_	
169-38	31035-31039	with	_	
169-39	31040-31045	fetal	_	
169-40	31046-31053	alcohol	_	
169-41	31054-31062	spectrum	_	
169-42	31063-31071	disorder	_	
169-43	31072-31073	(	_	
169-44	31073-31077	FASD	_	
169-45	31077-31078	)	_	
169-46	31079-31090	Small-world	_	
169-47	31091-31096	brain	_	
169-48	31097-31105	networks	_	
169-49	31106-31111	Brain	_	
169-50	31112-31120	dynamics	_	
169-51	31121-31123	in	_	
169-52	31124-31127	ASD	_	
169-53	31128-31134	during	_	
169-54	31135-31149	movie-watching	_	
169-55	31150-31154	show	_	
169-56	31155-31168	idiosyncratic	_	
169-57	31169-31179	functional	_	
169-58	31180-31191	integration	_	
169-59	31192-31195	and	_	
169-60	31196-31207	segregation	_	
169-61	31208-31216	Cortical	_	
169-62	31217-31221	hubs	_	
169-63	31222-31230	revealed	_	
169-64	31231-31233	by	_	
169-65	31234-31243	intrinsic	_	
169-66	31244-31254	functional	_	
169-67	31255-31267	connectivity	_	
169-68	31267-31268	:	_	
169-69	31269-31276	mapping	_	
169-70	31276-31277	,	_	
169-71	31278-31288	assessment	_	
169-72	31289-31291	of	_	
169-73	31292-31301	stability	_	
169-74	31301-31302	,	_	
169-75	31303-31306	and	_	
169-76	31307-31315	relation	_	
169-77	31316-31318	to	_	
169-78	31319-31330	Alzheimer's	_	
169-79	31331-31338	disease	_	
169-80	31339-31346	Complex	_	
169-81	31347-31352	brain	_	
169-82	31353-31361	networks	_	
169-83	31361-31362	:	_	
169-84	31363-31368	graph	_	
169-85	31369-31380	theoretical	_	
169-86	31381-31389	analysis	_	
169-87	31390-31392	of	_	
169-88	31393-31403	structural	_	
169-89	31404-31407	and	_	
169-90	31408-31418	functional	_	
169-91	31419-31426	systems	_	
169-92	31427-31440	Developmental	_	
169-93	31441-31453	connectomics	_	
169-94	31454-31458	from	_	
169-95	31459-31466	infancy	_	
169-96	31467-31474	through	_	
169-97	31475-31480	early	_	
169-98	31481-31490	childhood	_	
169-99	31491-31499	Clinical	_	
169-100	31500-31512	applications	_	
169-101	31513-31515	of	_	
169-102	31516-31519	the	_	
169-103	31520-31530	functional	_	
169-104	31531-31541	connectome	_	
169-105	31542-31546	Mild	_	
169-106	31547-31556	cognitive	_	
169-107	31557-31567	impairment	_	
169-108	31568-31570	in	_	
169-109	31571-31576	early	_	
169-110	31577-31581	life	_	
169-111	31582-31585	and	_	
169-112	31586-31592	mental	_	
169-113	31593-31599	health	_	
169-114	31600-31608	problems	_	
169-115	31609-31611	in	_	
169-116	31612-31621	adulthood	_	
169-117	31622-31626	AFNI	_	
169-118	31626-31627	:	_	
169-119	31628-31636	software	_	
169-120	31637-31640	for	_	
169-121	31641-31649	analysis	_	
169-122	31650-31653	and	_	
169-123	31654-31667	visualization	_	
169-124	31668-31670	of	_	
169-125	31671-31681	functional	_	
169-126	31682-31690	magnetic	_	
169-127	31691-31700	resonance	_	
169-128	31701-31712	neuroimages	_	
169-129	31713-31731	Symptom-correlated	_	
169-130	31732-31737	brain	_	
169-131	31738-31745	regions	_	
169-132	31746-31748	in	_	
169-133	31749-31754	young	_	
169-134	31755-31761	adults	_	
169-135	31762-31766	with	_	
169-136	31767-31780	combined-type	_	
169-137	31781-31785	ADHD	_	
169-138	31785-31786	:	_	
169-139	31787-31792	their	_	
169-140	31793-31805	organization	_	
169-141	31805-31806	,	_	
169-142	31807-31818	variability	_	
169-143	31818-31819	,	_	
169-144	31820-31823	and	_	
169-145	31824-31832	relation	_	
169-146	31833-31835	to	_	
169-147	31836-31846	behavioral	_	
169-148	31847-31858	performance	_	
169-149	31859-31869	Unraveling	_	
169-150	31870-31873	the	_	
169-151	31874-31882	miswired	_	
169-152	31883-31893	connectome	_	
169-153	31893-31894	:	_	
169-154	31895-31896	a	_	
169-155	31897-31910	developmental	_	
169-156	31911-31922	perspective	_	
169-157	31923-31935	Neuroimaging	_	
169-158	31936-31943	effects	_	
169-159	31944-31946	of	_	
169-160	31947-31955	prenatal	_	
169-161	31956-31963	alcohol	_	
169-162	31964-31972	exposure	_	
169-163	31973-31975	on	_	
169-164	31976-31979	the	_	
169-165	31980-31990	developing	_	
169-166	31991-31996	human	_	
169-167	31997-32002	brain	_	
169-168	32002-32003	:	_	
169-169	32004-32005	a	_	
169-170	32006-32014	magnetic	_	
169-171	32015-32024	resonance	_	
169-172	32025-32032	imaging	_	
169-173	32033-32039	review	_	
169-174	32040-32056	Interhemispheric	_	
169-175	32057-32067	functional	_	
169-176	32068-32073	brain	_	
169-177	32074-32086	connectivity	_	
169-178	32087-32089	in	_	
169-179	32090-32098	neonates	_	
169-180	32099-32103	with	_	
169-181	32104-32112	prenatal	_	
169-182	32113-32120	alcohol	_	
169-183	32121-32129	exposure	_	
169-184	32129-32130	:	_	
169-185	32131-32142	preliminary	_	
169-186	32143-32151	findings	_	
169-187	32152-32165	Network-level	_	
169-188	32166-32178	connectivity	_	
169-189	32179-32187	dynamics	_	
169-190	32188-32190	of	_	
169-191	32191-32196	movie	_	
169-192	32197-32205	watching	_	
169-193	32206-32208	in	_	
169-194	32209-32210	6	_	
169-195	32210-32211	-	_	
169-196	32211-32219	year-old	_	
169-197	32220-32228	children	_	
169-198	32229-32238	Preschool	_	
169-199	32239-32249	behavioral	_	
169-200	32250-32253	and	_	
169-201	32254-32270	social-cognitive	_	
169-202	32271-32279	problems	_	
169-203	32280-32282	as	_	
169-204	32283-32293	predictors	_	
169-205	32294-32296	of	_	
169-206	32297-32298	(	_	
169-207	32298-32301	Pre	_	
169-208	32301-32302	)	_	
169-209	32303-32313	adolescent	_	
169-210	32314-32324	disruptive	_	
169-211	32325-32333	behavior	_	
169-212	32334-32339	White	_	
169-213	32340-32346	matter	_	
169-214	32347-32356	integrity	_	
169-215	32357-32359	of	_	
169-216	32360-32363	the	_	
169-217	32364-32374	cerebellar	_	
169-218	32375-32384	peduncles	_	
169-219	32385-32387	as	_	
169-220	32388-32389	a	_	
169-221	32390-32398	mediator	_	
169-222	32399-32401	of	_	
169-223	32402-32409	effects	_	
169-224	32410-32412	of	_	
169-225	32413-32421	prenatal	_	
169-226	32422-32429	alcohol	_	
169-227	32430-32438	exposure	_	
169-228	32439-32441	on	_	
169-229	32442-32450	eyeblink	_	
169-230	32451-32463	conditioning	_	
169-231	32464-32473	Localized	_	
169-232	32474-32484	reductions	_	
169-233	32485-32487	in	_	
169-234	32488-32501	resting-state	_	
169-235	32502-32512	functional	_	
169-236	32513-32525	connectivity	_	
169-237	32526-32528	in	_	
169-238	32529-32537	children	_	
169-239	32538-32542	with	_	
169-240	32543-32551	prenatal	_	
169-241	32552-32559	alcohol	_	
169-242	32560-32568	exposure	_	
169-243	32569-32577	Unbiased	_	
169-244	32578-32585	average	_	
169-245	32586-32601	age-appropriate	_	
169-246	32602-32609	atlases	_	
169-247	32610-32613	for	_	
169-248	32614-32623	pediatric	_	
169-249	32624-32631	studies	_	
169-250	32632-32643	Association	_	
169-251	32644-32651	between	_	
169-252	32652-32662	depression	_	
169-253	32663-32671	severity	_	
169-254	32672-32675	and	_	
169-255	32676-32684	amygdala	_	
169-256	32685-32695	reactivity	_	
169-257	32696-32702	during	_	
169-258	32703-32706	sad	_	
169-259	32707-32711	face	_	
169-260	32712-32719	viewing	_	
169-261	32720-32722	in	_	
169-262	32723-32732	depressed	_	
169-263	32733-32745	preschoolers	_	
169-264	32745-32746	:	_	
169-265	32747-32749	an	_	
169-266	32750-32754	fMRI	_	
169-267	32755-32760	study	_	
169-268	32761-32777	Moment-to-moment	_	
169-269	32778-32783	brain	_	
169-270	32784-32790	signal	_	
169-271	32791-32802	variability	_	
169-272	32802-32803	:	_	
169-273	32804-32805	a	_	
169-274	32806-32810	next	_	
169-275	32811-32819	frontier	_	
169-276	32820-32822	in	_	
169-277	32823-32828	human	_	
169-278	32829-32834	brain	_	
169-279	32835-32842	mapping	_	
169-280	32843-32849	Volume	_	
169-281	32850-32857	changes	_	
169-282	32858-32861	and	_	
169-283	32862-32876	brain-behavior	_	
169-284	32877-32890	relationships	_	
169-285	32891-32893	in	_	
169-286	32894-32899	white	_	
169-287	32900-32906	matter	_	
169-288	32907-32910	and	_	
169-289	32911-32922	subcortical	_	
169-290	32923-32927	gray	_	
169-291	32928-32934	matter	_	
169-292	32935-32937	in	_	
169-293	32938-32946	children	_	
169-294	32947-32951	with	_	
169-295	32952-32960	prenatal	_	
169-296	32961-32968	alcohol	_	
169-297	32969-32977	exposure	_	
169-298	32978-32985	Imaging	_	
169-299	32986-32996	structural	_	
169-300	32997-33000	and	_	
169-301	33001-33011	functional	_	
169-302	33012-33017	brain	_	
169-303	33018-33029	development	_	
169-304	33030-33032	in	_	
169-305	33033-33038	early	_	
169-306	33039-33048	childhood	_	
169-307	33049-33058	Diffusion	_	
169-308	33059-33065	tensor	_	
169-309	33066-33073	imaging	_	
169-310	33074-33084	correlates	_	
169-311	33085-33087	of	_	
169-312	33088-33096	saccadic	_	
169-313	33097-33105	reaction	_	
169-314	33106-33110	time	_	
169-315	33111-33113	in	_	
169-316	33114-33122	children	_	
169-317	33123-33127	with	_	
169-318	33128-33133	fetal	_	
169-319	33134-33141	alcohol	_	
169-320	33142-33150	spectrum	_	
169-321	33151-33159	disorder	_	
169-322	33160-33166	Foetal	_	
169-323	33167-33174	alcohol	_	
169-324	33175-33183	spectrum	_	
169-325	33184-33193	disorders	_	
169-326	33194-33197	and	_	
169-327	33198-33209	alterations	_	
169-328	33210-33212	in	_	
169-329	33213-33218	brain	_	
169-330	33219-33222	and	_	
169-331	33223-33232	behaviour	_	
169-332	33233-33244	Out-of-sync	_	
169-333	33244-33245	:	_	
169-334	33246-33255	disrupted	_	
169-335	33256-33262	neural	_	
169-336	33263-33271	activity	_	
169-337	33272-33274	in	_	
169-338	33275-33284	emotional	_	
169-339	33285-33294	circuitry	_	
169-340	33295-33301	during	_	
169-341	33302-33306	film	_	
169-342	33307-33314	viewing	_	
169-343	33315-33317	in	_	
169-344	33318-33329	melancholic	_	
169-345	33330-33340	depression	_	
169-346	33341-33355	MRI-compatible	_	
169-347	33356-33361	audio	_	
169-348	33361-33362	/	_	
169-349	33362-33368	visual	_	
169-350	33369-33375	system	_	
169-351	33375-33376	:	_	
169-352	33377-33383	impact	_	
169-353	33384-33386	on	_	
169-354	33387-33396	pediatric	_	
169-355	33397-33405	sedation	_	
169-356	33406-33417	Development	_	
169-357	33418-33420	of	_	
169-358	33421-33426	human	_	
169-359	33427-33432	brain	_	
169-360	33433-33443	structural	_	
169-361	33444-33452	networks	_	
169-362	33453-33460	through	_	
169-363	33461-33468	infancy	_	
169-364	33469-33472	and	_	
169-365	33473-33482	childhood	_	
169-366	33483-33491	Cortical	_	
169-367	33492-33500	patterns	_	
169-368	33501-33503	of	_	
169-369	33504-33522	category-selective	_	
169-370	33523-33533	activation	_	
169-371	33534-33537	for	_	
169-372	33538-33543	faces	_	
169-373	33543-33544	,	_	
169-374	33545-33551	places	_	
169-375	33552-33555	and	_	
169-376	33556-33563	objects	_	
169-377	33564-33566	in	_	
169-378	33567-33573	adults	_	
169-379	33574-33578	with	_	
169-380	33579-33585	autism	_	
169-381	33586-33589	The	_	
169-382	33590-33599	brainstem	_	
169-383	33600-33609	reticular	_	
169-384	33610-33619	formation	_	
169-385	33620-33622	is	_	
169-386	33623-33624	a	_	
169-387	33625-33636	small-world	_	
169-388	33636-33637	,	_	
169-389	33638-33641	not	_	
169-390	33642-33652	scale-free	_	
169-391	33652-33653	,	_	
169-392	33654-33661	network	_	
169-393	33662-33670	Tracking	_	
169-394	33671-33674	the	_	
169-395	33675-33682	brain's	_	
169-396	33683-33693	functional	_	
169-397	33694-33702	coupling	_	
169-398	33703-33711	dynamics	_	
169-399	33712-33716	over	_	
169-400	33717-33728	development	_	
169-401	33729-33736	Altered	_	
169-402	33737-33747	functional	_	
169-403	33748-33760	connectivity	_	
169-404	33761-33767	during	_	
169-405	33768-33775	spatial	_	
169-406	33776-33783	working	_	
169-407	33784-33790	memory	_	
169-408	33791-33793	in	_	
169-409	33794-33802	children	_	
169-410	33803-33807	with	_	
169-411	33808-33813	heavy	_	
169-412	33814-33822	prenatal	_	
169-413	33823-33830	alcohol	_	
169-414	33831-33839	exposure	_	
169-415	33840-33847	Effects	_	
169-416	33848-33850	of	_	
169-417	33851-33859	prenatal	_	
169-418	33860-33867	alcohol	_	
169-419	33868-33876	exposure	_	
169-420	33877-33879	on	_	
169-421	33880-33885	child	_	
169-422	33886-33897	development	_	
169-423	33898-33906	Improved	_	
169-424	33907-33919	optimization	_	
169-425	33920-33923	for	_	
169-426	33924-33927	the	_	
169-427	33928-33934	robust	_	
169-428	33935-33938	and	_	
169-429	33939-33947	accurate	_	
169-430	33948-33954	linear	_	
169-431	33955-33967	registration	_	
169-432	33968-33971	and	_	
169-433	33972-33978	motion	_	
169-434	33979-33989	correction	_	
169-435	33990-33992	of	_	
169-436	33993-33998	brain	_	
169-437	33999-34005	images	_	
169-438	34006-34009	FSL	_	
169-439	34010-34020	Mechanisms	_	
169-440	34021-34023	of	_	
169-441	34024-34034	connectome	_	
169-442	34035-34046	development	_	
169-443	34047-34050	The	_	
169-444	34051-34058	alberta	_	
169-445	34059-34068	pregnancy	_	
169-446	34069-34077	outcomes	_	
169-447	34078-34081	and	_	
169-448	34082-34091	nutrition	_	
169-449	34092-34093	(	_	
169-450	34093-34098	APrON	_	
169-451	34098-34099	)	_	
169-452	34100-34106	cohort	_	
169-453	34107-34112	study	_	
169-454	34112-34113	:	_	
169-455	34114-34123	rationale	_	
169-456	34124-34127	and	_	
169-457	34128-34135	methods	_	
169-458	34136-34150	Neurocognitive	_	
169-459	34151-34158	profile	_	
169-460	34159-34161	in	_	
169-461	34162-34170	children	_	
169-462	34171-34175	with	_	
169-463	34176-34181	fetal	_	
169-464	34182-34189	alcohol	_	
169-465	34190-34198	spectrum	_	
169-466	34199-34208	disorders	_	
169-467	34209-34210	A	_	
169-468	34211-34223	longitudinal	_	
169-469	34224-34229	study	_	
169-470	34230-34232	of	_	
169-471	34233-34236	the	_	
169-472	34237-34246	long-term	_	
169-473	34247-34259	consequences	_	
169-474	34260-34262	of	_	
169-475	34263-34271	drinking	_	
169-476	34272-34278	during	_	
169-477	34279-34288	pregnancy	_	
169-478	34288-34289	:	_	
169-479	34290-34295	heavy	_	
169-480	34296-34298	in	_	
169-481	34299-34304	utero	_	
169-482	34305-34312	alcohol	_	
169-483	34313-34321	exposure	_	
169-484	34322-34330	disrupts	_	
169-485	34331-34334	the	_	
169-486	34335-34341	normal	_	
169-487	34342-34351	processes	_	
169-488	34352-34354	of	_	
169-489	34355-34360	brain	_	
169-490	34361-34372	development	_	
169-491	34373-34378	Brain	_	
169-492	34379-34388	diffusion	_	
169-493	34389-34402	abnormalities	_	
169-494	34403-34405	in	_	
169-495	34406-34414	children	_	
169-496	34415-34419	with	_	
169-497	34420-34425	fetal	_	
169-498	34426-34433	alcohol	_	
169-499	34434-34442	spectrum	_	
169-500	34443-34451	disorder	_	
169-501	34452-34459	Imaging	_	
169-502	34460-34463	the	_	
169-503	34464-34470	impact	_	
169-504	34471-34473	of	_	
169-505	34474-34482	prenatal	_	
169-506	34483-34490	alcohol	_	
169-507	34491-34499	exposure	_	
169-508	34500-34502	on	_	
169-509	34503-34506	the	_	
169-510	34507-34516	structure	_	
169-511	34517-34519	of	_	
169-512	34520-34523	the	_	
169-513	34524-34534	developing	_	
169-514	34535-34540	human	_	
169-515	34541-34546	brain	_	
169-516	34547-34554	Linking	_	
169-517	34555-34571	inter-individual	_	
169-518	34572-34583	variability	_	
169-519	34584-34586	in	_	
169-520	34587-34597	functional	_	
169-521	34598-34603	brain	_	
169-522	34604-34616	connectivity	_	
169-523	34617-34619	to	_	
169-524	34620-34629	cognitive	_	
169-525	34630-34637	ability	_	
169-526	34638-34640	in	_	
169-527	34641-34648	elderly	_	
169-528	34649-34660	individuals	_	
169-529	34661-34668	Altered	_	
169-530	34669-34679	functional	_	
169-531	34680-34692	connectivity	_	
169-532	34693-34701	observed	_	
169-533	34702-34704	at	_	
169-534	34705-34709	rest	_	
169-535	34710-34712	in	_	
169-536	34713-34721	children	_	
169-537	34722-34725	and	_	
169-538	34726-34737	adolescents	_	
169-539	34738-34748	prenatally	_	
169-540	34749-34756	exposed	_	
169-541	34757-34759	to	_	
169-542	34760-34767	alcohol	_	
169-543	34768-34779	Age-related	_	
169-544	34780-34790	functional	_	
169-545	34791-34796	brain	_	
169-546	34797-34804	changes	_	
169-547	34805-34807	in	_	
169-548	34808-34813	young	_	
169-549	34814-34822	children	_	
169-550	34823-34835	Sensorimotor	_	
169-551	34836-34843	network	_	
169-552	34844-34855	alterations	_	
169-553	34856-34858	in	_	
169-554	34859-34867	children	_	
169-555	34868-34871	and	_	
169-556	34872-34877	youth	_	
169-557	34878-34882	with	_	
169-558	34883-34891	prenatal	_	
169-559	34892-34899	alcohol	_	
169-560	34900-34908	exposure	_	
169-561	34909-34925	Intra-individual	_	
169-562	34926-34937	variability	_	
169-563	34938-34940	in	_	
169-564	34941-34949	behavior	_	
169-565	34949-34950	 	_	
169-566	34950-34951	:	_	
169-567	34952-34957	links	_	
169-568	34958-34960	to	_	
169-569	34961-34966	brain	_	
169-570	34967-34976	structure	_	
169-571	34976-34977	,	_	
169-572	34978-34995	neurotransmission	_	
169-573	34996-34999	and	_	
169-574	35000-35008	neuronal	_	
169-575	35009-35017	activity	_	
169-576	35018-35025	Dynamic	_	
169-577	35026-35036	functional	_	
169-578	35037-35049	connectivity	_	
169-579	35050-35052	of	_	
169-580	35053-35067	neurocognitive	_	
169-581	35068-35076	networks	_	
169-582	35077-35079	in	_	
169-583	35080-35088	children	_	
169-584	35089-35092	The	_	
169-585	35093-35104	development	_	
169-586	35105-35107	of	_	
169-587	35108-35109	a	_	
169-588	35110-35115	noisy	_	
169-589	35116-35121	brain	_	
169-590	35122-35127	Fetal	_	
169-591	35128-35135	alcohol	_	
169-592	35136-35144	spectrum	_	
169-593	35145-35154	disorders	_	
169-594	35154-35155	:	_	
169-595	35156-35162	recent	_	
169-596	35163-35175	neuroimaging	_	
169-597	35176-35184	findings	_	
169-598	35185-35197	Radiological	_	
169-599	35198-35205	studies	_	
169-600	35206-35208	of	_	
169-601	35209-35214	fetal	_	
169-602	35215-35222	alcohol	_	
169-603	35223-35231	spectrum	_	
169-604	35232-35241	disorders	_	
169-605	35242-35244	in	_	
169-606	35245-35251	humans	_	
169-607	35252-35255	and	_	
169-608	35256-35262	animal	_	
169-609	35263-35269	models	_	
169-610	35269-35270	:	_	
169-611	35271-35273	an	_	
169-612	35274-35281	updated	_	
169-613	35282-35295	comprehensive	_	
169-614	35296-35302	review	_	
169-615	35303-35311	Deficits	_	
169-616	35312-35314	in	_	
169-617	35315-35323	response	_	
169-618	35324-35334	inhibition	_	
169-619	35335-35344	correlate	_	
169-620	35345-35349	with	_	
169-621	35350-35360	oculomotor	_	
169-622	35361-35368	control	_	
169-623	35369-35371	in	_	
169-624	35372-35380	children	_	
169-625	35381-35385	with	_	
169-626	35386-35391	fetal	_	
169-627	35392-35399	alcohol	_	
169-628	35400-35408	spectrum	_	
169-629	35409-35417	disorder	_	
169-630	35418-35421	and	_	
169-631	35422-35430	prenatal	_	
169-632	35431-35438	alcohol	_	
169-633	35439-35447	exposure	_	
169-634	35448-35457	Diffusion	_	
169-635	35458-35464	tensor	_	
169-636	35465-35472	imaging	_	
169-637	35473-35475	of	_	
169-638	35476-35481	white	_	
169-639	35482-35488	matter	_	
169-640	35489-35492	and	_	
169-641	35493-35503	correlates	_	
169-642	35504-35506	to	_	
169-643	35507-35510	eye	_	
169-644	35511-35519	movement	_	
169-645	35520-35527	control	_	
169-646	35528-35531	and	_	
169-647	35532-35544	psychometric	_	
169-648	35545-35552	testing	_	
169-649	35553-35555	in	_	
169-650	35556-35564	children	_	
169-651	35565-35569	with	_	
169-652	35570-35578	prenatal	_	
169-653	35579-35586	alcohol	_	
169-654	35587-35595	exposure	_	
169-655	35596-35605	Emotional	_	
169-656	35606-35619	understanding	_	
169-657	35620-35622	in	_	
169-658	35623-35634	school-aged	_	
169-659	35635-35643	children	_	
169-660	35644-35648	with	_	
169-661	35649-35654	fetal	_	
169-662	35655-35662	alcohol	_	
169-663	35663-35671	spectrum	_	
169-664	35672-35681	disorders	_	
169-665	35681-35682	:	_	
169-666	35683-35684	a	_	
169-667	35685-35694	promising	_	
169-668	35695-35701	target	_	
169-669	35702-35705	for	_	
169-670	35706-35718	intervention	_	
169-671	35719-35726	Methods	_	
169-672	35727-35729	to	_	
169-673	35730-35736	detect	_	
169-674	35736-35737	,	_	
169-675	35738-35750	characterize	_	
169-676	35750-35751	,	_	
169-677	35752-35755	and	_	
169-678	35756-35762	remove	_	
169-679	35763-35769	motion	_	
169-680	35770-35778	artifact	_	
169-681	35779-35781	in	_	
169-682	35782-35789	resting	_	
169-683	35790-35795	state	_	
169-684	35796-35800	fMRI	_	
169-685	35801-35809	Evidence	_	
169-686	35810-35813	for	_	
169-687	35814-35818	hubs	_	
169-688	35819-35821	in	_	
169-689	35822-35827	human	_	
169-690	35828-35838	functional	_	
169-691	35839-35844	brain	_	
169-692	35845-35853	networks	_	
169-693	35854-35864	Predicting	_	
169-694	35865-35875	individual	_	
169-695	35876-35881	brain	_	
169-696	35882-35890	maturity	_	
169-697	35891-35896	using	_	
169-698	35897-35904	dynamic	_	
169-699	35905-35915	functional	_	
169-700	35916-35928	connectivity	_	
169-701	35929-35935	Global	_	
169-702	35936-35939	and	_	
169-703	35940-35948	regional	_	
169-704	35949-35954	white	_	
169-705	35955-35961	matter	_	
169-706	35962-35973	development	_	
169-707	35974-35976	in	_	
169-708	35977-35982	early	_	
169-709	35983-35992	childhood	_	
169-710	35993-35998	Fetal	_	
169-711	35999-36006	alcohol	_	
169-712	36007-36015	spectrum	_	
169-713	36016-36025	disorders	_	
169-714	36025-36026	:	_	
169-715	36027-36029	an	_	
169-716	36030-36038	cverview	_	
169-717	36039-36044	Fetal	_	
169-718	36045-36052	alcohol	_	
169-719	36053-36061	spectrum	_	
169-720	36062-36071	disorders	_	
169-721	36071-36072	:	_	
169-722	36073-36075	an	_	
169-723	36076-36084	overview	_	
169-724	36085-36089	with	_	
169-725	36090-36098	emphasis	_	
169-726	36099-36101	on	_	
169-727	36102-36109	changes	_	
169-728	36110-36112	in	_	
169-729	36113-36118	brain	_	
169-730	36119-36122	and	_	
169-731	36123-36131	behavior	_	
169-732	36132-36140	Prenatal	_	
169-733	36141-36148	alcohol	_	
169-734	36149-36157	exposure	_	
169-735	36158-36160	is	_	
169-736	36161-36171	associated	_	
169-737	36172-36176	with	_	
169-738	36177-36187	regionally	_	
169-739	36188-36195	thinner	_	
169-740	36196-36202	cortex	_	
169-741	36203-36209	during	_	
169-742	36210-36213	the	_	
169-743	36214-36227	preadolescent	_	
169-744	36228-36234	period	_	
169-745	36235-36245	Functional	_	
169-746	36246-36253	network	_	
169-747	36254-36265	integration	_	
169-748	36266-36269	and	_	
169-749	36270-36279	attention	_	
169-750	36280-36286	skills	_	
169-751	36287-36289	in	_	
169-752	36290-36295	young	_	
169-753	36296-36304	children	_	
169-754	36305-36316	Stereotaxic	_	
169-755	36317-36324	display	_	
169-756	36325-36327	of	_	
169-757	36328-36333	brain	_	
169-758	36334-36341	lesions	_	
169-759	36342-36356	Frontostriatal	_	
169-760	36357-36369	connectivity	_	
169-761	36370-36372	in	_	
169-762	36373-36381	children	_	
169-763	36382-36388	during	_	
169-764	36389-36396	working	_	
169-765	36397-36403	memory	_	
169-766	36404-36407	and	_	
169-767	36408-36411	the	_	
169-768	36412-36419	effects	_	
169-769	36420-36422	of	_	
169-770	36423-36431	prenatal	_	
169-771	36432-36447	methamphetamine	_	
169-772	36447-36448	,	_	
169-773	36449-36456	alcohol	_	
169-774	36456-36457	,	_	
169-775	36458-36461	and	_	
169-776	36462-36470	polydrug	_	
169-777	36471-36479	exposure	_	
169-778	36480-36487	Complex	_	
169-779	36488-36495	network	_	
169-780	36496-36504	measures	_	
169-781	36505-36507	of	_	
169-782	36508-36513	brain	_	
169-783	36514-36526	connectivity	_	
169-784	36526-36527	:	_	
169-785	36528-36532	uses	_	
169-786	36533-36536	and	_	
169-787	36537-36552	interpretations	_	
169-788	36553-36560	Default	_	
169-789	36561-36565	mode	_	
169-790	36566-36573	network	_	
169-791	36574-36585	dysfunction	_	
169-792	36586-36588	in	_	
169-793	36589-36595	adults	_	
169-794	36596-36600	with	_	
169-795	36601-36609	prenatal	_	
169-796	36610-36617	alcohol	_	
169-797	36618-36626	exposure	_	
169-798	36627-36629	An	_	
169-799	36630-36638	improved	_	
169-800	36639-36648	framework	_	
169-801	36649-36652	for	_	
169-802	36653-36661	confound	_	
169-803	36662-36672	regression	_	
169-804	36673-36676	and	_	
169-805	36677-36686	filtering	_	
169-806	36687-36690	for	_	
169-807	36691-36698	control	_	
169-808	36699-36701	of	_	
169-809	36702-36708	motion	_	
169-810	36709-36717	artifact	_	
169-811	36718-36720	in	_	
169-812	36721-36724	the	_	
169-813	36725-36738	preprocessing	_	
169-814	36739-36741	of	_	
169-815	36742-36755	resting-state	_	
169-816	36756-36766	functional	_	
169-817	36767-36779	connectivity	_	
169-818	36780-36784	data	_	
169-819	36785-36792	Mapping	_	
169-820	36793-36798	white	_	
169-821	36799-36805	matter	_	
169-822	36806-36815	integrity	_	
169-823	36816-36819	and	_	
169-824	36820-36835	neurobehavioral	_	
169-825	36836-36846	correlates	_	
169-826	36847-36849	in	_	
169-827	36850-36858	children	_	
169-828	36859-36863	with	_	
169-829	36864-36869	fetal	_	
169-830	36870-36877	alcohol	_	
169-831	36878-36886	spectrum	_	
169-832	36887-36896	disorders	_	
169-833	36897-36905	Abnormal	_	
169-834	36906-36914	cortical	_	
169-835	36915-36924	thickness	_	
169-836	36925-36928	and	_	
169-837	36929-36943	brain-behavior	_	
169-838	36944-36955	correlation	_	
169-839	36956-36964	patterns	_	
169-840	36965-36967	in	_	
169-841	36968-36979	individuals	_	
169-842	36980-36984	with	_	
169-843	36985-36990	heavy	_	
169-844	36991-36999	prenatal	_	
169-845	37000-37007	alcohol	_	
169-846	37008-37016	exposure	_	
169-847	37017-37023	Delays	_	
169-848	37024-37026	in	_	
169-849	37027-37035	auditory	_	
169-850	37036-37046	processing	_	
169-851	37047-37057	identified	_	
169-852	37058-37060	in	_	
169-853	37061-37070	preschool	_	
169-854	37071-37079	children	_	
169-855	37080-37084	with	_	
169-856	37085-37089	FASD	_	
169-857	37090-37101	Development	_	
169-858	37102-37104	of	_	
169-859	37105-37116	large-scale	_	
169-860	37117-37127	functional	_	
169-861	37128-37133	brain	_	
169-862	37134-37142	networks	_	
169-863	37143-37145	in	_	
169-864	37146-37154	children	_	
169-865	37155-37166	Development	_	
169-866	37167-37169	of	_	
169-867	37170-37180	functional	_	
169-868	37181-37184	and	_	
169-869	37185-37195	structural	_	
169-870	37196-37208	connectivity	_	
169-871	37209-37215	within	_	
169-872	37216-37219	the	_	
169-873	37220-37227	default	_	
169-874	37228-37232	mode	_	
169-875	37233-37240	network	_	
169-876	37241-37243	in	_	
169-877	37244-37249	young	_	
169-878	37250-37258	children	_	
169-879	37259-37271	Longitudinal	_	
169-880	37272-37275	mri	_	
169-881	37276-37283	reveals	_	
169-882	37284-37291	altered	_	
169-883	37292-37302	trajectory	_	
169-884	37303-37305	of	_	
169-885	37306-37311	brain	_	
169-886	37312-37323	development	_	
169-887	37324-37330	during	_	
169-888	37331-37340	childhood	_	
169-889	37341-37344	and	_	
169-890	37345-37356	adolescence	_	
169-891	37357-37359	in	_	
169-892	37360-37365	fetal	_	
169-893	37366-37373	alcohol	_	
169-894	37374-37382	spectrum	_	
169-895	37383-37392	disorders	_	
169-896	37393-37402	Automated	_	
169-897	37403-37413	anatomical	_	
169-898	37414-37422	labeling	_	
169-899	37423-37425	of	_	
169-900	37426-37437	activations	_	
169-901	37438-37440	in	_	
169-902	37441-37444	spm	_	
169-903	37445-37450	using	_	
169-904	37451-37452	a	_	
169-905	37453-37464	macroscopic	_	
169-906	37465-37475	anatomical	_	
169-907	37476-37488	parcellation	_	
169-908	37489-37491	of	_	
169-909	37492-37495	the	_	
169-910	37496-37499	MNI	_	
169-911	37500-37503	MRI	_	
169-912	37504-37518	single-subject	_	
169-913	37519-37524	brain	_	
169-914	37525-37532	Typical	_	
169-915	37533-37536	and	_	
169-916	37537-37545	atypical	_	
169-917	37546-37557	development	_	
169-918	37558-37560	of	_	
169-919	37561-37571	functional	_	
169-920	37572-37577	human	_	
169-921	37578-37583	brain	_	
169-922	37584-37592	networks	_	
169-923	37592-37593	:	_	
169-924	37594-37602	insights	_	
169-925	37603-37607	from	_	
169-926	37608-37621	resting-state	_	
169-927	37622-37626	fMRI	_	
169-928	37627-37633	Future	_	
169-929	37634-37644	directions	_	
169-930	37645-37648	for	_	
169-931	37649-37660	examination	_	
169-932	37661-37663	of	_	
169-933	37664-37669	brain	_	
169-934	37670-37678	networks	_	
169-935	37679-37681	in	_	
169-936	37682-37700	neurodevelopmental	_	
169-937	37701-37710	disorders	_	
169-938	37711-37717	Movies	_	
169-939	37718-37720	in	_	
169-940	37721-37724	the	_	
169-941	37725-37731	magnet	_	
169-942	37731-37732	:	_	
169-943	37733-37745	naturalistic	_	
169-944	37746-37755	paradigms	_	
169-945	37756-37758	in	_	
169-946	37759-37772	developmental	_	
169-947	37773-37783	functional	_	
169-948	37784-37796	neuroimaging	_	
169-949	37797-37807	Individual	_	
169-950	37808-37819	differences	_	
169-951	37820-37822	in	_	
169-952	37823-37833	functional	_	
169-953	37834-37846	connectivity	_	
169-954	37847-37853	during	_	
169-955	37854-37866	naturalistic	_	
169-956	37867-37874	viewing	_	
169-957	37875-37885	conditions	_	
169-958	37886-37894	Inscapes	_	
169-959	37894-37895	:	_	
169-960	37896-37897	a	_	
169-961	37898-37903	movie	_	
169-962	37904-37912	paradigm	_	
169-963	37913-37915	to	_	
169-964	37916-37923	improve	_	
169-965	37924-37934	compliance	_	
169-966	37935-37937	in	_	
169-967	37938-37948	functional	_	
169-968	37949-37957	magnetic	_	
169-969	37958-37967	resonance	_	
169-970	37968-37975	imaging	_	
169-971	37976-37982	GRETNA	_	
169-972	37982-37983	:	_	
169-973	37984-37985	a	_	
169-974	37986-37991	graph	_	
169-975	37992-38003	theoretical	_	
169-976	38004-38011	network	_	
169-977	38012-38020	analysis	_	
169-978	38021-38028	toolbox	_	
169-979	38029-38032	for	_	
169-980	38033-38040	imaging	_	
169-981	38041-38053	connectomics	_	
169-982	38054-38065	Graph-based	_	
169-983	38066-38073	network	_	
169-984	38074-38082	analysis	_	
169-985	38083-38085	of	_	
169-986	38086-38099	resting-state	_	
169-987	38100-38110	functional	_	
169-988	38111-38114	MRI	_	
169-989	38115-38121	Global	_	
169-990	38122-38132	functional	_	
169-991	38133-38145	connectivity	_	
169-992	38146-38159	abnormalities	_	
169-993	38160-38162	in	_	
169-994	38163-38171	children	_	
169-995	38172-38176	with	_	
169-996	38177-38182	fetal	_	
169-997	38183-38190	alcohol	_	
169-998	38191-38199	spectrum	_	
169-999	38200-38209	disorders	_	
169-1000	38210-38219	Diffusion	_	
169-1001	38220-38226	tensor	_	
169-1002	38227-38234	imaging	_	
169-1003	38235-38237	in	_	
169-1004	38238-38246	children	_	
169-1005	38247-38251	with	_	
169-1006	38252-38257	fetal	_	
169-1007	38258-38265	alcohol	_	
169-1008	38266-38274	spectrum	_	
169-1009	38275-38284	disorders	_	
169-1010	38285-38295	Functional	_	
169-1011	38296-38308	connectivity	_	
169-1012	38309-38322	abnormalities	_	
169-1013	38323-38326	and	_	
169-1014	38327-38337	associated	_	
169-1015	38338-38347	cognitive	_	
169-1016	38348-38356	deficits	_	
169-1017	38357-38359	in	_	
169-1018	38360-38365	fetal	_	
169-1019	38366-38373	alcohol	_	
169-1020	38374-38382	spectrum	_	
169-1021	38383-38392	disorders	_	
169-1022	38393-38394	(	_	
169-1023	38394-38398	FASD	_	
169-1024	38398-38399	)	_	
169-1025	38400-38417	Inter-Hemispheric	_	
169-1026	38418-38428	functional	_	
169-1027	38429-38441	connectivity	_	
169-1028	38442-38452	disruption	_	
169-1029	38453-38455	in	_	
169-1030	38456-38464	children	_	
169-1031	38465-38469	with	_	
169-1032	38470-38478	prenatal	_	
169-1033	38479-38486	alcohol	_	
169-1034	38487-38495	exposure	_	
169-1035	38496-38500	What	_	
169-1036	38501-38505	does	_	
169-1037	38506-38515	diffusion	_	
169-1038	38516-38522	tensor	_	
169-1039	38523-38530	imaging	_	
169-1040	38531-38537	reveal	_	
169-1041	38538-38543	about	_	
169-1042	38544-38547	the	_	
169-1043	38548-38553	brain	_	
169-1044	38554-38557	and	_	
169-1045	38558-38567	cognition	_	
169-1046	38568-38570	in	_	
169-1047	38571-38576	fetal	_	
169-1048	38577-38584	alcohol	_	
169-1049	38585-38593	spectrum	_	
169-1050	38594-38603	disorders	_	
169-1051	38604-38619	Microstructural	_	
169-1052	38620-38626	corpus	_	
169-1053	38627-38635	callosum	_	
169-1054	38636-38645	anomalies	_	
169-1055	38646-38648	in	_	
169-1056	38649-38657	children	_	
169-1057	38658-38662	with	_	
169-1058	38663-38671	prenatal	_	
169-1059	38672-38679	alcohol	_	
169-1060	38680-38688	exposure	_	
169-1061	38688-38689	:	_	
169-1062	38690-38692	an	_	
169-1063	38693-38702	extension	_	
169-1064	38703-38705	of	_	
169-1065	38706-38714	previous	_	
169-1066	38715-38724	diffusion	_	
169-1067	38725-38731	tensor	_	
169-1068	38732-38739	imaging	_	
169-1069	38740-38748	findings	_	
169-1070	38749-38757	BrainNet	_	
169-1071	38758-38764	viewer	_	
169-1072	38764-38765	:	_	
169-1073	38766-38767	a	_	
169-1074	38768-38775	network	_	
169-1075	38776-38789	visualization	_	
169-1076	38790-38794	tool	_	
169-1077	38795-38798	for	_	
169-1078	38799-38804	human	_	
169-1079	38805-38810	brain	_	
169-1080	38811-38823	connectomics	_	
169-1081	38824-38835	Delineating	_	
169-1082	38836-38839	the	_	
169-1083	38840-38850	macroscale	_	
169-1084	38851-38856	areal	_	
169-1085	38857-38869	organization	_	
169-1086	38870-38872	of	_	
169-1087	38873-38876	the	_	
169-1088	38877-38884	macaque	_	
169-1089	38885-38891	cortex	_	
169-1090	38892-38894	in	_	
169-1091	38895-38899	vivo	_	
169-1092	38900-38903	Sex	_	
169-1093	38903-38904	-	_	
169-1094	38905-38908	and	_	
169-1095	38909-38914	brain	_	
169-1096	38915-38927	size-related	_	
169-1097	38928-38939	small-world	_	
169-1098	38940-38950	structural	_	
169-1099	38951-38959	cortical	_	
169-1100	38960-38968	networks	_	
169-1101	38969-38971	in	_	
169-1102	38972-38977	young	_	
169-1103	38978-38984	adults	_	
169-1104	38984-38985	:	_	
169-1105	38986-38987	a	_	
169-1106	38988-38991	DTI	_	
169-1107	38992-39004	tractography	_	
169-1108	39005-39010	study	_	
169-1109	39011-39019	Abnormal	_	
169-1110	39020-39028	cortical	_	
169-1111	39029-39038	thickness	_	
169-1112	39039-39050	alterations	_	
169-1113	39051-39053	in	_	
169-1114	39054-39059	fetal	_	
169-1115	39060-39067	alcohol	_	
169-1116	39068-39076	spectrum	_	
169-1117	39077-39086	disorders	_	
169-1118	39087-39090	and	_	
169-1119	39091-39096	their	_	
169-1120	39097-39110	relationships	_	
169-1121	39111-39115	with	_	
169-1122	39116-39122	facial	_	
169-1123	39123-39136	dysmorphology	_	
169-1124	39137-39150	Resting-state	_	
169-1125	39151-39161	functional	_	
169-1126	39162-39165	MRI	_	
169-1127	39166-39173	studies	_	
169-1128	39174-39176	on	_	
169-1129	39177-39183	infant	_	
169-1130	39184-39190	brains	_	
169-1131	39190-39191	:	_	
169-1132	39192-39193	a	_	
169-1133	39194-39200	decade	_	
169-1134	39201-39203	of	_	
169-1135	39204-39215	gap-filling	_	
169-1136	39216-39223	efforts	_	
169-1137	39224-39234	NeuroImage	_	
169-1138	39235-39240	graph	_	
169-1139	39241-39252	theoretical	_	
169-1140	39253-39261	modeling	_	
169-1141	39262-39264	of	_	
169-1142	39265-39269	baby	_	
169-1143	39270-39275	brain	_	
169-1144	39276-39284	networks	_	
169-1145	39285-39298	Developmental	_	
169-1146	39299-39307	cortical	_	
169-1147	39308-39316	thinning	_	
169-1148	39317-39319	in	_	
169-1149	39320-39325	fetal	_	
169-1150	39326-39333	alcohol	_	
169-1151	39334-39342	spectrum	_	
169-1152	39343-39352	disorders	_	
169-1153	39353-39362	Preserved	_	
169-1154	39363-39371	cortical	_	
169-1155	39372-39381	asymmetry	_	
169-1156	39382-39389	despite	_	
169-1157	39390-39397	thinner	_	
169-1158	39398-39404	cortex	_	
169-1159	39405-39407	in	_	
169-1160	39408-39416	children	_	
169-1161	39417-39420	and	_	
169-1162	39421-39432	adolescents	_	
169-1163	39433-39437	with	_	
169-1164	39438-39446	prenatal	_	
169-1165	39447-39454	alcohol	_	
169-1166	39455-39463	exposure	_	
169-1167	39464-39467	and	_	
169-1168	39468-39478	associated	_	
169-1169	39479-39489	conditions	_	
169-1170	39490-39495	Human	_	
169-1171	39496-39508	connectomics	_	
169-1172	39509-39515	across	_	
169-1173	39516-39519	the	_	
169-1174	39520-39524	life	_	
169-1175	39525-39529	span	_	
169-1176	39530-39543	Supplementary	_	
169-1177	39544-39553	materials	_	
169-1178	39554-39567	Supplementary	_	
169-1179	39568-39576	material	_	
169-1180	39577-39587	associated	_	
169-1181	39588-39592	with	_	
169-1182	39593-39597	this	_	
169-1183	39598-39605	article	_	
169-1184	39606-39609	can	_	
169-1185	39610-39612	be	_	
169-1186	39613-39618	found	_	
169-1187	39618-39619	,	_	
169-1188	39620-39622	in	_	
169-1189	39623-39626	the	_	
169-1190	39627-39633	online	_	
169-1191	39634-39641	version	_	
169-1192	39641-39642	,	_	
169-1193	39643-39645	at	_	
169-1194	39646-39649	doi	_	
169-1195	39649-39650	:	_	
169-1196	39650-39657	10.1016	_	
169-1197	39657-39658	/	_	
169-1198	39658-39664	j.nicl	_	
169-1199	39664-39676	.2019.102082	_	
169-1200	39676-39677	.	_	
